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Individuals with functional pain disorders such as irritable bowel syndrome, interstitial 
cystitis/painful bladder syndrome, migraine, and fibromyalgia often present with 
symptoms of or are diagnosed with more than one disorder. Furthermore, these patients 
with co-morbid pain disorders are also more likely to present with mood disorders, 
including depression and anxiety, as well as with obesity-related metabolic syndrome. 
Exposure to stress or adversity early in life increases the risk of developing co-morbid 
chronic pain, mood, and obesity-related metabolic syndrome in adulthood. This may be 
due to altered functioning of the hypothalamic-pituitary-adrenal (HPA) axis, which 
regulates the stress response, alters our perception of pain, and has downstream 
metabolic effects. The overall goals of this dissertation are to expand our studies on the 
many consequences of early life stress and investigate potential non-pharmacological 
treatment options for patients with these disorders including exercise and an anti-
inflammatory diet (AID). To do this, I use a mouse model of early life stress, neonatal 
maternal separation (NMS), which exhibits increased urogenital sensitivity as well as 
altered limbic regulation of the HPA axis. This dissertation investigates the susceptibility 
of female NMS and non-stressed (naïve) sedentary (Sed) and exercised (Ex) mice to 
evoked migraine like-behaviors and the susceptibility of male NMS- and naïve-Sed and 
–Ex mice to the development of high-fat/high-sucrose diet-induced obesity-related 
metabolic syndrome. I focus on migraine and obesity-related metabolic syndrome due 
to the high clinical incidence of these disorders in chronic urogenital pain patients. 
Finally, I evaluate the effect of AID on putative early life stress0induced co-morbid 
disorders in female and male mice.  
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This work provides insight into the significant influence that environmental factors 
such as early life stress, diet, and exercise have on the development of chronic 
disorders as well as the complex interactions of these factors. Additionally, this research 
reveals sex differences in stress, pain, and metabolic pathways. The incidence of most 
chronic disorders differs in females and males, which makes sex another important 
factor to consider when studying these health conditions and potential therapeutic 
treatments. These studies are novel because each combines multiple environmental 
factors in an attempt to mimic human lifestyle choices to study chronic pain disorders, 
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Chapter I: Introduction to dissertation 
 
Parts of this chapter were previously published as an open access article (CC-BY) and 
reprinted here with additional, never-before published text. Eller-Smith, OC, Nicol, AL, 
Christianson, JA. Potential Mechanisms Underlying Centralized Pain and Emerging 
Therapeutics Interventions. Frontiers in Cellular Neuroscience. eCollection 2018 (1). 
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1.1 Early life stress  
Stress is defined as an alteration in homeostasis that can be caused by a 
psychological, environmental, or physiological threat (2). It has long been known to 
affect the perception of pain, in both acute and chronic settings. Acute stress is crucial 
for the survival of an organism: individuals are alerted to dangerous and life-threatening 
situations and can subsequently respond to the perceived or anticipated stress. 
However, stress can become detrimental when experienced in the long-term, especially 
early in life such as when children experience maltreatment, neglect, physical or 
emotional abuse, and witnessing parental turmoil. Early life stress is associated with the 
development of co-morbid chronic pain (e.g. migraine, fibromyalgia, and chronic pelvic 
pain), mood, and metabolic disorders in adulthood (3-8). This has been attributed to 
improper functioning of the hypothalamic-pituitary-adrenal (HPA) axis, which regulates 
the stress response and plays a role in pain perception (9, 10). Unfortunately, the 
prevalence rate of childhood maltreatment is shockingly high and is increasing (11). In 
the U.S Department of Health and Human services annual Child Maltreatment report 
from 2016, 676,000 children were victims of maltreatment with 74.8% of these children 
suffering from neglect, 18.2% being physically abused, and 8.5% sexually abused. The 
age group that showed the greatest maltreatment rate per 1000 children were those 
under 1-year old (12). This finding is particularly distressing because the HPA axis is not 
fully developed when children are born and therefore stressful events at this stage of 
development can permanently affect both the regulation and output of the stress 
response system, including its downstream effects on nociceptive processing and 
metabolic regulation in the periphery (13, 14). 
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1.2 The Hypothalamic Pituitary Adrenal (HPA) Axis  
Under normal conditions (schematized in Figure 1.1), an acute stressor will signal 
the paraventricular nucleus (PVN) of the hypothalamus to release corticotropin-
releasing factor (CRF) and arginine vasopressin into the hypophyseal portal veins, 
which causes the anterior pituitary gland to release adrenocorticotrophic hormone 
(ACTH). Circulating ACTH signals the adrenal cortex to release glucocorticoids (GCs; 
cortisol in humans and corticosterone in rodents) that have downstream metabolic 
effects including glucose and fat metabolism, control of the cardiovascular system, and 
regulation of the immune response (15-17). A negative feedback loop is established to 
turn off activation of the HPA axis by suppressing the production of CRF and ACTH 
upon cessation of the initial stressor (18, 19).  
Regulation of the HPA axis is driven in part by receptors that bind CRF family 
members or GCs and are located at every level of the HPA axis as well as in regulatory 
limbic regions. Corticotropin-releasing factor receptor 1 (CRF1) and 2 (CRF2) work in 
opposition to one another to enhance and reduce HPA output, respectively (20). This 
has been demonstrated by studies that have deleted CRF1 or CRF2 and measured 
anxiety- like behaviors in rodents. Deletion of CRF1 results in a significant decrease in 
anxiety-like behaviors (21) while deleting CRF2 results in a significant increase in these 
behaviors (22). GC-mediated regulation occurs via two receptors, mineralocorticoid 
receptor (MR) and GC receptor (GR), which are slow acting and function both as 
transcriptional regulators (23) and through GC-mediated retrograde endocannabinoid 
release from parvocellular neurons, which suppresses the release of excitatory 






Figure 1.1 Under normal conditions, an acute stressor will signal the paraventricular 
nucleus of the hypothalamus to release corticotropin-releasing factor (CRF) into the 
hypophysial portal veins, which causes the anterior pituitary gland to release 
adrenocorticotrophic hormone (ACTH). Circulating ACTH signals the adrenal cortex to 
release GCs (GC) that have downstream metabolic effects. A negative feedback loop is 
established to turn off activation of the HPA axis by suppressing the production of CRF 
and ACTH upon cessation of the initial stressor. The hippocampus and the amygdala 
play inhibitory and excitatory roles in regulation of the HPA axis, respectively. CRF 
released upon HPA axis activation also has peripheral effects. Mast cells (MC) can 
become activated by CRF, causing the release of cytokines and growth factors that 
have reciprocal interactions with peripheral nociceptors. Nociceptor activation signals 
through the dorsal horn of the spinal cord, leading to activation of supraspinal 
somatosensory brain regions. The descending pain pathway also plays a role in the 
regulation of painful experiences. 
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hypothalamic release of CRF (24).  
Limbic structures including the hippocampus, amygdala, and prefrontal cortex, assist 
in resetting the HPA axis following a stressful event, as well as regulate its tone. Neural 
projections from the hippocampus and prefrontal cortex are mostly glutamatergic and 
synapse on GABAergic interneurons within the PVN, thereby dampening HPA axis 
activation (16, 25). Lesioning the hippocampus leads to increased stress-induced HPA 
axis activation as evidenced by increased CRF immunoreactivity in the PVN, GC 
hypersecretion, and behavioral evidence of heightened anxiety in rats (26). Disruption of 
GR expression in the forebrain of mice resulted in heightened stress-induced locomotor 
activity and acute stress exposure increased ACTH secretion, plasma corticosterone 
levels, and CRF expression in the PVN (27). The amygdala works to activate the HPA 
axis through disinhibition, sending GABAergic projections to the GABAergic neurons of 
the PVN (16, 25). Administration of corticosterone to the amygdala in rats resulted in an 
increase in anxiety-like behaviors as well as somatic and visceral hypersensitivity (28). 
These observations were likely caused by GR and/or MR signaling as it was shown that 
repeated exposure to water avoidance stress (WAS) induced an increase in plasma 
corticosterone and visceral hypersensitivity that was inhibited in rats that received a GR 
(mifepristone) or MR (spironolactone) antagonist applied to the amygdala (29). Further 
evidence that the amygdala plays a role in HPA axis regulation comes from a study 
where either direct application of corticosterone onto the amygdala or exposure to WAS 
increased CRF expression in the amygdala, which coincided with visceral and somatic 
hypersensitivity (30). These effects were attenuated after engineered reduction of CRF 
gene expression in the central amygdala. Taken together, these studies highlight the 
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importance of inhibition/activation coming from the limbic structures, which plays a 
significant role in regulating normal stress responses from the HPA axis and ultimately 
affects the perception of pain.  
1.3 Downstream effects of the HPA axis 
1.3.1 Pain signaling 
While activation of the HPA axis does not directly initiate pain signaling, downstream 
mediators can influence the neuroimmune status of peripheral tissues and increase 
nociceptive tone. In human tissue, CRF1 has been observed in adrenal tissue, adipose, 
gonads, endometrium, myometrium, placenta, skin, spleen, and various immune cells; 
whereas CRF2 has been found in skin and all three types of muscle tissue. 
Immunoreactivity for both CRF receptors has been observed in rat colon, primarily in 
the mucosal layer, inflammatory cells, and enteric innervation for CRF1 and on goblet 
cells and in submucosal blood vessels for CRF2 (31). CRF signaling influences both 
contractility (32) and transepithelial resistance (33) of the gastrointestinal tract. Feline 
urothelial cells express functionally-active CRF1 and CRF2, as well as their intrinsic 
ligands CRF and Ucn1 (34). The naturally-occurring feline interstitial cystitis model 
shows altered CRF signaling in the urothelium, indicating a potential role for CRF in the 
etiology of IC. 
Exposure to chronic stress causes a decrease in GR expression in the 
hippocampus, which reduces the normal descending inhibition onto the PVN and 
therefore increases CRF release and propagates GC production (15, 16). In the 
amygdala, the GCs released upon chronic stress exposure activate GR receptors, 
which increase CRF release in the PVN and also GC production (35).  
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Mast cells (MCs) are a critical part of the innate immune system and are highly 
responsive to activation of the HPA axis, as they express five isoforms of the CRF1 
receptor, a single isoform of the CRF2 receptor, and contain one of the largest 
peripheral stores of CRF (36). They are found in highly vascularized tissues, most 
predominantly in areas with direct contact to the environment: skin, airway, 
gastrointestinal and urinary tracts. Mast cells are increased in a number of chronic pain 
disorders including irritable bowel syndrome (37), interstitial cystitis (38), migraine (39), 
and fibromyalgia (40). They are derived from hematopoietic stem cells, circulate in the 
blood stream as immature cells, and mature upon entry into peripheral tissues (41, 42). 
Their differentiation depends on the presence of cytokines and growth factors. The c-kit 
tyrosine kinase receptor and its ligand stem cell factor (SCF) are important in the 
migration and distribution of MC precursors (43). MC are filled with granules that contain 
histamine, heparin, tryptase, as well as other proteases and cytokines (44). They are 
activated by immune and non-immune signals, including endogenous neuropeptides 
such as CRF and substance P (SP), and cause hypersensitivity reactions (45, 46). 
Although the hallmark form of MC activation is evidenced by the partial or complete 
release of granular stores, stress-activated release of cytokines and growth factors from 
MC can occur in the absence of degranulation (36, 46).  
MCs are observed adjacent to unmyelinated nerves throughout the body, 
including the skin (47), trachea (48), and intestine (49) as well as in direct contact with 
nerve fibers in the dura mater (50). These afferents express receptors involved in 
nociception, including transient receptor potential vanilloid 1 (TRPV1), transient receptor 
potential ankyrin 1 (TRPA1), and protease-activated receptor 2 (PAR2) (51-53). PAR2 
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is a G protein-coupled receptor activated by MC tryptase, trypsin, and coagulation 
protease FVIIa, and FXa (54). Activation of PAR2 initiates downstream sensitization of 
TRPV1 and TRPA1 through several mechanisms including phosphorylation by protein 
kinase C (PKC) (55) and protein kinase A (PKA) (56), and TRPV1 channel release from 
phosphatidylinositol 4,5-bisphosphate (PIP2)- dependent inhibition through 
phospholipase C (PLC) activation (57). All three receptors are expressed on neurons 
with cell bodies in the dorsal root ganglia (DRG), trigeminal ganglia (TG), and nodose 
ganglia (58-60) and on peripheral projections to the skin and deeper tissues, such as 
muscle and viscera (61, 62). Both TRPV1 and TRPA1 have been shown to be involved, 
if not required, for the generation of visceral hypersensitivity (63-66). Increased 
activation of these receptors enhances pain-related afferent input to the central nervous 
system; however, they also generate and maintain peripheral neurogenic inflammation 
by releasing neuropeptides, including SP and CGRP, which perpetuates inflammatory 
mediator release in the proximate milieu. Therefore, increased peripheral CRF release 
due to dysregulated HPA axis activity (schematized in Figure 1.2) could result in MC 
activation and, in turn, sensitization of nearby sensory nerve endings and lowered pain 
thresholds. 
1.3.2 Glucocorticoid influence on metabolism 
Excessive GC secretion affects almost every tissue in the body due to the 
ubiquitous expression of GC cytosolic receptors (67). After binding to their receptor, 
GCs dimerize and translocate to the nucleus and subsequently influence gene 
transcription (68). Therefore, increased GCs are associated with deleterious changes in 






Figure 1.2 Chronic early life or adult stress leads to alteration in limbic regulation of the 
HPA axis. This is due to increased corticotropin-releasing factor (CRF) expression and 
drive from the amygdala (1) and decreased GC receptor (GR) and brain-derived 
neurotrophic factor (BDNF) expression in hippocampus, which dampens inhibition (2). 
These changes ultimately lead to increased CRF release from the hypothalamus (3), 
increased and prolonged release of adrenocorticotrophic hormone (ACTH) after 
cessation of the stressor (4), and increased GC (GC) production (5) with decreased 
negative feedback at higher structures. Increased CRF release leads to greater mast 
cell (MC) activation and infiltration (6) leading to enhanced peripheral nociceptor 
interaction (7). Increased peripheral drive can lead to hyperalgesic priming (8) and/or 
wind-up (9), eventually increasing ascending pain signaling, while simultaneously 
decreasing descending inhibition (10).  
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resistance, glucose intolerance, dyslipidemia, hypertension, and immunosuppression. 
These symptoms are seen in humans with endogenous Cushing’s disease, which is 
associated with increased cortisol levels (69), and in individuals receiving treatment with 
exogenous steroids (70). Many of these symptoms are also associated with metabolic 
syndrome, discussed in more detail below. 
One tissue that plays a significant role in metabolism is adipose tissue. When 
there is excess energy, either due to abundant calorie intake, low physical activity, or a 
combination of the two, this energy is stored as triglycerides in adipose tissue. 
Alternatively, when there is an energy deficit such as during fasting or exercise, 
triglycerides are broken down and fatty acids and glycerol are released into circulation. 
If dysregulation of this usually balanced system occurs there can be either an excess or 
deficit in the storage of triglycerides. Stress hormones, including both GCs and 
catecholamines, are key regulators of this energy balance (71).  
Glucocorticoids have been shown to be both lipolytic and adipogenic by causing 
the mobilization of lipids or differentiation of pre-adipocytes to adipocytes in body fat, 
respectively. However, they appear to favor adipogenesis (72). GCs’ adipogenic effects 
work at the tissue level as well as at the whole body level. At the tissue level, adipose 
tissue can grow in size through two different mechanisms: hyperplasia, or an increase in 
the number of adipocytes, and hypertrophy, or an increase in the size of existing 
adipocytes. For example, cortisol and dexamethasone have been shown to cause the 
differentiation of pre-adipocytes into mature adipocytes in vitro, demonstrating 
hyperplasia (73), while human Cushing’s patients (74) and rodents given exogenous 
steroids (75) have hypertrophic adipocytes. Another way that GCs work at the tissue 
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levels is by increasing the activity of lipoprotein lipase, which is an enzyme that 
promotes the uptake and storage of fatty acids (76). At the whole-body level, GCs 
increase adipose tissue by increasing food intake, specifically of palatable higher calorie 
‘comfort foods’. This has been demonstrated in rats (77, 78) as well as in humans (79, 
80). In one study evaluating this phenomenon, women with higher stress-induced 
cortisol levels displayed a greater caloric intake, particularly from high-fat/high-sugar 
foods, after novel stress exposure compared to those with lower cortisol levels. This 
effect of greater food consumption was not observed on the control day when 
participants were not stressed (79). It is hypothesized that this occurs due to GCs 
influence on other molecules such as neuropeptide Y (NPY) and leptin. Cortisol 
increases NPY Y2 receptor in abdominal fat (81) and its activation by NPY increases 
food intake as well as fat storage. GCs also cause the release of leptin from adipocytes, 
a molecule that usually serves as a satiety signal to the hypothalamus (82). However, 
when there is a long-term increase in GC signaling, leptin resistance can occur whereby 
the efficacy of leptin is reduced (83). Therefore, HPA axis hyperactivity could be 
involved in the leptin resistance that is often seen in human obesity.  
There are more GC receptors found in visceral compared to subcutaneous 
adipose in both humans (84) and rodents. This could explain why individuals with 
increased GC levels show significant increases in visceral adiposity in relation to other 
fat depots. Furthermore, inactive GCs, cortisone in humans and 11-
dehydrocorticosterone in rodents, are converted to their active forms, cortisol and 
corticosterone, by the enzyme 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1), 
which is upregulated in the adipose tissue in obese individuals (85, 86). This increase in 
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11β-HSD1 can lead to a subsequent increase in active GCs and therefore increase 
GCs’ actions in adipose tissue.  This is supported by pre-clinical research carried out by 
Masuzaki et al. where they overexpressed 11β-HSD1 in the adipose tissue of a 
transgenic mouse model and found that these mice developed visceral obesity as well 
as elevated corticosterone levels in their adipose tissue (87). 
Taken together, these data demonstrate that the output of the HPA axis, CRF, 
ACTH, and GCs, can have many downstream pain-related and metabolic effects. 
Therefore, when regulation of the HPA axis is disturbed, such as when individuals 
experience early life stress, there are many negative consequences. We are interested 
in studying these consequences by utilizing a mouse model, neonatal maternal 
separation (NMS), which is described in the following section.  
1.4 Neonatal maternal separation 
Dysregulation of the HPA axis is an established outcome of neonatal maternal 
separation (NMS), a model of early life stress that has predominantly been performed in 
rats. This is evidenced by higher basal plasma corticosterone concentrations and 
increased CRF1 expression in the PVN of NMS rodents (88, 89), decreased action of 
the negative feedback loop leading to prolonged release of ACTH and GCs after a 
stressful event (90, 91), changes in anxiety-like behaviors (92), and increased colorectal 
sensitivity (93, 94). In line with these observations, Aisa et. al. 2008 found that NMS 
female rats are more susceptible to chronic stress in adulthood compared to normally 
reared female rats. Additionally, augmented early life experiences (maternal licking and 
grooming) were found to reduce excitatory input onto CRF expressing neurons in rats. 
This leads to reduced CRF mRNA and protein levels in the hypothalamus and an 
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attenuated behavioral response to stress (95).  
Our lab has adapted a NMS paradigm in mice to investigate the impact of early life 
stress on the molecular regulation of the HPA axis and downstream histological and 
behavioral outcomes. We found that hypothalamic mRNA levels of CRF, Unc2, and 
CRF1 trend toward an increase in NMS female mice while CRF2 levels are significantly 
decreased (96). In the hippocampus, female NMS mice have significantly decreased 
GR and MR mRNA levels and display a trend toward decreased CRF1 and CRF2  
mRNA levels. This suggests NMS alters the development and function of important 
regulators of the stress response. To investigate the consequences of HPA axis 
disfunction, we have measured mechanical hypersensitivity and MC activation in 
urogenital organs of NMS and naïve mice. We found that NMS significantly increases 
urinary bladder (97) and vaginal sensitivity (96) in females and urogenital sensitivity in 
males(98, 99). We also saw an increase in the percent of degranulated MCs in the 
female (97) and male (100) urinary bladder, the vagina (unpublished observation), and 
the prostate (98). These results are similar to symptoms seen in patients with chronic 
urogenital pain disorders.  
Due to the fact that individuals with urogenital pain disorders often suffer from other 
disorders co-morbidly (3-8), we are now interested in investigating if NMS mice display 
evidence of evoked migraine (Chapter 2) or obesity-related metabolic syndrome 
(Chapter 3). And if these consequences of early life stress can be attenuated by non-
pharmacological interventions such as exercise (Chapters 2 & 3) or an anti-
inflammatory diet (Chapter 4). The following sections give more detail about the effect 
that dysfunction of the HPA axis has on the development of centralized pain disorders 
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as well as obesity-related metabolic syndrome. Therapeutic interventions commonly 
used to treat these disorders are also discussed.  
1.5 Centralized Pain Disorders 
Altered functioning of the HPA axis has been observed in patients suffering from 
a number of centralized pain disorders (101). Approximately 20%–25% of patients with 
stress-related disorders have hypocortisolism, which has been postulated to come 
about as a compensatory response to a preceding period of hypercortisolism and 
excessive GC release (102). GC resistance, either through reduced availability of GCs 
or impaired function of GR, has also been proposed to contribute toward co-morbidity of 
inflammatory disorders, including centralized pain syndromes (103). A history of abuse 
or early life stress is linked to both HPA abnormalities and chronic pain syndromes; 
however, a clear and convincing connection between all three has yet to be fully 
established in a clinical setting. Conflicting studies have shown both hypercortisolism 
(104, 105) and hypocortisolism (9, 106) in adults that report a history of childhood abuse 
or stress. It is likely that the form of abuse and sex of the patient may influence the 
eventual effect on GC production and more work is needed to determine these genetic 
and environmental interactions. The potential role of the HPA axis in three major 
centralized pain disorders, chronic pelvic pain, fibromyalgia, and migraine, is discussed 
in more detail below. 
1.5.1 Chronic Pelvic Pain 
Alterations in HPA axis output have been reported for all chronic pelvic pain syndromes, 
although the impact, in terms of hyper- or hypocortisolism, largely depends on the type 
of syndrome. Patients with irritable bowel syndrome (IBS) have increased basal and 
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evoked cortisol release that, in some cases, is linked to early life adverse events (107, 
108). Treatment with CRF1 antagonist has shown mixed clinical results with no effect on 
stooling symptoms in diarrhea-predominant IBS patients (109), but a positive impact on 
significantly reducing the blood oxygen level-dependent signal in the hypothalamus in 
IBS patients (with average or high levels of anxiety) during the expectation of abdominal 
pain (110). Men with CP/CPPS have greater waking cortisol levels (111) and delayed 
ACTH release in response to an acute stressor, which correlates with significant 
psychological disturbances (112). Finally, women with vulvodynia have blunted serum 
cortisol cycles and reported higher symptoms of stress compared to healthy controls 
(113). Despite showing disparate cortisol levels, chronic pelvic pain syndromes all have 
evidence of increased activation downstream of the HPA axis in affected peripheral 
tissues. Biopsies from patients with IBS (114), CP/CPPS (44, 115), IC/PBS (116, 117), 
and vulvodynia (118) all revealed increased MC infiltration and altered granular 
structure including a reduced proportion of intact MC. Serum (119) and urine (120) 
samples from IC/PBS patients also had elevated MC granule components, including 
nerve growth factor (NGF), histamine, and pro-inflammatory cytokines, indicating an 
increase in MC activation. Tissue biopsies from IC/PBS patients revealed increased MC 
infiltration in close proximity to densely-populated SP-immunopositive nerve fibers 
(121). Expressed prostatic secretions from CP/CPPS patients had elevated MC tryptase 
and NGF levels (122) and urine samples also had increased tryptase, as well as 
carboxypeptidase A3, a marker of MC activation (123). In line with these observations in 
humans, MC activation, histamine release, NGF expression, and associated pelvic 
organ hypersensitivity have all been shown to be increased by stress exposure in adult 
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male rats (124). We demonstrated that NMS increased vaginal (96), bladder (97), and 
referred prostatic (100, 125) sensitivity in mice, which corresponded to an increased 
percentage of degranulated MC in urogenital tissues, compared to naïve mice. 
Exposure to WAS further increased MC degranulation in the bladder of NMS and naïve 
female mice (97) and the prostate of NMS and naïve male mice (125). The limited 
nesting material method was also employed for assessing visceral sensitivity. Adult 
male rats that were exposed to limited nesting material as neonates exhibited increased 
colonic sensitivity and anxiety behaviors, which were not present in female littermates 
(126). The finding is particularly intriguing considering the larger number of female 
chronic pelvic pain patients, as well as the preponderance of preclinical research that 
has been done in male rodents. Both restraint stress and central administration of CRF 
caused MC degranulation in the colon in rats (127). The role of MC activation in stress 
induced pain is further illustrated by studies using MC stabilizers. When injected 30-
minutes before restraint stress, the MC stabilizer doxantrazole attenuated the stress-
induced increase in abdominal contractions during CRD (128). Pre-treatment with a 
non-specific CRF antagonist, a-helical-CRF, also prevented stress-induced visceral 
hypersensitivity in NMS rats following WAS, in a MC-dependent manner (129). 
Treatment with a MC stabilizer, but not a-helical-CRF, was also capable of reversing 
WAS-induced visceral hypersensitivity, suggesting that non-CRF dependent factors are 
involved in the maintenance of post-stress hypersensitivity. In a study of a transgenic 
autoimmune cystitis mouse model of IC/PBS that displays bladder inflammation, 
increased number of MC, and urinary tract dysfunction, treatment with the MC stabilizer 
cromolyn reversed these symptoms (130). Furthermore, crossing this transgenic model 
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with MC-deficient mice produced mice with reduced bladder inflammation and no 
urinary tract dysfunction. However, both of these symptoms were re-established upon 
MC reconstitution.  
1.5.2 Fibromyalgia 
Hypocortisolism has overwhelmingly been reported in fibromyalgia patients. A meta-
analysis and meta-regression of 85 case-control comparisons reported on HPA axis 
involvement in functional somatic disorders, including CFS, fibromyalgia, and IBS, and 
showed a significant reduction in basal cortisol in all CFS and female fibromyalgia 
patients compared to healthy controls (131). When compared to patients with shoulder 
and neck pain or healthy controls, fibromyalgia patients had significantly lower waking 
cortisol levels (132). Strikingly, the patients with shoulder and neck pain had waking 
cortisol levels higher than either control or fibromyalgia patients and the authors suggest 
that this group may represent an intermediate step in the progression from regional to 
widespread musculoskeletal pain similar to the proposed mechanism of 
hypercortisolism leading to hypocortisolism described by Fries et al. (2005) (102). A 
recent study compared basal and stress-evoked salivary cortisol levels between 
fibromyalgia and control patients with and without a history of early childhood abuse 
(133). They reported a decrease in stress-evoked cortisol release in fibromyalgia 
patients that was largely driven by increased cortisol release in control patients with a 
history of early childhood abuse. This observation again underscores the disparate 
effects of childhood experiences on later output of the HPA axis and its involvement in 
pain processing. Rodent models of adult stress are commonly used to induce behaviors 
and molecular changes similar to what is observed in fibromyalgia patients. These 
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models include intermittent cold stress (134), unpredictable sound stress (135), WAS 
(136), and restraint stress (137) and induce long-lasting widespread mechanical 
allodynia and hyperalgesia. An early life stress model of fibromyalgia that incorporates 
limited nesting material during the pre-weaning period produces adult rats that display 
mild muscle hyperalgesia that worsens following sound stress (138). We have reported 
hind paw mechanical hypersensitivity in both male (139) and female (96) mice that also 
demonstrate urogenital hypersensitivity (discussed above) following neonatal maternal 
separation (NMS). Interestingly, we observed evidence of decreased HPA axis output in 
male (125) and increased HPA axis output in female (97) NMS mice, suggesting that 
regardless the effect of early life stress on GC production, widespread allodynia is a 
common final pathway of HPA axis dysregulation in this model. The most commonly 
employed rodent models of fibromyalgia involve direct activation of the peripheral 
nervous system via intramuscular injection of carrageenan (140) or acidic saline (141). 
Carrageenan is a chemical nociceptive stimulus that evokes inflammation and excites 
muscle nociceptors (142). When injected intramuscularly, grip strength is reduced in the 
ipsilateral limb (140). Repeated intramuscular injection of low pH saline causes 
ipsilateral and contralateral mechanical hyperalgesia lasting 4-weeks after the second 
injection (141), likely via activation of acid-sensing ion channels (ASIC) present on 
primary afferent fibers (143). The use of these stress- or nociceptor-induced models can 
be used to tease out the various ‘‘bottom-up’’ and ‘‘top-down’’ mechanisms that likely 





Stress is a commonly-reported trigger for migraine attack (145, 146) and while evidence 
of altered cortisol release, compared to other centralized pain syndromes, is less 
prevalent among migraine patients, many migraineurs have shown abnormal HPA axis 
activity (147-149). A recent literature review of seven cross-sectional studies largely 
showed no baseline differences in cortisol level between migraineurs and healthy 
controls (150). A potential for increased HPA axis responsiveness was noted, as 
nitroglycerin- and CRF-evoked cortisol levels were reportedly higher in migraineurs, 
compared to healthy controls, across four observational studies. Another study looking 
at blood cortisol levels over a 12-hour period revealed a greater total cortisol release 
and peak in migraineurs compared to control patients (147). One prospective study of 
17 migraine patients reported on stress related parameters prior to and during a 
migraine attack (151). While a subgroup of patients did report an increase in perceived 
stress, which also reportedly triggered their migraine attacks, no objective measures of 
increased cortisol or other measures of a biological stress response were present either 
prior to or during a migraine attack. The mouse model of Familial Hemiplegic Migraine 
type 1 (FHM1), which was generated by knocking-in an R192Q missense Cav2.1 Ca2C 
channel mutation, displayed an increase in cortical spreading depression following 
treatment with corticosterone, which was blocked by pretreatment with a GR antagonist 
(152). The same FHM1 mice did not show increased cortical spreading depression 
following an acute stress. The authors explained this discrepancy as a direct effect of 
corticosterone on glutamatergic neurotransmission, via a GR-mediated mechanism, that 
is otherwise counteracted during bouts of acute stress. This observation suggests that 
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future studies on the effect of stress and the HPA axis on migraine should take into 
account the type of stressor and etiology of the patient, as migraineurs represent a 
heterogeneous population of patients. It has been known for several decades that 
patients with migraine have increased plasma histamine levels, an indicator of MC 
activation, both during migraine attack and at rest, when compared to healthy controls 
(153). MC reside in the dura and have been hypothesized to release their pro-
inflammatory contents following activation by neuropeptides released from nearby 
sensory nerve endings, thereby generating neurogenic inflammation (154). A recent 
study revealed that cultured human MCs do not express receptors for either calcitonin 
gene-related peptide (CGRP) or pituitary adenylate cyclase-activating polypeptide 
(PACAP), the two neuropeptides most commonly associated with migraine, but rather 
express and release PACAP upon activation (155). Animal models of migraine have 
investigated the role of MCs more thoroughly and shown that application of MC 
mediators can sensitize dural afferents and evoke migraine-like behaviors (156). 
Restraint stress has also been shown to induce dural MC degranulation and increase 
protease I levels in the cerebrospinal fluid (157). These outcomes could be attenuated 
by pretreatment with antisera to CRF or neonatal treatment with capsaicin to deplete 
peptidergic innervation, further supporting the role of neuropeptide release in MC 
activation and the generation of migraine. 
1.6 Obesity related metabolic syndrome  
The development of obesity involves a complex interaction of both genetic and 
environmental factors (158). One environmental factor found to be significantly 
associated with the development of obesity is stress (6) and dysregulation of the HPA 
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axis is often seen in obese individuals (159). Childhood neglect and maltreatment have 
both been shown to be associated with the development of obesity in adulthood (160-
162). Furthermore, research utilizing early life stress paradigms in non-human primates 
(163)  and rodents (164) also show this same effect. Obesity is generally considered a 
pre-requisite in the development of metabolic syndrome (165). However, there is a 
subset of individuals that are metabolically obese but normal weight (166). Metabolic 
syndrome is diagnosed when an individual suffers from 3 of the following 5 criteria: 
central obesity, insulin resistance, hypertension, high triglycerides, and low HDL-
cholesterol (167). 
Adipose tissue distribution and composition is important in predicting the 
development of obesity-related diseases because it plays a key role in regulating 
systemic metabolic function and inflammation (168). Visceral fat accumulation is 
associated with a greater risk of metabolic dysfunction (169) and leads to chronic low-
grade inflammation (170). This low-grade inflammation is associated with increased 
macrophage infiltration (171) and has been demonstrated in both obese mice and 
humans (172). MCs were also increased in visceral adipose tissue of obese humans 
compared to non-obese (173, 174). Furthermore, Liu et. al (2009) investigated the role 
of MCs in diet-induced obesity. They found that when fed a Western diet for 12-weeks, 
MC-deficient mice gained significantly less body weight and had less body fat than wild-
type controls. Additionally, wild type mice treated with a MC stabilizer, also gained less 
weight and body fat compared to controls. Interestingly, when control mice originally fed 
a western diet were switched to a control diet and treated with a MC stabilizer, they had 
improved glucose tolerance and body weight compared to groups only switched to 
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control diet (175). These data suggest that MC have a role in the development of 
obesity.  
1.7 Therapeutic interventions 
Non-pharmacological therapeutic intervention is a growing area of research for 
treating chronic pain and metabolic disorders. These therapies include exercise, 
cognitive behavioral therapy (CBT), trigger point injection, physical therapy, 
neuromodulation (176, 177), and diet alterations (178-181). The advantage of these 
therapeutic interventions is that they generally result in symptom improvement without 
the harmful side effects commonly associated with pharmacological treatments. Another 
benefit is that these forms of intervention can be used singly or in combination with each 
other. This allows treatment plans to be personalized on a case-by-case basis 
depending on what results in the greatest improvement for a particular patient. Evidence 
of these interventions for the treatment of centralized pain syndromes and obesity 
related-metabolic syndrome are listed in Table 1.1.  
1.7.1 Cognitive Behavioral therapy (CBT) 
One form of non-pharmacological therapy is CBT, which consists of educating 
patients about their pain, techniques on how to cope with their pain, such as relaxation 
training, and how to implement these cognitive coping techniques in real-life situations 
(182). Although this technique cannot be used in rodents, it is particularly useful in 
stress-induced pain syndromes in humans as the premise behind CBT is to reduce 
stress and emotional responses and thereby subsequently reduce symptom severity or 
frequency. The use of CBT for improving symptoms of depression and anxiety has been  
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Table 1.1 Evidence of non-pharmacological therapies for the treatment of centralized 
pain symptoms and associated co-morbidites 
Therapeutic 
treatment 










Depression scores; anxiety scores; mood (183) 
Irritable bowel 
syndrome 
Irritable bowel specific quality of life, GI 
symptoms (constipation, diarrhea, pain) 





Pain scores; quality of life (186-188) 
Migraine Headache frequency, headache intensity, 
number of headache days, disability, quality 
of life, depression, anxiety 
(189-192) 
Fibromyalgia Fibromyalgia Impact Questionnaire score, 6-
minute walk test, self-efficacy, grip strength, 
pain severity, social functioning, quality of 
life, psychological distress, brain response 




Percent body fat, abdominal visceral fat, 
fasting insulin, insulin sensitivity, metabolic 














Pelvic pain, widespread pain, dyschezia, 
dyspareunia, quality of life, disability, 
depression, anxiety 
(205, 206) 
Migraine Headache frequency, headache duration, 






Fibromyalgia Impact Questionnaire score, 6-
minute walk test, self-efficacy, quality of life, 
social functioning, psychological distress, 
McGill ratings of pain, physical functioning  
(195, 197, 208) 
Metabolic 
syndrome 
Adherence to a Mediterranean diet, waist 








Weight, lipid and glucose parameters, 





Frequency of headache, quality of life (179)  
Inflammatory 
joint pain 
Patient and physician assessed pain, 
number of painful joints, duration of morning 








well-established (202-204). In a study evaluating CBT as a form of fibromyalgia 
treatment, a greater percentage of patients displayed improvement in physical 
functioning after CBT compared to patients that received standard care in the form of 
pharmacological management of symptoms (208). Although CBT is most commonly 
used in treating symptoms in fibromyalgia patients, it has also been used effectively to 
treat chronic pelvic pain symptoms. In a study of women with endometriosis-associated 
pelvic pain, CBT was implemented in addition to somatosensory stimulation in the form 
of acupuncture and this combination of treatments resulted in a decrease in pelvic pain 
and an increase in quality of life (206). Additionally, a recent review categorized studies 
that used Internet-delivered CBT into headache and non-headache chronic pain 
conditions. They found that pain, disability, depression, and anxiety were reduced in 
non-headache chronic pain conditions and there was insufficient evidence to make 
conclusions in headache conditions due to having only two studies to analyze (205). 
However, another review focused on CBT in headache disorders found that CBT 
reduced headache activity 30%–60% on average across studies but notes that there 
are a fair number of patients who were non-responders (40%–70%; (207)). It is 
hypothesized that the positive effects of CBT seen in the treatment of chronic pain are 
due to structural changes in the gray matter in regions of the brain associated with pain 
management and/or in the functional connectivity of these regions (Figure 1.3). CBT 
induced changes in gray matter volume have been observed when implemented to treat 
patients with chronic pain disorders (212), CFS (213), and posttraumatic stress disorder 
(214). One study found that 11-weeks of CBT in a mixed group of chronic pain patients 






Figure 1.3 Non-pharmaceutical interventions restore proper signaling within the 
hypothalamic-pituitary-adrenal (HPA) axis and between higher structures. Exercise 
increases dendritic complexity and brain-derived neurotrophic factor (BDNF) expression 
in the hippocampus, which restores negative input onto the hypothalamus to restore 
proper HPA axis output (1). Decreased CRF release stabilizes mast cell (MC) activation 
and infiltration associated with chronic pain disorders (2), thereby reducing peripheral 
nociceptive input. Exercise influences the descending pain pathway, likely through 
release of endogenous opioids, increasing neuronal activity, and balancing excitatory 
and inhibitory transmission (3). Cognitive behavioral therapy (CBT) alters the intrinsic 
functional connectivity (iFC) between brain regions associated with pain management, 
including connections between the prefrontal cortex (PFC) and amygdala and 
somatosensory cortex and the basal ganglia network (BGN) (4). Cortical and 
hippocampal gray matter densities are also increased in patients following CBT (5). 
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areas as measured using voxel-based morphometry (212). The majority of the CBT 
induced changes were increases in gray matter, however one region, the 
supplementary motor area (SMA), showed a significant gray matter decrease after CBT. 
The patients in this study showed significant improvements in pain measurements as 
well as region specific positive and negative correlations in gray matter changes and 
pain catastrophizing. Changes in intrinsic functional connectivity (iFC) are also seen in 
areas of the brains of chronic pain patients. Baliki et al. found that functional 
connectivity patterns between the medial prefrontal cortex and nucleus accumbens 
could predict whether a patient with sub-acute back pain would recover or develop 
persistent pain (215). They also describe iFC differences in other brain regions including 
the insula and basal ganglia in these patients (215). In a study investigating the effect of 
CBT on iFC, 11-weeks of CBT in patients with various types of chronic musculoskeletal 
pain led to significant pre-post changes in iFC. Specifically, they found a decrease in 
iFC between the medial prefrontal cortex and amygdala and PAG and an increase in 
iFC between the basal ganglia network (BGN) and the right secondary somatosensory 
cortex. These changes were correlated with significant improvements in clinical 
measures of pain. CBT patients that showed the greatest improvement in self-efficacy 
and pain symptoms exhibited the greatest pre-post change in iFC. These results were 
not seen in an active control group who received educational materials that did not 
include CBT (216). 
Cognitive behavioral therapy is used most commonly in obesity caused by binge-
eating-disorder (BED) (217). CBT has been shown to reduce BED, however it does not 
usually produce actual weight loss (218). Behavioral weight loss strategies, such as 
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changes in physical activity and diet, are typically necessary to produce physiological 
changes (219). One study measured the efficacy of using CBT to assist with adherence 
to a Mediterranean Diet in patients with metabolic syndrome. They found significant 
improvements in waist circumference and triglyceride levels compared to the control 
group (209). Therefore, combining CBT with behavioral changes could prove to be the 
most effective in treating obesity related-disorders and maintaining weight loss. 
1.7.2 Exercise 
Another form of non-pharmacological intervention is exercise. Exercise is defined 
as physical activities that are planned, structured, repetitive, and centered on an 
improvement in physical health (220). In humans, exercise therapy can take the form of 
a wide range of activities such as walking, aerobic strength training, yoga, Pilates, or 
swimming. This variety is important so that a patient can find an activity that they enjoy 
and therefore are more likely to view exercise as a long-term lifestyle change rather 
than a quick-fix treatment. Exercise has been shown to relieve stress and reduce 
depression and anxiety (183) and has successfully been implemented in the treatment 
of chronic pain disorders including chronic pelvic pain (184), migraine (189), and 
fibromyalgia (198) as well as in the treatment of symptoms associated with metabolic 
syndrome (221). In a 12-week exercise intervention in patients with IBS, exercise led to 
improvements in the IBS Severity Scoring System score, which includes measurements 
in pain severity and pain frequency, and IBS-quality of life score, which measures 
qualities related to emotional functioning compared to patients that received usual care 
for IBS (185). Similarly, in a cohort of women with chronic pelvic pain, an 8-week yoga 
intervention resulted in improvement in pain and quality of life scores compared to the 
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control group that was treated with non-steroidal anti-inflammatory drugs (NSAID) (187). 
The frequency, intensity, and duration of migraine pain was significantly reduced when 
12-weeks of outdoor walking was added to the treatment regime of migraine patients 
taking amitriptyline (192) and Nordic walking (walking with poles) for 15-weeks resulted 
in improvements in the Fibromyalgia Impact Questionnaire score compared to control 
fibromyalgia patients (196). A study evaluating the effect of exercise on body 
composition in adult females with metabolic syndrome found that high-intensity exercise 
training reduced abdominal and subcutaneous fat compared to sedentary or low-
intensity exercise groups (199). Another study found that moderate-intensity exercise 
was able to improve insulin resistance and hyperinsulinemia in obese individuals (200). 
Not only has exercise been used as a therapeutic intervention for chronic pain 
and obesity-related metabolic disorders, being more physically active has also been 
shown to reduce the chance of developing these disorders while a sedentary lifestyle is 
associated with a greater risk of developing these disorders. Specifically, higher levels 
of both moderate- and high-intensity physical activity were associated with a lower risk 
of developing CP/CPPS in older men (188) and endometriosis in young adult women 
(186). Additionally, a prospective cross-sectional study found an association between 
low levels of physical activity and an increase in prevalence of migraine and non-
migraine headache (222). Furthermore, a study investigating glucose tolerance and 
insulin sensitivity in young and old lifelong athletes and untrained men demonstrated 
that the older lifelong athletes were protected from worsening glucose tolerance and 
insulin insensitivity that is often associated with ageing (223). Finally, it has been shown 
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that physically active individuals are 30-50% less likely to develop non-insulin 
dependent diabetes mellitus compared to sedentary individuals (224).  
In rodents, exercise has been shown to have positive effects on 
neurodevelopment (225), increase neuronal survival and resistance to brain insult (226), 
and stimulate brain vascularization (227). In a rodent model of high-fat diet induced 
metabolic syndrome, exercise improved visceral obesity, hyperglycemia, dyslipidemia, 
and hypertension (228). Furthermore, exercise in rodents has been shown to be 
beneficial in the prevention of development of symptoms similar to those seen in chronic 
pain disorders. Previous research from our lab has demonstrated this for chronic pelvic 
pain symptoms (100, 229). Exercise has also been shown to prevent the development 
of autonomic dysfunction and paw and muscle allodynia in a mouse model of 
fibromyalgia (230). Exercise protocols in rodents can take the form of resistance training 
or aerobic exercise such as wheel running, treadmill running, and swimming. Forced 
treadmill running in rodents could be considered a stressor due to the fact that it 
generally involves the use of an aversive stimulus, such as probing or foot shock, to 
provoke the rodent to continue running. In contrast, voluntary wheel running is 
considered rewarding, as most rodents will choose to run when provided a running 
wheel (231) and therefore this form of exercise is generally not viewed as a stressor. In 
support of this, corticosterone levels and anxiety behaviors have been shown to be 
elevated after forced treadmill running compared to sedentary controls, but these effects 
were not seen in rodents following voluntary wheel running (232-234). Furthermore, 
voluntary exercise induced higher hippocampal brain-derived neurotrophic factor 
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(BDNF) concentration compared to rats subjected to forced exercise or sedentary 
controls (233).  
A potential explanation for the beneficial effects of exercise is that it influences 
gene expression and structural complexity in the limbic structures that regulate the HPA 
axis (Figure 1.3). Specifically, running wheel access has been shown to normalize 
hippocampal GR and BDNF mRNA levels in NMS rats (235), and increase 
neurogenesis and dendritic spine density in the hippocampus of adult rats (236). Other 
groups have also evaluated the effects of exercise on stress-induced changes in 
rodents. It was shown that chronic unpredictable stress induced a depressive 
phenotype in rats, decreased hippocampal BDNF and GR mRNA levels, and increased 
circulating corticosterone, while 4-weeks of voluntary wheel running attenuated these 
effects (237). Similarly, 3-weeks of voluntary wheel running before exposure to 
immobilization stress was able to prevent the decrease in BDNF protein levels caused 
by the stressor (238). These findings are relevant to the study of treatment of chronic 
pain as well as obesity-related metabolic syndrome because of the association of stress 
causing or exacerbating symptoms of these disorders as described above. 
 Another hypothesis for the mechanism underlying the positive influence of 
exercise on pain specifically is through improved conditioned pain modulation (CPM), 
formerly referred to as diffuse noxious inhibitory control (DNIC). CPM is a ‘‘pain inhibits 
pain’’ mechanism and represents a measure of the function of descending analgesic 
pathways. This system has been shown to be defective in chronic pain patients (239) 
and these deficits in pain inhibitory pathways are involved in the development of central 
sensitization (240). The relationship between exercise and improved CPM was 
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demonstrated in a study evaluating the ability of self-reported physical activity to predict 
thermal sensitivity as well as pain facilitatory and inhibitory function, tested by temporal 
summation (TS; perceived increase in pain intensity to repeated stimulation at a 
constant stimulus intensity, reflecting central sensitization) and CPM respectively. 
Results indicated that individuals reporting greater total physical activity showed 
reduced TS of pain and greater CPM (241). 
 There are different mechanisms that could explain the beneficial influence of 
exercise on CPM including causing an increase in endogenous opioids, stimulating 
brain structures involved in descending analgesic pathways, and/or maintaining the 
balance between excitatory (glutamate) and inhibitory (GABA) neurotransmitters in the 
CNS (241). Exercise increases endogenous opioids in the CNS (242) and the effects of 
this increase are often compared to effects following administration of the opioid 
receptor antagonist naloxone. One study assessing changes in pain threshold after 
swimming found that there was a significant increase in hind limb hot plate withdrawal 
threshold in exercised mice that received saline injection before exercise but no 
increase in pain threshold in exercised mice that received naloxone (243). Similar 
results were seen in humans when saline or naloxone was administered to long-
distance runners after a run. Long-distance running produced thermal and ischemic 
hypoalgesia and mood elevation, but most of these effects were attenuated after 
administration of naloxone (244). Further evidence of the influence of exercise on CPM 
comes from studies evaluating brain activity in areas involved in descending pain 
modulation pathways. Ellingson et al. (194) examined brain activity during 
administration of painful heat stimuli following moderate intensity cycling exercise or 
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quiet rest in fibromyalgia patients. They found that exercise, but not quiet rest, prior to 
heat stimulation, elicited increased activity in brain regions involved in the anterior insula 
and dorsolateral prefrontal cortex, as well as lower pain ratings. A final potential 
mechanism regarding the beneficial role of exercise on CPM is that exercise can 
influence the balance of excitatory and inhibitory transmission in pain pathways. Four 
weeks of voluntary wheel running in rats resulted in significant changes in the forebrain 
GABAergic system compared to sedentary control rats (245). All of the previously 
described results suggest that exercise significantly alters structures and signals 
involved in CPM and these alterations could begin to explain why exercise has been 
shown to reduce pain symptoms in many chronic pain disorders. 
 Regarding the positive influence of exercise on obesity-related metabolic 
syndrome, there are many mechanisms involved and considerable research is still 
necessary to understand them all. However, it is known that during exercise, the body 
works through many systems to maintain energy homeostasis. For example, the liver 
increases glucose output through gluconeogenesis and adipose tissue increases 
lipolysis and free fatty acid (FFA) mobilization, while skeletal muscle increases glucose 
and FFA uptake (246). Whether carbohydrates or lipids are preferentially metabolized 
depends on many different factors including the intensity of the exercise, diet, sex, and 
prior training conditions (247). Exercise also increases resting metabolic rate (RMR), 
which is the metabolic cost of maintaining all body systems at rest. RMR can stay 
elevated for several hours after the end of high-intensity exercise (248). Furthermore, 
exercise, unlike dietary interventions alone, preserves lean body mass (249), which is 
important because the largest component of overall energy expenditure is fat free mass 
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(FFM) (250). Utilization of energy stores by skeletal muscle and increasing overall 
energy expenditure is important in creating an energy deficit that can eventually lead to 
weight loss, especially when paired with a healthy diet.  
Because obesity is generally considered the first step in developing obesity-
related metabolic syndrome, loss of visceral adipose tissue can lead to improvement in 
the other symptoms of metabolic syndrome including increased insulin sensitivity, 
improved glucose tolerance (251), and reduced inflammation. Exercise reduces 
inflammation by reducing the accumulation of visceral fat and its associated pro-
inflammatory macrophage population (252), as well as through the release of anti-
inflammatory cytokines and/or “myokines”, which are cytokines and peptides produced 
by muscle tissue (253). These myokines can directly influence adipose tissue 
metabolism as well as exert their own anti-inflammatory effects. The first myokine 
released during exercise is IL-6 followed by the anti-inflammatory myokines IL-1ra and 
IL-10. Another way exercise creates an anti-inflammatory environment is by inhibiting 
the production of the pro-inflammatory cytokine TNFα (254). Creating an anti-
inflammatory environment is important because many metabolic and chronic pain 
disorders are associated with a chronic state of low-grade inflammation (255, 256).   
It is important to note that the length of exercise protocol, as well as intensity of 
exercise, have been shown to have differential outcomes. In regards to duration of 
exercise intervention in rodents, both short- and long-term periods of voluntary wheel 
running increased cell proliferation in the rat hippocampus, but a longer-term exercise 
protocol was required to increase neurogenesis (14- days) and LTP (56- days; (257)). In 
a study comparing the effects of low-intensity running, high-intensity running, or 
 37 
sedentary conditions in rats, it was found that low-intensity running increased BDNF 
levels and dendritic complexity and branching in the hippocampus while not significantly 
affecting corticosterone levels. In contrast, high-intensity exercise did not increase 
hippocampal BDNF levels or induce structural hippocampal changes but did cause a 
significant increase in corticosterone. This suggests that the high-intensity exercise 
elicited a stressful response and therefore did not have the beneficial effects that the 
low-intensity exercise did (258). These preclinical results are similar to what is seen in 
humans, where there appears to be a narrow ‘‘therapeutic window’’ for the use of 
exercise in chronic pain treatment. For example, the majority of studies evaluating the 
efficacy of exercise for fibromyalgia treatment have found that low or moderate levels of 
aerobic training reduces tender point pain compared to before training or a control 
group. However, more strenuous exercise regimes often result in an increase in 
fibromyalgia pain (101). Additionally, it has been shown that the greatest improvement 
in fibromyalgia patients is seen after long-term (12-weeks) moderate intensity aerobic 
training (193). There is evidence that exercise can be a trigger or increase pain during 
migraine attacks (191). However, it is suggested that exercise treatment for migraine be 
implemented with a slow increase in intensity and duration to allow the patient to 
habituate to exercise and eventually see benefits (190). Therefore, in the instances 
where exercise has been found to have detrimental effects on chronic pain symptoms, it 
is likely due to improper application of exercise treatment. This highlights the 
importance of tailoring exercise regimes specifically to individual patients to achieve the 
most benefit and avoid exacerbation of pain symptoms due to overly intense exercise 
prescription. 
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The benefits of exercise on metabolic syndrome, (increased RMR, improvements 
in insulin sensitivity and glucose tolerance) will return to baseline after a few days of 
sedentary behavior (259, 260). This finding highlights the importance of making 
exercise a lifestyle change rather than an occasional activity. The American College of 
Sports Medicine (ACSM), recommends that most adults “engage in moderate-intensity 
cardiorespiratory exercise training 30min/day for 5- days a week, vigorous-intensity 
cardiorespiratory exercise training for 20min/day for 3-days a week, or a combination of 
moderate and vigorous-intensity exercise to achieve a total energy expenditure of 500-
1000 MET min/week.” MET is an index of energy expenditure and is a ratio of the rate 
of energy expended during activity to the rate of energy expended at rest. They also 
recommend incorporating resistance training and flexibility exercises into an exercise 
routine. The interaction between frequency, intensity, and duration of exercise is 
important in reaching the appropriate ‘overload stimulus’ that will allow an individual to 
see an effect. Although a lower stimulus is correlated with a lower training effect, health 
benefits from exercise can be achieved even at this lower stimulus (261). This is 
important because many individuals with metabolic syndrome are not able to complete 
the recommendations for activity described above. However, if an exercise plan is 
appropriately developed to match an individual’s abilities, they will still see results and 
eventually be able to increase their activity over time. 
Regarding which type of exercise therapy is the most efficient for the treatment of 
metabolic syndrome specifically, multiple studies have been published as part of the 
Studies Targeting Risk Reduction Interventions Through Defined Exercise-Aerobic 
Training and/or Resistance Training (STRRIDE/AT/RT). These studies compare various 
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metabolic syndrome diagnostic criteria between 3 treatment groups: aerobic training, 
resistance training, or a combination of aerobic and resistance training (an exact 
combination of both). These studies have found that aerobic training and aerobic 
training + resistance training showed greater improvement of metabolic syndrome score 
than resistance training alone (262). Improvements were seen in reduced visceral, 
subcutaneous, and liver fat, as well as in fasting insulin levels (263). These data 
suggest that consistent aerobic training might be the most efficient way to treat 
metabolic syndrome. However, as recommended by the ACSM, a variety of types of 
exercise is important for overall health (261).  
 The previously described benefits of exercise should not be too surprising. 
Humans evolved during a time when energy dense foods were not readily abundant and 
required greater physical activity to attain. This led to the evolution of the most efficient 
way to store energy, or the ”thrifty genes” (264). This lifestyle was much more active 
than most human lifestyles today, where energy dense foods are actually the more 
convenient option. Likewise, rodent activity in research settings is greatly restricted 
compared to what is experienced in the wild. Therefore, although exercise in both 
human and rodent research is viewed as a ‘treatment’, if society could get back to 
seeing exercise as the normal human condition, the development of many of the 
debilitating diseases caused by sedentary lifestyle could be avoided. Considerable 
research is still needed to understand all the pathways that are influenced by exercise. 
Hopefully the trend of discovering the plethora of benefits associated with exercise will 
encourage this research. 
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1.7.3 Anti-inflammatory Diet 
One problem commonly seen in prescribing exercise for the treatment of chronic 
pain, depression, or metabolic syndrome is lack of adherence. If progress is not seen 
instantly or if exercise is perceived as too difficult or time consuming, patients often stop 
exercising. Another lifestyle change that could be paired with exercise or stand alone is 
improving one’s diet. Studies often find that exercise + diet interventions show the 
greatest benefit for individuals (265). For example, increasing physical activity and 
consuming a healthier diet has been shown to be effective in the prevention of type 2 
diabetes in over-weight individuals with impaired glucose tolerance (266). However, it 
has also been found that diets with strict rules or complete elimination of certain food 
groups can lead to weight loss followed by weight regain after cessation of the diet. 
Therefore, adapting lifestyle changes that can be maintained long-term is important 
(267).  
Many chronic pain, mood, and metabolic disorders are associated with a chronic 
state of low-grade inflammation (255, 256, 268). Therefore, a diet high in anti-
inflammatory components could be a good diet treatment for these patients (269). An 
anti-inflammatory diet, which is very similar to the Mediterranean diet, is high in fruits, 
vegetables, lean protein or plant based protein, whole grains, high fiber, and healthy 
fats such as omega-3 fatty acids (FAs) (270). Diets with a high content of fruits and 
vegetables have been shown to lower inflammatory markers in the blood (271). For an 
animal protein source to be considered anti-inflammatory the source of fat within the 
protein needs to be from omega-3 FAs, such as in certain fish, as opposed to omega-6 
FAs (272). Plant-based proteins (e.g. soy legumes, tempeh, and tofu) should be a 
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significant source of protein and have been shown to have anti-inflammatory properties 
(273). Whole grains (e.g. buckwheat, barley, and rye) should predominate over refined 
carbohydrates because they are high in fiber, an important property to be considered in 
regards to inflammation (274). Other dietary components found to have anti-
inflammatory properties include tea, specifically green or white, red wine, because it 
contains resveratrol, and spices such as ginger and turmeric (275). Long-term 
consumption of a Mediterranean diet was associated with a significant reduction in 
mortality in a Greek population (276-278).  
 Anti-inflammatory diets have been shown to improve many of the symptoms of 
metabolic syndrome in humans. For example, patients with metabolic syndrome on a 
Mediterranean diet for 2- years showed decreased weight, cardiovascular benefits, and 
increased insulin sensitivity compared to the non-intervention group (279). An anti-
inflammatory diet also elicits a widespread reduction in inflammation (280). This form of 
diet has also been shown to reduce the development of diabetes by around 20% (210). 
In the treatment of pain disorders, most studies focus on increasing a particular anti-
inflammatory ingredient rather than a full dietary intervention. For example, an increase 
in omega-3 FA consumption paired with a reduction in omega-6 FA reduced headache 
pain and improved quality of life in a study of chronic headache patients (179). Goldberg 
and Katz (2007) found that adding omega-3 FAs to the diet of patients with rheumatoid 
arthritis, as well as joint pain associated with inflammatory bowel diseases and 
dysmenorrhea, reduced joint pain intensity, number of painful joints, and NSAID 
consumption for the treatment of joint pain (180). A study comparing treatment of knee 
osteoarthritis patients with curcumin, the main active ingredient in turmeric, versus 
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ibuprofen found that both treatments were effective but curcumin had less reported 
gastrointestinal problems (181). There appears to be a lack of studies investigating an 
anti-inflammatory diet as a therapeutic intervention for the treatment of depression and 
anxiety in humans. However multiple studies have found an association of increased 
inflammatory diet pattern and the development of mood disorders (281). 
Limited studies investigating the benefits of an entire anti-inflammatory diet in 
rodents exist, as most studies focus on the addition of one anti-inflammatory ingredient. 
An exception to this is one study in mice that demonstrated that an anti-inflammatory 
diet shortened the recovery time after an injection with the inflammatory solution 
complete Freund’s adjuvant (282). A different study looked at the effect of various 
tocochromanol phytochemicals, which are the different groups of Vitamin E compounds 
and are thought to have anti-inflammatory and other health promoting properties, in 
reducing symptoms associated with diet-induced metabolic syndrome in rats. They 
found that delta-tocotrienol in particular was beneficial in reducing diet-induced 
inflammation, normalizing glucose tolerance, reducing total fat mass, and improving 
heart and liver function in high-fat high-sucrose fed rats (283). A study investigating the 
effect of omega-3 FA supplementation in high-fat diet induced obese mice showed that 
including omega-3 FAs in the diet prevented the increased macrophage infiltration in 
adipose tissue normally seen in a high-fat diet not supplemented with omega-3 FAs. 
Interestingly, body weight was higher in the mice whose diet was supplemented by 
omega-3 FAs but their plasma triglyceride concentrations were significantly lower (284). 
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1.8 Western Diet 
A western or high-fat/high-sucrose (HFS) diet is high in saturated fat, such as 
omega-6 FAs, and refined carbohydrates both of which are considered pro-
inflammatory (269, 285). This type of diet is also low in fiber, fruits, and vegetables (286, 
287). HFS diet consumption has grown due to the convenience and lower cost of fats 
and sugars compared to healthier foods, such as fruits and vegetables (288). Long-term 
consumption of HFS diet has many health consequences in humans including the 
development of obesity (178, 289), type 2 diabetes (290), cardiovascular disease (291), 
and adverse impacts on brain function and behavior (292). The brain functions 
particularly impacted are those involved in memory (293) and reward processing (294).  
Rodent studies find similar results, such that a HFS diet leads to a significant 
increase in visceral body fat and the subsequent development of other symptoms 
associated with metabolic syndrome (164, 252, 282). It also appears that early life 
stress paired with HFS diet consumption has an even more detrimental effect on weight 
gain. For example, in a mouse model of early life stress using limited nesting material, 
after 8-weeks on a HFS diet, the stressed mice had a 1.9 fold increase in body fat 
percentage compared to non-stressed mice that had a 1.6 fold increase. Plasma leptin 
levels were also influenced by early life stress. Therefore, the authors suggest that 
leptin could be one mediator of early life stress and HFS diet induced obesity and 
subsequent development of metabolic syndrome (164). Memory impairment (295) and 
reduced inhibitory control on a long-term HFS diet is also demonstrated in rodents. It 
has been suggested that these behaviors are due to a reduction in BDNF in the 
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hippocampus and prefrontal cortex, which has been shown to be caused by a long-term 
HFS diet (296). 
1.9 Sex differences 
Sex differences have been found in animal responses to stress (297). Females 
display higher levels of basal circulating corticosterone compared to males, which could 
be due to estrogen interacting with the HPA axis (298). Furthermore, MC activation has 
been shown to be influenced by estradiol and progesterone (299) and dural MCs have 
stained weakly for the estrogen receptor (300). Therefore, differences in estrogen levels 
could be causing the sex differences seen in stress responses. In humans, women are 
more susceptible to stress-related illnesses, such as migraine, than men (301). 
Additionally, metabolic syndrome is more prevalent in women than men (302). However, 
female mice are resistant to diet-induced weight gain compared to male mice (303). 
Therefore, the evoked migraine study in this dissertation uses female mice (Chapter 2) 
and the Western diet study uses male mice (Chapter 3). Both sexes were used in the 
anti-inflammatory diet study to investigate if there are differences in this particular diet 
intervention (Chapter 4). 
1.10 Central Hypothesis and Specific Aims 
Early life stress has many long-term consequences including increased 
susceptibility to developing co-morbid pain and obesity-related metabolic syndrome in 
adulthood. Other risk factors for developing these conditions include a sedentary 
lifestyle and poor diet. Research is needed to investigate the interaction between stress-
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induced co-morbid disorders and lifestyle factors to find appropriate therapeutic 
interventions.  
 The studies in the following chapters were focused on investigating if our mouse 
model of early life stress, NMS, that shows behavioral and molecular evidence similar to 
symptoms experienced by chronic urogenital pain patients also shows evidence of 
susceptibility to evoked migraine and HFS diet-induced obesity-related metabolic 
syndrome. Additionally, exercise or an anti-inflammatory diet is used to evaluate the use 
of these therapeutic interventions in the treatment of these putative stress-induced 
disorders. The central hypothesis of this dissertation is that early life stress in mice 
elicits symptomologies indicative of co-morbid widespread chronic pain and obesity-
related metabolic syndrome, which are exacerbated by long-term HFS diet 
consumption, and can be prevented by non-pharmacological interventions such as 
exercise or an anti-inflammatory diet. This hypothesis was investigated with the 
following three aims: 
Aim 1: Investigating the long-term consequences of early life stress and exercise on 
evoked migraine in mice. 
Aim 2: Investigating the influence of early life stress, exercise, and a long-term high-
fat/high-sucrose diet on the development of obesity-related metabolic syndrome in mice. 
Aim 3: Investigating the effect of an anti-inflammatory diet intervention on early life 











Chapter II: The effect of early life stress and exercise on evoked 




2.1 Abstract  
Migraine is a complex chronic pain disorder that is highly prevalent in today’s 
society. This neurological disorder affects three times more women than men and can 
be triggered by many endogenous and exogenous factors. Migraineurs are often 
diagnosed with other chronic pain disorders as well as mood disorders. Although the 
exact cause of this co-morbidity is not fully understood, a commonality in many of these 
patients is that they have a dysfunctional hypothalamic-pituitary-adrenal (HPA) axis, 
which helps regulate the stress response and influences the perception of pain. The 
HPA axis is programmed during the formative years. Therefore, adverse childhood 
experiences, such as stress, can have adverse long-term consequences on the 
appropriate development of the HPA axis. In this chapter, I use a mouse model of early 
life stress, neonatal maternal separation (NMS), which exhibits urogenital 
hypersensitivity and altered limbic regulation of the HPA axis, to determine if female 
NMS mice are more susceptible to evoked migraine-like behaviors compared to female 
non-stressed (naïve) mice. Additionally, I investigate the influence of exercise in the 
form of voluntary wheel running as a therapeutic intervention for evoked migraine-like 
behaviors. This non-pharmacological intervention was used because exercise 
successfully reduces frequency, duration, and intensity of migraines in humans and 
voluntary wheel running attenuates urogenital hypersensitivity in NMS mice. In this 
study, I first assessed mast cell (MC) characteristics in the dura mater, a tissue 
important in migraine pathophysiology. When MCs are activated, they release pro-
inflammatory cytokines and proteases that can lead to migraine-pain. It was discovered 
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that female NMS-Sedentary mice had increased MC activation and male NMS-
Sedentary mice had an increase in the number of MCs compared to naïve-sedentary or 
exercised mice.  I then used two methods to evoke migraine in female mice: a novel 
non-surgical method to apply an inflammatory soup (IS) directly onto the dura mater and 
intraperitoneal nitroglycerin (NTG) injection. Following administration of the noxious 
solutions, mouse grimace, paw mechanical withdrawal threshold, and photophobia, or 
sensitivity to light, were measured. I found that dural application of IS resulted in a 
decrease in forepaw withdrawal threshold in all groups of mice and that NTG increased 
mouse grimace in all groups of mice. NMS-Sedentary mice appeared more susceptible 
to NTG induced hind paw sensitivity and photophobia-like behavior compared to Naïve-
Sedentary or NMS-Exercised mice. Interestingly, in both naïve and NMS mice, exercise 
increased mouse grimace following dural application of IS and saline as well as in mice 
with no dural stimulation. Taken together, these findings demonstrate that selecting the 
appropriate method to evoke migraine as well as the assessment of proper migraine-
like behaviors are important when designing a migraine study in rodents. Additionally, 
these results suggest that female NMS-Sedentary mice are more susceptible to NTG 
induced hind paw hypersensitivity and photophobia-like behavior, potentially due to their 
increased dural MC activation. Future studies in our laboratory will further investigate 
the mechanism behind this association.  
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2.2 Introduction  
Migraine is the 3rd most prevalent and 6th most debilitating illness in the world (304). It 
often starts around puberty and affects three times more women than men (305, 306). 
Migraine is a neurological disorder that presents as throbbing cranial pain, sensitivity to 
light (photophobia) and sound (phonophobia), nausea, fatigue, irritability, muscle 
tenderness, and cutaneous allodynia (307). It can be triggered and exacerbated by both 
endogenous and exogenous factors including hormonal changes, stress, sleep 
deprivation, certain foods and smells, alcohol, and noise (308). Migraine pain is thought 
to originate from chemical activation of sensory nerves that interact with intracranial 
blood vessels and the meninges, primarily the dura mater, which is the outermost 
covering of the brain (309). The trigeminovascular pathway facilitates nociceptive 
communication from the meninges to the brain.  Sensory neurons from the trigeminal 
ganglia (TG) have peripheral axons that innervate the dura and cerebral arteries and 
their central projections terminate at the spinal trigeminal nucleus (SpV) (310, 311) as 
well as the upper cervical spinal cord (C1-C2) (312), which together are referred to as 
the trigeminocervical complex (TCC). The innervation associated with migraine 
pathophysiology is predominately through one branch of the trigeminal nerve, the 
ophthalmic (V1) division. The other two divisions of the trigeminal nerve, maxillary (V2) 
and mandibular (V3), play a lesser role in migraine (313). The TCC also receives 
signals from periorbital skin and pericranial muscles (314). Second order TCC neurons 
then project to higher pain processing centers including the thalamus, as well as to 
brainstem nuclei, hypothalamic nuclei, and basal ganglia nuclei (315).   
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The origination of migraine pain has not been established. One proposed 
mechanism is that stimulation of the trigeminal nerve causes the release of peptides, 
including calcitonin gene-related peptide (CGRP) and substance P (SP) (316), from 
trigeminal nerve endings. These peptides then cause meningeal vasodilation and 
activation of dural mast cells (MC). Alternatively, meningeal MCs could become 
activated first and lead to subsequent sensitization of meningeal nociceptors (317, 318). 
When MCs become activated, they release vasoactive, nociceptive, and inflammatory 
molecules (e.g. histamine, bradykinin, tryptase, serotonin, CGRP, SP) (44). Despite the 
uncertainty regarding the origination of migraine, it is generally accepted that MCs play 
a role in the propagation of migraine pain. MCs are increased in migraineurs (39) and 
they can expand their population during immune and inflammatory responses by 
increasing recruitment, survival, and maturation of MC precursors in the area (319). 
They reside close to sensory nerve endings (47-49) and dural MCs have even been 
demonstrated to be in direct contact with nerve fibers (50). Additional evidence of MC 
involvement in migraine is that histamine levels, a major component of MC granules 
released upon activation, are higher in the serum of migraineurs during migraine attacks 
(153).  
One-third of migraineurs experience migraine with aura, which is described as 
transient neurological symptoms including visual and speech deficits usually 
experienced before other migraine symptoms and is hypothesized to be caused by 
cortical spreading depression (CSD) (320). This can be modeled in rodents by 
electrical, mechanical, or chemical stimulation of the cortex (321). While CSD is an 
important factor in migraine pathophysiology, it is beyond the scope of this study.  
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Stress and migraine 
Migraine is often triggered or exacerbated by stress (145, 146) and experiencing 
multiple stressful life events has been linked to the transformation of episodic migraine 
to chronic migraine (322). Furthermore, stress experienced early in life is associated 
with increased susceptibility to developing migraine in adulthood (323-325). One of the 
first studies to document this relationship was published using data from the Adverse 
Childhood Experiences (ACE) study. The ACE study used a sample of 9,500 adults and 
investigated the prevalence rate of early life stress. It included questions about 
childhood maltreatment including neglect, physical, sexual, and emotional abuse, 
witnessing parental substance abuse, and parental divorce. They found that half of the 
individuals surveyed reported at least one ACE and one-fourth reported two or more 
ACEs (323). From this original cohort of individuals, over 50 studies have been 
published investigating the long-term consequences of early life stress. Anda et al., 
(324) used childhood maltreatment data from the ACE study and looked into the 
prevalence of headaches in these individuals as adults. They found that as the ACE 
score increased, so did the prevalence of frequent headaches in both males and 
females The American Migraine Prevalence and Prevention study also found an 
association between early life stress and headaches in adults. This association was 
particularly strong for childhood emotional abuse and migraine compared to tension 
type headache (326). Finally, Brennenstuhl and Fuller-Thomson (325) used data from 
the 23,000 individuals that participated in the Canadian Community Health Survey-
Mental Health, which measured three types of self-reported childhood stress: sexual 
abuse, physical abuse, and witnessing parental violence. In this cohort of individuals, 
they found that all three types of early life stress were associated with the development 
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of migraine in adulthood in both men and women. They also found that as the number 
of childhood adversities increased, so did the odds of developing migraine in adulthood.  
The exact mechanism underlying the relationship between early life stress and 
migraine has not been fully established. However, many individuals that suffer from 
migraine show signs of a dysfunctional hypothalamic-pituitary-adrenal axis (HPA) (147-
149), which is described in detail in the following section.  
Hypothalamic pituitary adrenal (HPA) axis and migraine 
Early life stressors, such as childhood neglect and abuse or witnessing parental 
discord in the home, can negatively impact neurodevelopment resulting in lifelong 
physical and physiological changes. Specifically, early life stress causes a disruption in 
the functional output of the HPA axis (105, 106), which regulates the stress response 
and influences the perception of pain (9, 10). Under normal conditions, an acute 
stressor will signal the paraventricular nucleus (PVN) of the hypothalamus to release 
corticotropin-releasing factor (CRF) and arginine vasopressin, which causes the anterior 
pituitary gland to release adrenocorticotrophic hormone (ACTH). ACTH signals the 
adrenal cortex to release glucocorticoids (cortisol in humans and corticosterone in 
rodents) that have downstream metabolic effects (15, 16). CRF also works in the 
periphery by stimulating MC degranulation, causing neurogenic inflammation (45, 46). A 
negative feedback loop is established to turn off activation of the HPA axis by 
suppressing the production of CRF and ACTH upon cessation of the initial stressor (18, 
19). Limbic structures, including the hippocampus, amygdala, and prefrontal cortex, 
regulate the HPA axis as well (Figure 1.1). The hippocampus and prefrontal cortex 
usually dampen the HPA axis activation, while the amygdala usually activates it (25). 
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Chronic migraine sufferers have shown abnormal HPA axis activity (147-149). A 
study evaluating HPA axis response in patients with chronic migraine and medication-
overuse headache found that after administration of CRF, both ACTH and cortisol were 
significantly elevated in migraineurs compared to control patients (147). A different 
study administered nitroglycerin (NTG), a known migraine trigger, to migraineurs and 
controls and measured plasma cortisol levels. 22 out of 30 migraineurs developed a 
migraine and their plasma cortisol levels significantly increased compared to the 
controls, none of which developed a migraine (149). These studies suggest that 
migraineurs might have a hyperactive HPA axis and that stress hormones could play an 
important role in migraine pathogenesis. These findings could also explain the 
association between individuals that suffer from early life stress being more susceptible 
to the development of migraine in adulthood.  
Migraineurs often suffer co-morbid mood disorders, such as depression and anxiety, 
as well as other chronic pain disorders, including interstitial cystitis, irritable bowel 
syndrome, fibromyalgia, arthritis, and chronic fatigue syndrome (8). Similar to migraine, 
these disorders are also more prevalent in individuals that have experienced early life 
stress (3-7) and it appears that one common underlying mechanism in these disorders 
is a dysfunctional HPA axis (9, 105, 108). The association between early life stress and 
the development of migraine and other chronic disorders in adulthood is particularly 
worrying because the rate of childhood maltreatment in the United States is increasing 
(11). This implies that the incidence of early life stress induced disorders will also 
increase. Therefore, finding an appropriate way to study this association as well as 
finding treatment options is important.  
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Neonatal maternal separation (NMS) 
NMS is a method used in rodents that mimics early life stress in humans. NMS 
protocols vary in length of separation, but the general concept is that pups are removed 
from the dam for a set amount of time each day over a pre-determined time period. For 
example, our lab’s NMS paradigm is separation of the whole litter from the dam for 3-
hours/day from post-natal day 1(P1)-P21 (98). Dysregulation of the HPA axis is an 
established outcome of NMS. This is evidenced by higher basal plasma corticosterone 
concentrations and increased CRF1 expression in the PVN of NMS rodents (88, 89), 
decreased action of the negative feedback loop leading to prolonged release of ACTH 
and glucocorticoids after a stressful event (90, 91), and changes in anxiety-like 
behaviors (92). In line with these observations, Aisa et. al. found that NMS female rats 
are more susceptible to chronic stress in adulthood compared to normally reared female 
rats (88).  Our lab has found that in NMS mice, hypothalamic and hippocampal mRNA 
levels of CRF receptors are dysregulated (96, 97). Additionally, we have measured 
mechanical hypersensitivity and MC activation in urogenital organs of NMS and naïve 
mice and found that NMS significantly increases urinary bladder (97) and vaginal (96) 
sensitivity in females and urogenital sensitivity (98) in males. We also saw an increase 
in the percentage of degranulated MCs in the female (97) and male (100) urinary 
bladder, the vagina (unpublished observation), and the prostate (98). 
The goal of this study was to investigate susceptibility to evoked migraine in NMS 
mice. To my knowledge, this is the first study to combine early life stress with evoked 
migraine to evaluate the relationship between early life stress and the susceptibility to 
migraine in adulthood in rodents. 
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Models of migraine 
Many methods to study migraine in rodents exist, including evoked and genetic 
models (327). One rodent model of evoked migraine involves administration of various 
noxious solutions to the dura mater. These noxious solutions include calcitonin-gene-
related peptide (CGRP) (328), inflammatory soup (IS; bradkyinin, histamine, 5-HT, and 
prostaglandin E2) (329, 330), mustard oil (MO), and the environmental irritant 
umbellulone (331). These substances are applied with the goal of stimulating the TG 
afferents that innervate the dura, thus activating the trigeminovascular system. These 
inflammatory agents are used because they have been shown to be algesic in humans 
(332).  Following noxious dural stimulation, rodents display behavioral and 
electrophysiological evidence indicative of migraine-like symptoms including facial and 
extracephalic allodynia, or sensitivity to something that does not normally evoke a 
painful response, (329-331, 333, 334), increased motivated behavior to seek pain relief 
(335), the suppression of exploratory behavior (336), light and sound aversion, 
grimacing behaviors, and alterations in activation of meningeal and trigeminal pain-
sensitive neurons that can last for many hours (337, 338). Until recently, rodent dural 
stimulation had only been accomplished with a surgically implanted cannula. However, 
a novel non-surgical method has been developed in mice that uses a modified injection 
cannula to penetrate the skull without puncturing the dura mater (339). This non-
surgical method was adapted in this study to attempt to evoke migraine-like behaviors. 
Another form of evoked migraine in rodents is intraperitoneal or intravenous 
administration of pharmacological solutions including nitroglycerin (NTG) (340) and 
CGRP (341), which trigger migraines in human migraineurs (342, 343). NTG is a nitric 
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oxide donor that evokes a delayed severe headache along with other migraine 
symptoms in migraineurs, and occasionally a milder headache without the associated 
migraine symptoms in healthy subjects (344). In rodents, NTG administration has been 
shown to induce photophobia-like behavior (345) and mechanical and thermal hind paw 
allodynia (340, 346). Similar to the delayed effect of NTG seen in humans, the effects of 
NTG on mechanical allodynia in rodents start between 30-60- minutes after injection 
and are still present 4- hours later (347). Reuter et al. studied the effects of intravenous 
NTG administration on the rat meninges (348). They found that NTG infusion caused a 
delayed increase in dural plasma protein extravasation as well as increased 
inflammatory markers IL-1β and IL-6. Furthermore, NTG caused significant dural MC 
degranulation. These findings suggest that NTG evokes migraine symptoms by 
increasing dural inflammation. IP NTG injection is another method used in this study to 
attempt to evoke migraine-like behaviors. 
Transgenic mouse models of migraine have also been developed and are still being 
characterized. These include models of monogenic migraine mutations for familial 
hemiplegic migraine (FHM), cerebral autosomal dominant arteriopathy with subcortical 
infarcts and leukoencephalopathy (CADASIL), and familial advanced sleep-phase 
syndrome (FASPS) (349). All of these models show increased susceptibility to CSD 
(350-352).  FHM mice show signs of grimace behavior (353), photophobia, increased 
head grooming, and increased blinking with one eye closed (354). The transgenic 
FASPS mouse model has been shown to be more susceptible to NTG induced 
mechanical and thermal allodynia compared to wildtype mice (352). In addition to these 
mouse models created from human mutations, a transgenic mouse model with 
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increased expression of a subunit of the CGRP receptor has also been created. This 
model consistently displays photophobia-like behaviors that are further exacerbated 
after CGRP administration and can be blocked by a CGRP receptor antagonist (355, 
356).  
Despite the association between stress and migraine in humans, a limited number of 
pre-clinical studies have investigated this. One study evaluated the effect of both acute 
and chronic restraint stress prior to IP NTG injection on latency of response in a tail-flick 
test. They found that in non-stressed mice, NTG injection caused hyperalgesia, or 
greater sensitivity to a painful stimulus, in the tail-flick test compared to non-injected 
mice. They then found that acute restraint stress caused an analgesic state in the tail-
flick test both before and after NTG injection compared to non-stressed controls, while 
chronic immobilization stress over 7- days caused a hyperalgesic state in the tail-flick 
test that was exacerbated by NTG injection (357).  Another study used both 14- day 
social defeat stress (SDS) and 40- day chronic variable stress (CVS) paradigms and 
evaluated hind paw mechanical allodynia before and after the stress as baseline 
measurements and then 75- and 120- minutes after NTG injection. They found a 
significant reduction in baseline mechanical withdrawal threshold in the CVS paradigm 
but not in the SDS paradigm or control mice. After NTG injection, control and both 
stressed groups showed a significant reduction in hind paw mechanical allodynia at 
both time points with no significant differences between the groups (346). Theoharides 
et al., (1995) demonstrated that dural MC degranulation is increased following restraint 
stress and pretreating rats with polyclonal antiserum to CRF significantly reduced the 
percent of MC degranulation during restraint stress (157). Finally, a transgenic mouse 
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model of FHM showed an increase in CSD following treatment with corticosterone, 
which was blocked by pretreatment with a glucocorticoid receptor antagonist. However, 
this same model did not show increased CSD following acute stress (152). Taken 
together, these data demonstrate that stress plays a role in the development of some 
migraine-like symptoms in rodents and that the type of stressor as well as the outcome 
measured are important variables to consider.  
Migraine Treatment  
There are two broad classifications of pharmacological treatments of migraine. 
These are drugs that are taken as acute treatment during a migraine attack or drugs 
that are taken as a daily preventative treatment to reduce frequency and severity of 
attacks. The first class of drugs specifically developed to be taken during migraine 
attacks are the triptans, which are 5-HT (serotonin) receptor agonists (358).  However, 
they are only efficacious in some migraineurs (359). Other drugs used acutely for the 
treatment of migraine include ergot alkaloids and non-steroidal anti-inflammatory drugs 
(360). These drugs are also not universally successful. Until recently, the most well 
accepted preventative treatments have been β−adrenergic-receptor antagonists, 
however these are not specific to migraine and they have several unpleasant side 
effects (360). In 2018, a new class of preventative drugs specific to migraine was 
approved by the FDA: monoclonal antibodies targeting calcitonin gene-related peptide 
(CGRP) and its receptor (361). These antibodies are novel because they are too large 
to cross the blood-brain barrier and therefore work peripherally (313). So far, these 
drugs have been well tolerated with none of the substantial side effects associated with 
other preventative treatments (362). However, long-term data are still needed.  
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Anti-migraine drugs have shown some success in rodent migraine models. For 
example, sumatriptan, an acute migraine treatment, attenuated IP NTG induced 
mechanical and thermal hind paw allodynia (347). Additionally, Pradhan et al., (2014) 
studied sumatriptan as well as topiramate, a migraine preventative therapy. They found 
that sumatriptan was able to reduce acute NTG induced mechanical hyperalgesia, but 
was not successful in their chronic migraine model of multiple NTG injections. However, 
topiramate was able to attenuate both acute and chronic mechanical hyperalgesia 
(340). Finally, a CGRP anti-body was administered to a medication over-use headache 
rodent model. They found that this anti-body was able to inhibit NTG or bright light 
stress evoked cutaneous allodynia (363).  
In addition to the pharmacological treatments described above, several non-
pharmacological treatments for migraine exist. Most research in this area has focused 
on behavioral headache management including relaxation training, biofeedback, and 
cognitive behavioral therapy (177). Exercise has also been investigated as a treatment 
for migraine prevention. A prospective cross-sectional study found an association 
between low levels of physical activity and an increase in prevalence of migraine and 
non-migraine headache (222). Aerobic exercise improves migraine frequency and 
intensity as well as stress level in migraineurs (364, 365). Additionally, Varkey and 
colleagues (2011) found that there were no significant differences in headache 
frequency between individuals that participated in aerobic exercise and those that 
received either topiramate or relaxation treatment (366), suggesting that exercise could 
be as effective as pharmacological treatment of migraine in some individuals. There are 
some studies that have found exercise-induced migraine. However, the majority of 
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these studies use unusually strenuous exercise (367) coupled with other factors that are 
known to precipitate migraine such as drinking a large amount of caffeine while 
consuming little food (368). These are not the types of exercise that would be 
prescribed as therapy for migraineurs. It is usually suggested that migraineurs slowly 
habituate to exercise to avoid exercise becoming a migraine trigger (369).  
Due to the multitude of effects that exercise has on the body, there are multiple 
mechanisms that could underlie exercise’s effect on migraine symptoms. The influence 
of exercise on pain and stress are of particular relevance to our work. One hypothesis 
regarding the development of chronic migraine is that long-term stress can decrease the 
efficacy of the endogenous antinociceptive system, leading to chronicity of symptoms 
(322). Exercise can improve descending analgesic pathways by altering conditioned 
pain modulation (CPM) or the “pain-inhibits-pain” mechanism (241) by increasing 
endogenous opioids (242), stimulating brain structures involved in descending analgesic 
pathways (194), and/or maintaining the balance between excitatory (glutamate) and 
inhibitory (GABA) neurotransmitters in the CNS (245). In support of this, aerobic 
exercise is associated with an analgesic response in both humans and animals (85). 
Another hypothesis as to how exercise benefits migraineurs is through the reduction of 
depression, anxiety, and stress (370), which as described previously is a common 
migraine trigger. Dientsbier (1989) suggests that long-term exercise can help an 
individual develop a greater stress tolerance and adapt quicker to stressful situations 
(371). Exercise induced endorphin production could also decrease stress and anxiety 
(244).  
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Exercise has been shown to influence the regulation of the HPA axis, specifically 
in the hippocampus, which is important in dampening HPA axis activation. If 
migraineurs have a hyperactive HPA axis, increasing inhibitory control could be 
important in treating this disorder. We have previously used exercise in the form of 
voluntary wheel running in our mice and have shown that it increases brain-derived-
neurotrophic factor (BDNF) mRNA in the hippocampus (229). Other groups have also 
found that exercise normalizes NMS-induced changes in hippocampal mRNA including 
glucocorticoid receptor and BDNF (233, 235). Furthermore, exercise has been shown to 
increase neurogenesis and dendritic spine density in the hippocampus (236). In addition 
to changes in the hippocampus, we have demonstrated that exercise normalizes NMS 
induced urogenital hypersensitivity and increased MC degranulation (100, 229). 
Therefore, in this study voluntary wheel running is used to evaluate if exercise is also 
beneficial in preventing the development of migraine-like behaviors in evoked migraine 
models.   
Due to the fact that patients with chronic urogenital pain disorders frequently suffer 
co-morbidly from migraine, the goal of this study is to evaluate evoked migraine-like 
symptoms in a mouse model of early life stress, NMS, which has previously displayed 
behavioral and molecular evidence similar to what is experienced by chronic urogenital 
pain patients. I hypothesized that NMS mice would display behaviors indicating that 
they are more susceptible to evoked migraine compared to non-stressed mice. 
Additionally, because we have seen that voluntary wheel running is beneficial in 
preventing the development of chronic urogenital pain symptoms in our NMS mice, I 
 62 
also evaluated the influence of voluntary wheel running on evoked migraine-behaviors. I 
hypothesized that exercise would prevent the proposed sensitization caused by NMS.  
2.3 Methods 
Three different cohorts of mice (A, B, and C) were used in the following experiments. 
All groups were subject to NMS and late (A) or early (B & C) exercise paradigms. The 
evoked migraine experiments that were implemented are different between the groups. 
A timeline of events is displayed in Figure 2.1 for clarity. 
NMS: Pregnant C57Bl/6 dams at 14-16- day gestation were ordered from Charles River 
and housed at the Department of Laboratory Animal Resources at the University of 
Kansas Medical Center. Litters were divided equally into NMS and naïve groups. NMS 
pups were removed as whole litters from their home cage for 180- minutes (11am-2pm) 
daily beginning at postnatal day 1 (P1) until P21. During separation, pups were placed 
in a clean glass beaker with bedding from their home cage. The beaker was placed in 
an incubator maintained at 33°C and 50% humidity. Naïve mice remained undisturbed 
in their home cage except for normal animal husbandry. All mice were weaned on P22 
and housed 2-5/cage with same sex litter mates and ad libitum access to food and 
water. 
Exercise: Group A: At 8-weeks of age, male and female NMS and naïve mice were 
equally divided into exercised (Ex) and sedentary (Sed) groups. Groups B & C: We 








Figure 2.1: Group A: Female and male mice either underwent NMS from postnatal day 
1 (P1) to P21 or remained in their home cage until weaning (naïve). At 8-weeks of age 
NMS and naïve mice were further divided into exercised (Ex) or sedentary (Sed) 
groups. At 12-weeks of age, all mice were sacrificed and dura mater was collected to 
evaluated mast cell characteristics. Group B: Female mice underwent NMS from P1 to 
P21 or were naïve. At 4-weeks of age NMS and naïve mice were divided into Ex or Sed 
groups. At 8-weeks of age, mice received either inflammatory soup (IS) or saline 
applied to the dura mater. At 19-weeks of age, a two application method to the dura was 
used: First application: either IS or saline and 3-days later the second application: all IS. 
At 40-weeks of age, mice either received an IP nitroglycerin (NTG) or saline injection. At 
each treatment time point mouse grimace score and paw mechanical withdrawal 
threshold were measured. Group C: Female mice underwent NMS from P1 to P21 or 
were naïve. At 4-weeks of age NMS and naïve mice were divided into Ex or Sed 
groups. At 40-weeks of age, all mice received an IP NTG injection and photophobia-like 
behavior was measured.  
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benefit. Therefore, in these groups at 4-weeks of age, female NMS and naïve mice 
were divided equally into Ex or Sed groups. To avoid the added stress of singly 
housing, all Ex mice were pair housed with a litter mate of the same sex in cages 
equipped with a stainless steel running wheel (STARR Life Sciences Corp, Oakmont, 
PA) and Sed mice remained in their home cage with no access to a running wheel. 
Distance ran was recorded by STARR Life Sciences VitalView Activity Software version 
1.1.  
Dural mast cells: Group A: Mice were sacrificed at 12-weeks of age and perfused with 
4% cold paraformaldehyde (PFA). Dura was removed from the skull and post-fixed in 
4% cold PFA for 1- hour then placed in 30% sucrose. Dura was whole mounted on a 
glass microscope slide and stained for 10- minutes with 1% toluidine blue (TB) solution 
acidified with 1M HCL. Slides were allowed to dry for 2- hours in a 37°C oven, washed 
in 95% then 100% EtOH, fixed in xylene, and cover slipped. Light microscopy (Nikon 
eclipse 90i, Nikon Instruments, Inc., Melville, NY) was used to take images of each dura 
sample (QIClick digital CCD Camera, QImaging, Surrey, BC, Canada). The total 
number and the number of degranulated MCs were counted in 10 non-adjacent fields 
(800 um2 per field) per tissue. The percent of degranulated MCs was quantified using 
the following equation: (Degranulated MC/total MC) x 100. 
Timelines on experiment days: Group B experiment 1: Naïve- and NMS-Sed and Ex 
mice received a dural application (described below) of inflammatory soup (IS) or saline. 
Mice were then allowed to recover from anesthesia for 1- hour before their behavior was 
recorded to evaluate facial behaviors for the mouse grimace scale (MGS) for 1- hour. 
Forepaw mechanical withdrawal threshold was then measured. Group B experiment 2: 
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Naïve- and NMS-Sed and Ex mice either received a dural application of IS or saline and 
were allowed to recover for 1- hour. Then, behavior was recorded to evaluate facial 
behaviors for 1- hour and forepaw mechanical withdrawal threshold was measured. 72- 
hours later, all groups received an IS application to the dura and the same behavior was 
recorded again. Group B experiment 3: Naïve- and NMS-Sed and Ex mice received 
an IP NTG or saline injection (described below). 30- minutes after injection behavior 
was recorded for 1- hour to evaluate facial behaviors and then hind paw mechanical 
withdrawal threshold was measured. Group C: Naïve- and NMS- Sed and Ex mice 
received an IP NTG injection and 30- minutes later photophobia-like behavior was 
measured.  
Dural injection:  Under inhaled isoflurane a modified cannula injector (Plastics One) was 
inserted at the lamboidal suture without penetrating the dura (339).  10 microliters IS 
(1mM histamine, 1mM 5-hydroxytryptamine, 1 mM bradykinin, and 0.1 mM 
prostaglandin E2 in PBS) or saline was slowly dispersed onto the dura and the injector 
was removed.  
NTG injection: Mice received an IP NTG or saline injection at 10 mg/kg.  
Mouse grimace scale (MGS): The MGS is a measure of facial expressions indicating 
‘pain’ in mice. It is a set of five behaviors: orbital tightening, nose bulge, cheek bulge, 
ear position, and whisker change. Each facial expression is rated as “not present 
(scored 0), moderate (scored 1), or severe (scored 2)” and then an overall score is 
assigned (353). Mice were placed on top of a wire mesh screen elevated 55cm above a 
table and enclosed under an over-turned 500 mL glass beaker. Behavior was video 
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recorded for 1- hour. Facial screen shots were then taken from the videos every 5- 
minutes. Photographs of each mouse were randomized and grimace score was 
assigned to each picture according to a modified version of the MGS established by 
Langford et al 2010 (353). Only orbital tightening and ear position were scored due to 
the difficulty of scoring the other features (nose bulge, cheek bulge, and whisker 
change) on a C57Bl/6 mouse. An average grimace score of each mouse was quantified.  
Paw sensitivity: Before testing for paw mechanical sensitivity, mice were acclimated to a 
sound proof room and the testing table for 2- days before the day of testing. This 
acclimation consisted of 30- minutes within the sound proof room followed by 30- 
minutes inside of a clear plastic chamber (11x5x3.5cm) on a wire mesh screen elevated 
55cm above a table. Paw mechanical withdrawal threshold was measured using a 
standard set of graded von Frey monofilaments (1.65, 2.36, 3.22, 3.61, 4.08, 4.31, 
4.74g; Stoelting, Wood Dale, IL) following the up-down method. The 3.22g 
monofilament was used to apply force to one paw. If there was no response, the next 
larger grade of monofilament was used on the next round of application. If there was a 
positive response (e.g. raising of the forepaw from the table, licking forepaw), the next 
smaller grade of monofilament was used on the next round of application. After the first 
positive response, the up-down method was continued on alternating paws for four 
more applications with a minimum of five or a maximum of nine applications. The 
withdrawal threshold of each mouse was then quantified as a 50% g threshold for each 
mouse (372).  
Photophobia: Group C: A modified force plate actimeter was used to assess light 
aversion behavior. An opaque insert with an opening in the middle was placed in the 
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center of the box on the actimeter. This allowed the mice to move freely between both 
sides. The light side of the chamber was equipped with lights affixed to the ceiling and 
controlled by a single dimmer with low, medium, and high settings. The high setting was 
used and the intensity on the light side was 950 +/- 20 lux. The light level in the home 
cage was 170 +/- 20 lux.  Two mice could be tested simultaneously in a 20- minute 
session with a maximum of 15 mice tested in one day between 0800 and 1200- hours, 
during the light cycle. Mice were tested 6- days and 3- days before the day of treatment 
to establish a baseline. Mice were always acclimated to the room for 1- hour before 
testing. During the testing period, mice were placed in the lit compartment facing away 
from the opening and allowed to freely move between the light and dark compartments 
for 20- minutes. Movement was recorded using FPARun software (Bioanalytical 
Systems Inc. West Layfette, IN). 
Serum corticosterone ELISA: Group C: Trunk blood was collected at the time of 
sacrifice between 0900-1100- hours, allowed to clot for 1- hour on ice, and centrifuged 
at 10,000 rpm for 10- minutes. Serum was collected and stored at -20°C until analysis. 
Serum corticosterone was quantified using an ELISA kit according to the manufacturer’s 
instructions (ALPCO, Salem, NH).  
Statistical analysis: Calculations of the measurements described above were made in 
Excel (Microsoft, Redmond, WA) and statistical analyses were performed using 
GraphPad Prism (GraphPad, La Jolla, CA) or IBM SPSS Statistics (IBM Corporation, 
Armonk, NY). Differences between groups were determined by non-repeated or 
repeated-measure multi-variate ANOVA and Fisher’s LSD or Bonferroni posttest. 
Statistical significance was set at p<0.05.  
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2.4 Results 
NMS influences dural MC characteristics in female and male mice and exercise 
attenuates these effects.  
Experiment A: The total number of MCs and the number of degranulated MCs in 10 
non-adjacent fields (800 um2 per field) per dura were quantified in female and male 
Naïve- and NMS-Sed and –Ex mice. In female mice, there were no significant 
differences between groups for total number of dural MC, but there was a trend for 
NMS-Sed to have a greater number than the other groups (Figure 2.2A). There was a 
significant overall NMS/exercise interaction effect on the percent degranulated dural 
MCs in female mice (p<0.05, Figure 2.2B). Female NMS-Sed mice had a significantly 
higher dural MC degranulation rate compared to female Naïve-Sed mice (p<0.05) and 
NMS-Ex mice (p<0.05). In male mice, there was an overall NMS/exercise interaction in 
the total number of dural MCs (p<0.05; Figure 2.2C). Male NMS-Sed mice had a 
significantly greater number of dural MCs compared to male Naïve-Sed (p<0.01), but 
this effect was not seen in male Naïve- and NMS-Ex mice (Figure 2.2C). There were no 
significant differences in the percent of degranulated dural MCs in the male mice 
(Figure 2.2D). 
Exercise increases MGS in female NMS and naïve mice after dural application of IS or 
saline, while dural application of IS evokes a decrease in forepaw withdrawal threshold 
in female mice. 






Figure 2.2. Dura mater was stained with toluidine blue to visualize mast cells (MCs) and 
the total number and percent of degranulated MCs were quantified in female (A & B) 
and male (C & D) mice. A) Female NMS-Sed mice trended toward a greater number of 
MC in the dura compared to female Naïve-Sed and NMS-Ex mice but this did not reach 
significance. B) There was a significant NMS/exercise interaction on the percent of 
degranulated dural MCs in female mice. Female NMS-Sed mice had a significantly 
greater percent of degranulated dural MC compared to female Naïve-Sed. This effect 
was attenuated by exercise, as NMS-Ex mice had a significantly lower percent of 
degranulated MC compared to Naïve-Sed mice. C) There was a significant 
NMS/exercise interaction on the total number of dural mast cells in male mice. Male 
NMS-Sed mice had a significantly greater number of dural MC compared to male 
Naïve-Sed mice and this effect was attenuated by exercise. D) There were no 
significant differences in percent of degranulated MC in male mice. E) Representative 
image of dura mater stained with toluidine blue. Arrow heads indicate intact MCs and 
arrows indicate degranulated or activated MCs. Bracket indicates a significant 
NMS/exercise interaction (+ p<0.05), 2-way ANOVA; *, ** p<0.05, 0.01 vs. naïve, # 
p<0.05 vs. sedentary, Bonferroni posttest. 
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naïve- and NMS-Sed and –Ex mice. 1- hour later, they were evaluated for grimace 
behavior and forepaw mechanical sensitivity. Following the application of either IS or 
saline to the dura of female naïve- and NMS-Sed and –Ex mice there was an overall 
effect of exercise (p<0.0001) on MGS score. Exercise significantly increased MGS 
score in naïve-Ex-Saline, NMS-Ex-Saline, and NMS-Ex-IS compared to their sedentary 
counterparts (p<0.05; Figure 2.3A). There was also an overall effect of IS on lowering 
forepaw withdrawal thresholds (p<0.05; Figure 2.3B). Experiment B2: In this 
experiment, IS or saline was applied to the dura and grimace and forepaw withdrawal 
threshold were measured. 72- hours later, IS was applied to the dura of all mice and 
grimace and forepaw withdrawal threshold were measured again. Following the first 
application of either IS or saline to the dura there were no significant differences in MGS 
(p>0.05; Figure 2.4A). The NMS-Sed-IS group had a significantly lower forepaw 
withdrawal threshold compared to the NMS-Ex-IS group (p<0.05; Figure 2.4B). After the 
second application, where all groups received IS, there was a significant overall effect of 
exercise on MGS (p<0.001; Figure 2.4C). All exercised groups had significantly greater 
MGS compared to their sedentary counterparts (p<0.05; Figure 2.4C). Additionally, 
there was an overall significant interaction effect of exercise and drug on forepaw 
mechanical withdrawal threshold (p<0.05). Naïve-Sed-IS-IS mice had a significantly 
higher withdrawal threshold compared to Naïve-Sed-Saline-IS mice (p<0.05) and Naïve-
Ex-IS-IS mice (p<0.05; Figure 2.4D). 
Exercise increases MGS in female NMS and naïve mice that have not received any 
form of dural stimulation 






Figure 2.3. Inflammatory soup (IS) or saline was applied to the dura mater of female 
mice through a modified injection cannula. 1- hour after injection, mouse grimace score 
(MGS) was evaluated by recording facial features for 1- hour. Forepaw mechanical 
withdrawal threshold was then measured. A) There was an overall effect of exercise on 
MGS. Naïve-Ex-Saline, NMS-Ex-Saline, and NMS-Ex-IS all had significantly higher 
MGS compared to their sedentary counter parts. B) There was an overall effect of IS on 
forepaw mechanical withdrawal threshold. IS groups generally had lower forepaw 
mechanical withdrawal thresholds compared to saline groups. Bracket indicates a 
significant effect of exercise (γγγ p<0.001) or IS (δ p<0.05), 3 way ANOVA; # p<0.05 vs. 






Figure 2.4: Inflammatory soup (IS) or saline was applied to the dura of female mice 
through a modified injection cannula. 1- hour after injection, mouse grimace score 
(MGS) was evaluated by recording behavior for 1- hour. Forepaw mechanical 
withdrawal threshold was then measured. 3- days later, all groups received a dural 
application of IS and the same behaviors were measured. A) There were no significant 
differences in MGS after the first application of IS or saline. B) There was a significant 
effect of exercise on MGS after the 2nd application, where all groups received IS. All 
exercised groups had significantly higher MGS compared to their sedentary 
counterparts. C) NMS-Sed-IS mice had a significantly lower forepaw withdrawal 
threshold compared to Naïve-Sed-IS after the first application. D) There was a 
significant overall exercise/drug interaction after the 2nd application, where all groups 
received IS. Naïve-Sed-IS-IS had a higher forepaw withdrawal threshold then Naïve-
Sed-Saline-IS. Naïve-Ex-IS-IS had a significantly lower forepaw withdrawal threshold 
compared to Naïve-Sed-IS-IS. Bracket indicates a significant effect of exercise (γγγ 
p<0.001) or exercise/drug interaction (+, p<0.05), 3-way ANOVA; #, ## p<0.05, 0.01 vs. 
sedentary, & p<0.05 vs. saline, LSD posttest. 
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had increased MGS scores after dural application of either IS or saline, the effect that 
exercise has on MGS in mice in the absence of dural stimulation was also evaluated. 
Interestingly, even after no dural stimulation, there was an overall effect of exercise on 
MGS score (p<0.001; Figure 2.5). Naïve-Ex mice had significantly greater MGS score 
than Naïve-Sed (p<0.01) and NMS-Ex mice trended toward an increase in MGS score 
compared to NMS-Sed but it did not reach significance (p=0.0601 Figure 2.5). 
Intraperitoneal NTG injection increases MGS and alters hind paw mechanical sensitivity 
Experiment B3: Female Naïve- and NMS-Sed and -Ex mice received an IP injection of 
either NTG or saline and  mouse grimace and hind paw mechanical withdrawal 
threshold were measured 30- minutes later. There was an overall effect of drug on MGS 
(p<0.0001; Figure 2.6A). Naïve-Ex-NTG had a significantly higher MGS score compared 
to Naïve-Sed-NTG (p<0.05), Naïve-Ex-Saline (p<0.0001), and NMS-Ex-NTG (p<0.05). 
NMS-Ex-NTG had a significantly higher MGS score compared to NMS-Ex-Saline 
(p<0.05). There was a significant overall effect of NMS (p<0.05) and a NMS/exercise 
interaction (p<0.05) on hind paw withdrawal threshold (Figure 2.6B). Naïve-Sed-Saline 
had a significantly higher withdrawal threshold than Naïve-Ex-Saline (p<0.05) and NMS-
Sed-Saline (p<0.05). There were no significant differences between the NTG groups, 
but the NMS-Sed-NTG group had a lower withdrawal threshold than Naïve-Sed-NTG 
and NMS-Ex-NTG groups. 
IP NTG injection evokes photophobia-like behavior in NMS mice 
Experiment C: Female Naïve- and NMS-Sed and –Ex mice were exposed for 20- 
minutes to a light/dark box on a force place actimeter on days 3 and 6 prior to the 
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Figure 2.5: Female mice were briefly anesthetized and 1- hour later behavior was 
recorded for 1- hour to evaluate mouse grimace score (MGS). There was a significant 
overall effect of exercise (γγγ p<0.001; 2-way ANOVA). Naïve-Ex had a significantly 
greater MGS compared to Naïve-Sed (## p<0.01; Bonferroni posttest).  
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Figure 2.6  
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Figure 2.6: Nitroglycerin (NTG) or saline was injected intraperitoneally in female mice. 
30- minutes after injection, mouse grimace score (MGS) was evaluated by recording 
facial features for 1- hour. Hind paw mechanical withdrawal threshold was then 
measured. A) There was a significant overall effect of NTG on MGS. Naïve-Ex-NTG 
had a significantly higher MGS then Naïve-Sed-NTG and Naïve-Sed-Saline. NMS-Ex-
NTG had a significantly lower MGS compared to Naïve-Ex-NTG and a significantly 
higher MGS than NMS-Ex-Saline. B) There was a significant overall effect of NMS and 
a NMS/exercise interaction on hind paw mechanical withdrawal threshold. NMS-Sed-
Saline and Naïve-Ex-Saline had significantly lower hind paw withdrawal thresholds 
compared to Naïve-Sed-Saline. Bracket indicates a significant effect of NTG (δδδδ 
p<0.0001), NMS (ψ p<0.05) or a NMS/exercise interaction (+ p<0.05), 3-way ANOVA; # 




experiment to obtain baseline photophobia data. On the day of the experiment, all 
groups received an IP injection of NTG and were placed in the light/dark box for 20- 
minutes to assess photophobia-like behavior. Time spent in the light and distance 
traveled were quantified at each time point. There was a significant overall effect of time 
on the percent of time spent in the light side of the box over the 3 experiment days 
(p<0.0001; Figure 2.7A). Naïve-Sed, NMS-Sed, and NMS-Ex all spent significantly less 
time in the light on the NTG treatment day compared to the first baseline day (6- days 
before the experiment; p<0.05; Figure 2.7A). NMS-Sed mice was the only group that 
had a significantly lower percent time in light on the NTG treatment day compared to the 
second baseline day (3- days before the experiment; p<0.01; Figure 2.7A). There was a 
significant overall effect of time on distance traveled during the 2- acclimation days and 
the treatment day (p<0.001; Figure 2.7B). From baseline day 1 to baseline day 2 all 
groups trended towards traveling more but the only group that reached significance was 
NMS-Ex (p<0.05). The only group that did not decrease the distance traveled between 
baseline 2 and treatment day was Naïve-Ex, however these decreases were not 
significant (p>0.05; Figure 2.7B). On the treatment day, there was a significant overall 
effect of NMS on percent time spent in the light (p<0.05; Figure 2.7C). Both NMS 
groups spent less time in the light compared to their naïve counterparts (p<0.05). The 
second baseline day was used to calculate a change from baseline for the percent time 
spent in light and there was an overall effect of NMS on decreasing the percent of time 








Figure 2.7: Photophobia-like behavior was measured in female mice following IP NTG 
injection. 3- and 6- days before the NTG treatment day, mice were placed in a light/dark 
box placed on a force plate actimeter for 20- minutes to obtain baseline measurements 
of time spent in light and distance traveled. On the treatment day, NTG, was 
administered by IP injection to all mice. 30- minutes after NTG injection mice were 
placed in the light/dark box for 20- minutes. A) The percent of time spent on the light 
side of the box was quantified at each time point. There was a significant overall effect 
of time and a NMS/time interaction on the time spent in the light. Between the first 
baseline day and the treatment day Naïve-Sed, NMS-Sed, and NMS-Ex mice 
decreased their time spent in the light. Between the second baseline day and the 
treatment day, only the NMS-Sed group significantly decreased their time spent in the 
light. B) Total distance traveled was also quantified at each time point and there was a 
significant overall effect of time. From the first baseline day to the second baseline day, 
NMS-Ex significantly increased their distance traveled. From the second baseline day to 
the treatment day, the only group that did not decrease their distance traveled was 
Naïve-Ex group. C) On the NTG treatment day, there was a significant overall effect of 
NMS on the time spent on the light side of the box. NMS groups spent less time in the 
light on treatment day compared to naïve groups. D) There was a significant overall 
effect of NMS on the percent change from the second baseline day on the time spent in 
the light. Bracket indicates a significant effect of time (ττττ p<0.0001), a NMS/time 
interaction (η p<0.05), or NMS (ψ p<0.05), 2-way RM ANOVA or 2-way ANOVA. a, 
p<0.05 Naïve-Sed between time points, bb, bbbb p<0.01, 0.0001 NMS-Sed between 
time points, d, dd p<0.05, 0.01 NMS-Ex between time points, Bonferroni posttest. 
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 Serum corticosterone is not significantly influenced by NMS or exercise after IP NTG 
injection  
Experiment C: Mice were sacrificed 2- hours after IP NTG injection. Trunk blood 
was collected and serum was frozen until analysis using a corticosterone ELISA kit. 
There were no significant differences in serum corticosterone levels overall or between 
groups (Figure 2.8).  
2.5 Discussion 
Migraine is a debilitating neurological disorder that affects 9.7% of males and 
20.7% of females in the United States (373). It is a complicated condition with many 
symptoms that can be triggered by both endogenous and exogenous factors (45, 46), 
making it difficult to understand and treat. One trigger of migraine is stress and early life 
stress is associated with the development of migraines in adulthood (323-325). Different 
preclinical migraine models have been reported in the literature to study the 
pathophysiology of migraine. This research has led to discoveries of pharmacological 
migraine treatments that show some success, but there are often harmful off-target side 
effects associated with these drugs. Therefore, it is important to develop safer 
therapeutic interventions for migraine, such as exercise (364-366). This study used a 
mouse model of early life stress, NMS, to investigate the susceptibility of NMS mice to 
evoked migraine-like behaviors compared to non-stressed mice and if voluntary wheel 







Figure 2.8 Mice were sacrificed 2- hours after NTG injection and after assessment of 
photophobia-like behavior. Trunk blood was collected and serum was frozen until 
analysis using a corticosterone ELISA. There were no significant overall differences (2-
way ANOVA) or differences between groups (Bonferroni posttest). 
  
 88 
One tissue that plays an important role in migraine pathophysiology is the dura 
mater. It contains MCs and is highly innervated by TG neurons (309-311). Dural MCs 
can become activated by several molecules including CGRP and substance P (45, 46). 
Furthermore, they are highly responsive to activation of the HPA axis, as they express 
five isoforms of the CRF1 receptor, a single isoform of the CRF2 receptor, and contain 
one of the largest peripheral stores of CRF (36). This could explain why stress is a 
common trigger of migraine; increased peripheral CRF release during a stressful event 
results in dural MC activation and the subsequent release of inflammatory cytokines 
causing a hypersensitivity reaction (45, 46) that leads to migraine pain. In support of 
this, I found that early life stress caused an increase in the percent of degranulated MCs 
in the dura mater of female sedentary mice and an increase in the total number of dural 
MCs in male sedentary mice. Another group has shown increased dural MC 
degranulation in rats subject to restraint stress, but treatment with polyclonal antiserum 
to CRF reduced this effect (157). An additional finding in this study was that exercise 
normalized the NMS-induced increases in MC degranulation and MC number in NMS 
sedentary female and male mice, respectively (Figure 2.2). This effect could be due to 
voluntary wheel running lowering rodent susceptibility to stress, which has been 
demonstrated in a rodent model of uncontrollable tail shock (374). In this study, 
compared to rats that had access to running wheels for 6-weeks, sedentary rats 
displayed more shock-elicited freezing behavior and escape deficits. This effect is 
similar to exercise reducing stress and frequency of migraine symptoms in migraineurs 
(364, 365). I did not evaluate MC degranulation in our studies of evoked migraine 
because the substances administered cause MC degranulation (348). Therefore, it 
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would not be possible to determine if the MCs were degranulated because of previous 
stress or because of the trigger used to evoked migraine. 
Facial and extracephalic hypersensitivity are commonly seen during a migraine 
attack in migraineurs (329, 375-377) and after evoked migraine in rodents (329, 330, 
334). Facial allodynia is likely caused by sensitization of second order trigeminovascular 
neurons found in the TCC that receive input from the dura and the periorbital skin (338), 
while extracephalic allodynia is likely caused by central sensitization (329, 375, 376). I 
hypothesized that NMS mice would display paw hypersensitivity after evoked migraine 
compared to naïve mice and that exercise would attenuate this effect. However, after 
one dural IS application, there was an overall effect of IS lowering forepaw withdrawal 
thresholds with no significant differences between groups (Figure 2.3). In the IP NTG 
injection-evoked migraine paradigm, I found that there was a significant overall effect of 
NMS on hind paw sensitivity, and NMS-Sed mice had a lower withdrawal threshold 
compared to naïve-Sed, however this did not reach significance (Figure 2.6B). Similar to 
these findings regarding a lack of significance between NMS and naïve groups, 
Kaufmann et al., (346) found that both stressed and non-stressed rats developed hind 
paw mechanical hypersensitivity after NTG injection. This suggests that stress may not 
be a factor in the development of IS or NTG evoked widespread hypersensitivity. 
However, I only measured forepaw or hind paw sensitivity at one time point. It would be 
interesting to see if withdrawal thresholds changed over time in NMS and naïve mice 
and if exercise had any influence on this. It is possible that NMS mice could develop IS- 
or NTG-evoked mechanical hypersensitivity quicker than naïve mice or that it takes 
longer for NMS mice to return to baseline measurements. By only measuring withdrawal 
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threshold at one time point, I could have missed significant differences throughout the 
time course of the IS and NTG effects.  
I also employed an evoked migraine paradigm where we administered saline or 
IS then 3- days later administered IS to all groups. I chose to explore this method 
because it has been shown that one migraine-like event can lead to meningeal 
sensitization, or priming, to subsequent events (378). However, I did not see consistent 
patterns in mechanical withdrawal thresholds with this method (Figure 2.4). The method 
of multiple administrations of migraine-evoking solutions has also been used with IP 
NTG administration in mice and has demonstrated the progression of widespread 
hypersensitivity as evoked migraine becomes chronic (340). I only evaluated behavioral 
responses after one NTG injection. But, if multiple NTG injections had been 
administered to mimic the multiple migraines that migraineurs usually experience 
throughout their life, widespread allodynia might have developed, similar to what is seen 
in migraineurs. I hypothesize that NMS mice would be more susceptible to this chronic 
NTG administration compared to naïve mice, however it has yet to be tested. Finally, 
another factor that could be altered in these studies to see if there are differences in 
widespread sensitivity between stressed and non-stressed groups is to use a lower 
dose of NTG. For the previously described studies 10 mg/kg NTG was used, but 5 
mg/kg and 10 mg/kg NTG are both commonly used in the literature for evoked migraine 
in rodents. If the lesser dose of 5 mg/kg was used, it is possible that NMS mice could 
develop widespread allodynia while the naïve mice do not. 
Paw mechanical sensitivity is a form of evoked pain-like behavior. I also 
measured mouse grimace, which is an accepted measure of spontaneous pain-like 
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behavior (353), and hypothesized that NMS-sed mice would have a higher MGS score 
compared to naïve or exercised mice. Interestingly, there was consistently an increase 
in MGS score in both naïve- and NMS-Ex groups after dural IS and saline application 
(Figure 2.3A and 2.4B), as well as in non-injected mice (Figure 2.5). A higher MGS is 
associated with more spontaneous painful behaviors. However, in previous studies in 
our lab, exercise has mitigated chronic urogenital pain symptoms (100, 229). The 
differences could be due to the fact that past measurements were of evoked pain and 
this was our lab’s first evaluation of spontaneous pain. One factor that could influence 
these MGS results is that only two measurements of the MGS were evaluated: eye 
squint and ear position. However, there are three other behaviors that were not 
evaluated: whisker position, cheek bulge, and nose bulge. Evaluating these three 
behaviors in black mice proved to be very challenging. Available software to 
automatically evaluate these measures has only been developed for white rodents 
(379). An automated ‘eye squint’ assay has also been developed that highly correlates 
with MGS (380), suggesting that eye squint alone is predictive of what all 5 MGS 
behaviors will reveal and that the limited analysis in this study is likely a valid measure.  
The significant impact that exercise had on MGS, even in the absence of dural 
stimulation, was a novel finding. It is unknown what impact voluntary wheel running has 
on mouse facial features and how this may impact scoring, particularly in terms of eye 
squint and ear position. In some instances, exercise has been shown to elicit migraine 
in humans. However, this is usually after strenuous exercise (367) or if exercise is novel 
and therefore it is suggested that migraineurs be slowly habituated to exercise (369). 
Our exercised mice had access to running wheels for an extended amount of time 
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before evaluating grimace, and therefore likely did not elicit a migraine attack because 
of novelty. Further support of this is that exercise decreased dural MC degranulation in 
our NMS mice (Figure 2.2).  
Mechanical hypersensitivity and MGS are not behaviors specific to migraine;  
therefore, to follow up these initial studies, photophobia, or sensitivity to light, was 
measured, which is one symptom that meets the diagnostic criteria of migraine 
according to the International Classification of Headache Disorders (381). Using a 
light/dark box placed on a force plate actimeter, similar to the method published by 
Rossi et al., (382), the location of the mouse was continuously measured during each 
20- minute testing period in order to quantify distance traveled and the percent time 
spent in the light. All groups, with the exception of Naïve-Ex, significantly decreased 
their time spent on the light side of the box from the first baseline day to the treatment 
day. However, the only group that significantly decreased their time in the light from the 
second baseline day to the treatment day was the NMS-Sed group (Figure 2.7A). The 
percent change in time spent in the light on the treatment day from the second baseline 
day was then quantified and there was an overall effect of NMS reducing the time spent 
in light (Figure 2D). These data suggest that the NMS-Sed mice were more sensitive to 
the light after NTG injection compared to naïve or exercised mice. Total distance 
traveled during the two baseline measurements and on the treatment day were also 
evaluated. Interestingly, the only group that did not decrease their distance traveled 
from the second baseline day to the treatment day was the Naïve-Ex group (Figure 
2.7B). Other groups have evaluated photophobia-like behavior in migraine models (341, 
 93 
345, 356); however, to our knowledge this is the first study to combine a stress and 
exercise component.  
Serum corticosterone after IP NTG injection and subsequent photophobia 
assessment was also measured. Human plasma cortisol levels are increased in 
migraineurs after NTG injection and this increase significantly correlated with the 
development of migraine (149). Due to the fact that NMS and exercise have been 
shown to influence HPA axis activity, I hypothesized that the combination of NMS and 
NTG would evoke an increase in circulating corticosterone compared to naïve mice, and 
exercise would prevent this effect. However, there was no significant effect of NMS or 
exercise on serum corticosterone level. NMS-Sed mice trended toward an increase in 
corticosterone, however it did not reach significance. Although this result implies that 
corticosterone may not have an effect on evoked migraine-like behaviors, corticosterone 
level was only measured at one time point. Circulating corticosterone is known to follow 
a circadian rhythm, which peaks in the early evening just before the dark cycle in 
laboratory rodents and is lowest at the beginning of the light cycle (383). This is 
opposite to the circadian rhythm of cortisol in humans, which peaks in the early hours of 
the morning and decreases throughout the day (384). Migraineurs have been shown to 
have a greater peak cortisol level compared to control patients (147). In this study, 
serum corticosterone was measured when it should have been in a trough. If 
corticosterone had been measured in our mice during peak hours, there might have 
been different results.  
In conclusion, these results indicate that female and male NMS-Sed mice have 
altered dural MC degranulation characteristics compared to naïve mice and that 
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voluntary wheel running attenuates this. Furthermore, female NMS-Sed mice appear to 
be more susceptible to NTG induced photophobia-like behavior compared to naïve or 
exercised mice. Increased MC degranulation and photophobia are two characteristics 
are also seen in migraineurs. Therefore, these data suggest that female NMS-Sed mice 
might be more susceptible to the development of migraine-like symptoms compared to 
naïve or exercised mice. Although the mechanism behind this has yet to be 
investigated, future work in our laboratory will involve c-fos staining in the TCC as well 
as phosphorylated extracellular signal related kinase (pERK) staining in the TG to 
determine if NMS-Sed mice have greater activation in these tissues, which are both 
relevant to migraine pathophysiology (308). If NMS-Sed mice have increased activation 
in these tissues, this would provide molecular evidence coinciding with our behavioral 
photophobia data and make a stronger argument that NMS-Sed mice are in fact more 















Chapter III: The influence of early life stress, exercise, and a long-term 
high-fat/high-sucrose diet on the development of obesity-related 




The development of obesity-related metabolic syndrome involves a complex 
interaction of genetic and environmental factors. An individual is diagnosed with this 
disorder when they meet at least 3 of the following 5 criteria: central obesity, insulin 
resistance, hypertension, high triglycerides, and low HDL-cholesterol. One 
environmental factor found to be significantly associated with the development of 
obesity-related metabolic syndrome is early life stress. Early life stress is known to 
cause a dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis, which helps 
regulate the stress response, influences our perception of pain, and impacts 
downstream metabolic functions including glucose and fat metabolism, control of the 
cardio vascular system, and regulation of the immune response. In this chapter I use a 
mouse model of early life stress, neonatal maternal separation (NMS), which displays 
urogenital hypersensitivity and altered limbic regulation of the HPA axis, to expand our 
research on the many consequences of early life stress and investigate if NMS mice 
can also be used as a model of early life stress-induced obesity-related metabolic 
syndrome. Additionally, I use various lifestyle conditions, including a high-fat/high-
sucrose (HFS) diet and exercise, to investigate if these environmental factors influence 
NMS and non-stressed (naïve) mice differently in the development of obesity-related 
metabolic syndrome. Results indicate that adult female and male NMS-Sedentary (Sed) 
mice have altered body composition compared to female and male Naïve-Sed or 
exercised (Ex) mice on a standard chow diet. Next, male naïve- and NMS- Sed and -Ex 
mice were given ad libitum access to a HFS or control diet starting at 16-weeks of age 
for 11-weeks. Results indicate that all of the HFS diet groups gained a significant 
 97 
amount of weight and body fat compared to the control diet groups, with the exception 
of the Naïve-Ex-HFS group, which appeared to be protected from HFS diet-induced 
obesity compared to the other groups. Naïve-Ex-HFS mice were also more protected 
from a HFS diet-induced increase in pro-inflammatory macrophages in visceral adipose 
tissue compared to NMS-Ex-HFS mice. I hypothesize this is due to the fact that naïve 
mice run significantly more than NMS mice and therefore could attain more benefit from 
exercise. However, exercise was still partially protective in our NMS-HFS mice. For 
example, both Naïve- and NMS-Ex-HFS groups had significantly lower fasting insulin 
level and were more glucose tolerant compared to Naïve- and NMS-Sed-HFS groups. 
Interestingly, the NMS-Sed-HFS group displayed the highest fasting insulin level as well 
as the greatest increase in pro-inflammatory macrophage, pro-inflammatory cytokine 
TNFα, and mast cell tryptase mRNA in visceral adipose. These data suggest that this 
group of mice was particularly susceptible to diet-induced alterations in metabolic 
function. Finally, NMS-Sed-Control group had greater feed efficiency, which is the ability 
to turn food consumed into weight gain, was more glucose intolerant, had more pro-
inflammatory macrophage mRNA in visceral adipose tissue, and was leptin resistant. 
These findings are particularly interesting because they demonstrate that before any 
form of diet or exercise intervention, mice subjected to early life stress have altered 
metabolic functioning compared to naïve mice. Taken together, this study demonstrates 
that NMS in mice models early life stress-induced changes in metabolic function and 
that exercise is an effective therapeutic intervention for the prevention of some of the 




An estimated 39.6% of individuals aged 20 and over in the United States are 
obese and 7.7% are morbidly obese according to the 2015-2016 National Health and 
Nutrition Examination Survey (NHANES). These statistics have consistently been rising 
over the past decade and represent significant increases from the 2007-2008 NHANES, 
in which the prevalence of obesity was 33.7% and morbid obesity was 5.7% (385). 
Obesity is generally considered a pre-requisite to the development of metabolic 
syndrome (165), which is diagnosed when an individual suffers from 3 of the following 5 
criteria: central obesity, insulin resistance, hypertension, high triglycerides, and low 
HDL-cholesterol (167). However, there is a subset of individuals that are metabolically 
obese but normal weight (166). According to NHANES from 2003-2012, overall 
prevalence of metabolic syndrome in the US was 33% (302).  Additionally, individuals 
with metabolic syndrome are three times more likely to develop cardiovascular disease 
and five times more likely to develop type 2 diabetes. These data indicate that obesity is 
a serious public health problem that can lead to the development of other severe and 
life-threatening diseases.  
Obesity is more prevalent among women (386), while type 2 diabetes mellitus is 
diagnosed at a lower age and body mass index in men (387). These differences have 
been partially linked to adipose tissue distribution. Central adiposity, particularly visceral 
adipose tissue, is considered more detrimental to one’s health compared to lower body 
adipose accumulation in the form of subcutaneous adipose tissue (388). Women tend to 
have more subcutaneous adipose and less visceral adipose compared to males (389). It 
has been suggested that sex chromosomes are responsible for the differences in fat 
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distribution and the development of diet-induced obesity and/or diet-induced insulin 
resistance (390). 
Metabolic complications associated with obesity can be attributed to systemic 
processes, such as widespread metabolic inflammation, and changes at the cellular 
level, such as mitochondrial dysfunction (391).  An obesogenic environment is one in 
which the amount of energy available exceeds the lipid storage capacity of adipocytes. 
Therefore, free fatty acids and cytokines can be released into circulation (392) and 
cause inflammation that leads to the development of health complications including 
endothelial dysfunction, non-alcoholic fatty liver disease, and insulin resistance (393, 
394). This chapter is focused on factors that influence the risk of developing widespread 
metabolic inflammation as well as other symptoms involved in obesity-related metabolic 
syndrome. 
Stress and obesity-related metabolic syndrome 
The development of obesity involves a complex interaction of both genetic and 
environmental factors (158). One environmental factor found to be significantly 
associated with the development of obesity is stress (6). Although acute stress is 
necessary for survival, long-term stress has detrimental consequences. The 
hypothalamic-pituitary-adrenal (HPA) axis is one neuroendocrine system that helps 
control the stress response (10). During a stressful event, the paraventricular nucleus of 
the hypothalamus releases corticotropin-releasing factor (CRF), which signals the 
anterior pituitary gland to release adrenocorticotrophic hormone (ACTH). ACTH then 
causes the adrenal cortex to release glucocorticoids (GCs), which include cortisol in 
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humans and corticosterone in rodents (15). GCs have many downstream metabolic 
effects including glucose and fat metabolism as well as control of the cardiovascular 
system and the immune response (17).  Upon cessation of the stressor, GCs work to 
create a negative feedback loop to turn off the HPA axis at both the pituitary and 
hypothalamic level (19). Limbic structures, including the hippocampus, amygdala, and 
prefrontal cortex also play a role in regulating the HPA axis. The hippocampus and 
prefrontal cortex reduce HPA axis activity while the amygdala increases it (25). CRF 
can also work in the periphery by activating mast cells (MC), which release cytokines 
and proteases that contribute to the formation of an inflammatory environment (45, 46).  
The HPA axis is not fully developed when children are born and therefore 
stressful events at this stage of development can cause long-term permanent damage 
on the regulation and output of this system leading to health problems in adulthood, 
including obesity (6). Childhood neglect and maltreatment are two forms of early life 
stress that are associated with the development of obesity in adulthood in humans (160-
162). Additionally, HPA axis hyperactivity is seen in patients with visceral obesity (395, 
396). Research in non-human primates (163)  and rodents (164) also show early life 
stress-induced alterations in metabolic functions. 
According to the 2016 U.S Department of Health and Human services annual 
Child Maltreatment report, 676,000 children were victims of maltreatment, which shows 
a 3% increase from data reported 5- years previously. In 2016, 74.8% of these 
maltreated children were neglected, 18.2% were physically abused, and 8.5% were 
sexually abused. The age group that showed the greatest maltreatment rate per 1000 
children were those under 1 year old (12). This finding is particularly distressing with the 
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knowledge that during this time, the stress system is still developing (13) and therefore 
is vulnerable to alterations that can have long-term consequences such as 
dysregulation of the HPA axis in adulthood. One such form of dysregulation is impaired 
inhibitory control of the HPA axis by the hippocampus. The hippocampus has been 
shown to be particularly sensitive to stress-induced atrophy (397). This brain region 
expresses both glucocorticoid and mineralocorticoid receptors (GR and MR, 
respectively), which bind the GCs that are released during stress. During a time of 
chronic stress, such as early life stress, these receptors are constantly occupied. This 
can lead to hippocampal dendritic atrophy (397), which causes altered function within 
the hippocampus (398). Without appropriate hippocampal inhibition of the HPA axis, 
hypersecretion of GC stress hormones can occur. Increased circulating GCs has been 
associated with the development of obesity, particularly in the visceral region, and other 
symptoms of metabolic syndrome including insulin resistance, dyslipidemia, and 
hypertension (399).  
Neonatal maternal separation 
Dysregulation of the stress system is not only associated with the development of 
obesity, but also with a plethora of other disorders, including chronic pain and mood 
disorders, which are often experienced co-morbidly with obesity (3-7). To investigate the 
complicated relationship between early life stress and the subsequent development of 
obesity-related metabolic syndrome in adulthood, I used a mouse model called neonatal 
maternal separation (NMS). In this model, pups are separated as a litter from their mom 
for 3-hours/day from postnatal day (P) 1 to P21. Our laboratory previously used NMS to 
study the association between early life stress and the development of symptoms 
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similar to those experienced by chronic urogenital pain patients (96, 98). The goal of 
this study is to see if mice subjected to NMS also develop characteristics of obesity-
related metabolic syndrome. Furthermore, I evaluate whether or not lifestyle conditions 
such as exercise or diet have an influence on symptoms associated with this syndrome. 
Lifestyle factors and obesity 
A sedentary lifestyle (400-402) and a diet with a high proportion of saturated fat 
and refined sugars (HFS), referred to as a ‘western diet’ (286, 287) are significant 
environmental risk factors associated with obesity and related chronic diseases.  
Unfortunately, HFS diet consumption has grown due to its convenience and lower cost 
compared to healthier foods such as fruits and vegetables (288). Long-term 
consumption of HFS diet has many negative health consequences including the 
development of obesity (178, 289), type 2 diabetes (290), cardiovascular disease (291), 
and adverse impacts on brain function and behavior (292). Sedentary behavior is also 
highly prevalent in the United States, where most individuals do not meet the 
recommended requirements for daily physical activity (403). Sedentary behavior is 
associated with 35 chronic diseases, including metabolic syndrome, obesity, insulin 
resistance, hypertension, cognitive dysfunction, depression, and anxiety (402).  
Due to the fact that lifestyle factors are significantly associated with the 
development of obesity-related metabolic syndrome and other chronic health conditions, 
making lifestyle changes such as a healthier diet and increased physical activity may be 
the best way to prevent or treat the symptoms associated with these disorders. To 
successfully treat obesity, it is essential to reverse the positive energy balance that 
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underlies obesity into an energy deficit by decreasing energy intake and/or increasing 
energy expenditure. Exercise improves symptoms of metabolic syndrome in humans 
(221, 287) and rodents (228, 404), while the combination of diet and exercise 
interventions has the greatest therapeutic effect (405). There are pharmacotherapies for 
the treatment of obesity-related metabolic syndrome that can be used in addition to 
lifestyle changes, but these have been shown to be only marginally efficacious (406, 
407). ‘Exercise mimetics’ are also being studied, which attempt to mimic some of 
exercise’s influence on the body including mitochondrial remodeling, increased 
mitochondrial oxidative phosphorylation, and fatty acid metabolism (408). However, due 
to the wide-range of effects that exercise has on the body (246), these are unlikely to be 
able to completely replace physical activity, suggesting exercise still remains the best 
option for the treatment of some of these chronic disorders. Additionally, heat therapy is 
being investigated as a treatment option for individuals with obesity-related metabolic 
syndrome or type 2 diabetes because of the significant role that heat shock proteins 
play in metabolic regulation (409). Gupte et al., (410) demonstrated that weekly heat 
treatments (41°C for 20 mins) in high-fat diet fed rats improved many measures related 
to metabolic syndrome. Specifically, heat-treated rats had reduced epididymal fat pad 
weight and fasting insulin level as well as improved glucose tolerance compared to non-
heated treated high-fat diet fed rats. This group is now evaluating the influence of heat-
treatments in clinical studies to determine if their pre-clinical findings can be translated 
to humans. This would provide a novel therapeutic intervention that would be easier for 
many individuals with obesity-related metabolic syndrome to partake in compared to 
some exercise regimens. 
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Models of obesity and exercise intervention in rodents 
Both genetic and diet-induced rodent models of obesity are highly prevalent in 
the literature (411). Diet-induced obesity is a particularly relevant model due to the 
current lifestyle trends in today’s society. These experimental designs usually allow 
rodents free access to calorie-dense foods that are high in fats, sugar, or both, to mimic 
the Western diet consumption of humans. The development of obesity and metabolic 
disorders is then monitored (411). Many different factors can influence the results of 
these experiments, including strain, sex, and age of the rodent. Certain strains of mice 
are more susceptible to diet-induced obesity and related disorders than others. For 
example, C57Bl/6J are highly susceptible to these disorders (412) while A/J mice are 
less susceptible (413). The sex of mice used is also an important factor to consider 
because male mice are more susceptible to diet-induced obesity-related metabolic 
syndrome compared to female mice (303, 414). Finally, age should be considered as 
well. In general, body weight in C57Bl/6J increases over time and older mice have 
increased fat mass compared to younger mice (415). Additionally, Nishikawa et al., 
(2007) demonstrated that starting a high-fat diet at an older age in C57Bl/6J produced 
more robust changes in adipose tissue and hepatic lipid accumulation compared to 
starting the high-fat diet in younger mice (416). 
Genetic mouse models of obesity include knockout models of genes in the 
hypothalamic leptin-melanocortin feeding pathway such as Lepr, Mc4r, Pomc, and 
Pcsk1. These models have been shown to have altered energy homeostasis and body 
weight (417). Other genetic models of obesity include the ob/ob and db/db mice, which 
have deficiencies in leptin or leptin receptor production, respectively (418). ob/ob mice 
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develop severe obesity and subsequently develop mild hyperglycemia and insulin 
resistance.  db/db mice develop severe hyperinsulinemia early on but eventually insulin 
levels drop significantly as pancreatic β− cells atrophy, leading to a hyperglycemic state 
(411).  
 Exercise interventions in rodents include both resistance training and aerobic 
exercise such as wheel running, treadmill running, and swimming. Forced treadmill 
running is considered a stressor, while voluntary wheel running is considered rewarding 
(232-234), as most rodents run when provided a running wheel (231). Our laboratory 
has incorporated voluntary wheel running into our studies and have previously shown 
that it can prevent or attenuate NMS-induced urogenital MC degranulation and pain-like 
behaviors (100, 229). Therefore, in this chapter voluntary wheel running is used to 
evaluate the influence of exercise on diet-induced obesity-related metabolic syndrome. 
Significance 
This study is novel because it is investigating the influence of three factors, early 
life stress, voluntary wheel running, and HFS diet, on the development of obesity-
related metabolic syndrome. I adapted paradigms similar to the human experience in an 
attempt to make our studies as translatable as possible. Early life stress mimics 
childhood neglect, which is the most prevalent form of childhood maltreatment, 
voluntary wheel running mimics humans choosing to exercise and avoids the added 
stress of forced exercise paradigms, and a HFS diet mimics the Western diet that has 
increased in consumption in recent years. This work is important in advancing our 
knowledge regarding the prevention of potentially modifiable risk factors, such as early 
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life stress, poor diet, and sedentary behavior, in the development of obesity-related 
metabolic syndrome.  
3.3 Methods 
Neonatal maternal separation: Pregnant C57Bl/6 dams at 14-16- day gestation were 
ordered from Charles River and housed in the Department of Laboratory Animal 
Resources at the University of Kansas Medical Center. Litters were divided equally into 
NMS and naïve groups. NMS pups were removed as whole litters from their home cage 
for 180- minutes (1100-1400- hours) daily beginning at postnatal day 1 (P1) until P21. 
During separation, pups were placed in a clean glass beaker with bedding from their 
home cage. The beaker was placed in an incubator maintained at 33°C and 50% 
humidity. Naïve mice remained undisturbed in their home cage except for normal animal 
husbandry. All mice were weaned on P22 and pair-housed with same sex litter mates 
and ad libitum access to food and water. 
Exercise: At 4-weeks of age, female and male NMS and naïve mice were equally 
divided into exercised (Ex) or sedentary (Sed) groups. Ex mice were pair housed with a 
same sex litter mate in cages equipped with a stainless steel running wheel (STARR 
Life Sciences Corp, Oakmont, PA) and Sed mice were pair housed with a same sex 
litter mate but no access to a running wheel. Distance ran/pair was recorded by STARR 
Life Sciences VitalView Activity Software version 1.1. 
Experimental designs: Female mice: At 40-weeks of age, NMS- and Naïve- Sed and -
Ex mice body composition was evaluated; they were then sacrificed and adipose tissue 
was removed. Male mice: At 14-weeks of age, NMS- and Naïve- Sed and -Ex mice 
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body composition was evaluated. At 16-weeks of age, mice were further divided into 
control diet or high-fat/high-sucrose (HFS) groups. Body composition was measured 
every 2-3-weeks while food consumption and running distance were measured weekly 
throughout the experiment. At 27-weeks of age, fasting insulin and glucose tolerance 
were measured. Mice were sacrificed the morning after these measurements and 
adipose tissue was removed. 
Body composition analysis: Mice were weighed and then placed in an EchoMRI 2015 to 
measure lean mass and fat mass. Total weight, percent body fat, and free fat mass 
were quantified every 2-3-weeks. 
Periovarian adipocyte size: Female mice at 40-weeks of age were over dosed with 
inhaled isoflurane. Periovarian adipose tissue was dissected out and a piece was post-
fixed in 4% PFA for 48-hours then placed in 70% EtOH. It was then paraffinized, 
sectioned, and stained with hematoxylin and eosin to assess adipocyte size.  
High-fat/high-sucrose diet (HFS): At 16-weeks of age, male naïve- and NMS-Sed and -
Ex groups were divided equally into HFS and control diet groups. HFS diet was 
composed of 20% protein, 35% carbohydrates, and 45% fat (Research Diets Inc; New 
Brunswick, NJ; Table 3.1).  
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Table 3.1: Control and HFS diet components 
 Control diet 
Research diets D12110704 
HFS diet  
Research diets D12451 
 gm% kcal% gm% kcal% 
Protein 19.2 20 24 20 
Carbohydrate 67.3 70 (3.5% sucrose) 41 35 (15% sucrose) 
Fat 4.3 10 24 45 
Total  100  100 
Kcal/g 3.85  4.73  
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Food consumption and feed efficiency: Food consumption per pair of mice was 
measured weekly. Feed efficiency was quantified every week using the following 
equation: ((weight change per pair)/(calories consumed per pair))*1000. It is presented 
as the average feed efficiency over the 11-weeks of the experiment after the start of the 
HFS diet. 
Glucose Tolerance Test: At 27-weeks of age, following a 6-hour fast, mice were given 
an intraperitoneal injection of glucose at 1 g/kg body weight. Blood glucose levels were 
measured via tail clip immediately before glucose injection and 15, 30, 60, and 120- 
minutes thereafter (glucose diagnostic reagents, Sigma). 
Fasting insulin level: At 27-weeks of age, following a 6- hour fast, blood was collected 
via tail-clip, placed on ice for 1-hour, and centrifuged at 10,000 rpm for 10-minutes. 
Serum was collected and frozen until analysis using an insulin ELISA kit.  
mRNA extraction and RT-PCR: Mice were overdosed with inhaled isoflurane. 
Epididymal adipose tissue was dissected and immediately frozen in liquid nitrogen. 
Frozen tissue was then crushed (Cellcrusher, Portland, OR) and total RNA was isolated 
using QIAzol Lysis Reagent and the RNeasy Lipid Tissue Mini Kit (Qiagen, Valencia, 
CA). The concentration and purity were determined using NanoDrop 2000 (Thermo 
Fisher Scientific, Wilmington, DE) and cDNA was synthesized from total RNA using the 
iScript cDNA Synthesis Kit (Bio-Rad, Hercules, CA). Quantitative RT-PCR was 
performed using SsoAdvanced SYBR Green Supermix (Bio-Rad) and a Bio-Rad iCycler 
IQ real time PCR system with indicated 20uM primers (Table 3.2; Integrated DNA 
Technologies, Coralville, IA). Samples were run in triplicate and negative control  
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Table 3.2: Forward and reverse primers used for RT-PCR 
Gene Forward (5’-3’) Reverse (3’-5’) 
PPiB GGCTCCGTCGTCTTCCTTTT CCTCTACTTAGACATCCTGCTCA 
F4/80 TGACTCACCTTGTGGTCCTAA CCTTTCTGACCTAAGACCCTTC 
CD68 CCTCGCCTAGTCCAAGGTC TCGGGTTTAAGTTTAGGCTTAGG 
CD11b GGGAGGACAAAAACTGCCTCA TACGACGCTTCTAGGATCAACA 
CD11c CCAAGACATCGTGTTCCTGATT ACGACCTGAAACAATTTCGACA 
TNFα CAGGCGGTGCCTATGTCTC GATGACTTGAAGCCCCACTAGC 
IL-6 TCTATACCACTTCACAAGTCGGA TTTCTCAACACGTTACCGTTAAG 
IL-1B GCAACTGTTCCTGAACTCAACT TCAACTGCCTGGGGTTTTCTA 
INFγ ACAGCAAGGCGAAAAAGGATG AGTAGGCTCACCAGGTGGT 
Tryptase GCCAATGACACCTACTGGATG GTTGTTCCAGTCTCATGTCGAG 
Leptin GTGGCTTTGGTCCTATCTGTC CCTAGTTACTGTAAAGTGTGTGC 
GR GACTCCAAAGAATCCTTAGCTCC CTCCACCCCTCAGGGTTTTAT 
11βHSD1 GGAGCCCATGTGGTATTGACT TACCTTCTGTACTGTAAACGCC 
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reactions were run with each amplification series. To reduce variability among efficiency 
due to fluctuations in baseline fluorescence, the raw PCR data was imported to the 
LinRegPCR software and PCR efficiency values were derived for each individual 
sample. Threshold cycle values were subtracted from that of the housekeeping gene 
PPiB and the percentage of fold change over Naïve-Sed-Control was calculated using 
the Pfaffl method (419). 
Statistical analysis: Calculations of the above measurements were made in Excel 
(Microsoft, Redmond, WA) and statistical analyses were performed using GraphPad 
Prism (GraphPad, La Jolla, CA) or IBM SPSS Statistics (IBM Corporation, Armonk, NY). 
Differences between groups were determined by 2- or 3-way ANOVA or 4-way RM 
ANOVA. Fisher’s LSD or Bonferroni posttest were used. Statistical significance was set 
at p<0.05.  
3.4 Results 
Adult NMS female Sed mice have altered body composition compared to naïve and Ex 
female mice 
Female mice were divided into sedentary (Sed) or exercised (Ex) groups at 4-
weeks of age and were allowed ad libitum access to a standard chow diet. At 40-weeks 
of age, EchoMRI was used to assess female NMS- and naïve- Sed and Ex body 
composition. There was a significant overall effect of NMS (p<0.001) and NMS/exercise 
interaction (p<0.05) on body weight (Table 3.3). NMS-Sed mice weighed significantly 
more than naïve-Sed mice (p<0.01) and this effect was prevented by exercise. There 
was a significant effect of NMS (p<0.01), exercise (p<0.01), and a NMS/exercise  
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Table 3.3 Female body composition at 40-weeks of age 
Variable Overall 
analyses 
Naïve-Sed NMS-Sed Naïve-Ex NMS-Ex 
Body weight (g) ψψψ + 24.483 ± 
1.047 




26.589 ± 0.871 # 
Body fat 
percentage (%) 
ψψ γγ + 15.292 ± 
1.405 




15.816 ± 1.930 
## 
Fat free mass (g) ψ 20.675 ± 
0.606 
22.442 ± 0.902 21.511 ± 
0.397 
22.278 ±0.422 
Fat mass (g) ψψ γγ + 3.808  ± 
0.499 
 
7.998  ± 1.221 
** 
3.576  ± 
0.426 
 




 0.755 ±0.134 1.496 ± 0.273 
* 
0.743 ± 0.114 0.963 ± 0.187 
Retroperitoneal 
fat mass (g) 
 0.235 ± 0.049 0.524 ± 0.111 
* 
0.229 ± 0.047 0.316 ± 0.066 
Data are displayed as mean ± S.E.M. Overall analyses were performed using two-way 
ANOVA. Significant effect of NMS, ψψ, ψψψ p< 0.01, 0.001, exercise, γγ  p<0.01, or a 
NMS/exercise interaction + p<0.05 are denoted.*,** p<0.05, 0.01 vs. naïve;  #, ## 
p<0.05, 0.01 vs. sedentary; Bonferroni posttest. 
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interaction (p<0.05) on body fat percentage and total fat mass. NMS-Sed had a 
significantly higher body fat percentage (p<0.05) and greater total body fat (p<0.01) 
compared to naïve-Sed and NMS-Ex (p<0.01). There was a significant effect of NMS on 
fat free mass (p<0.5) but no significant differences between groups. After sacrifice, 
periovarian and retroperitoneal adipose tissue was removed and weighed. NMS-Sed 
mice had significantly more periovarian and retroperitoneal adipose tissue compared to 
naïve or exercised mice (p<0.05; Table 3.3). Additionally, NMS-Sed mice had larger 
periovarian adipocytes compared to naïve and exercised mice (Figure 3.1). 
Adult male NMS mice have greater body fat percentage compared to adult male naïve 
mice 
Male mice were divided into Sed or Ex groups at 4-weeks of age and were 
allowed ad libitum access to a standard chow diet. At 14-weeks of age, EchoMRI was 
used to assess male NMS- and naïve- Sed and -Ex body composition. There was a 
significant overall effect of exercise on body weight (p<0.05; Table 3.4). There was a 
significant overall effect of NMS (p<0.05) and exercise (p<0.001) on fat mass and body 
fat percentage. NMS-Ex had significantly less fat mass and a lower body fat percentage 
compared to NMS-Sed (p<0.01) and a significantly higher body fat percentage 
compared to Naïve-Ex (p<0.05). Naïve-Ex had significantly less fat mass and a lower 
body fat percentage compared to naïve-Sed (p<0.01). No significant differences in fat 








Figure 3.1 Periovarian adipose tissue from 40-week-old female mice on a standard 
chow diet was paraffinized, sectioned, and stained with hematoxylin and eosin to 
observe the size of the adipocytes. NMS-Sed (B) had larger adipocytes compared to 




Table 3.4 Male body composition at 14-weeks of age  
Variable Overall 
analyses 
Naïve-Sed NMS-Sed Naïve-Ex NMS-Ex 
Body 
weight (g) 




ψ γγγ 16.451 ± 0.578 19.745 ± 2.712 7.651 ± 0.747 
## 




 22.891 ± 0.421 22.279 ± 0.464 23.514 ± 0.513 22.113 ± 0.675 
Fat mass 
(g) 




Data are displayed as mean ± S.E.M. Overall analyses were performed using two-way 
ANOVA. Significant effect of NMS ψ  p<0.05, or exercise, γ, γγγ  p<0.05, 0.001; 
#, ## p<0.05, 0.01 vs. sedentary; Bonferroni posttest. 
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Long-term HFS diet and exercise alter body composition in male mice 
To determine if NMS increases obesogenic susceptibility to a HFS diet, male NMS- and 
naïve-Sed and -Ex groups were placed on high-fat/high-sucrose (HFS) diet or control 
diet at 16-weeks of age. All mice were sacrificed at 27-weeks of age, which 
corresponded with 11-weeks after the introduction of the HFS diet. There was a 
significant overall effect of diet (p<0.0001) on body weight, body fat percentage, and 
total fat mass as well as on fat free mas (p<0.05; Table 3.5). Exercise had a significant 
overall effect on body weight (p<0.05), body fat percentage (p<0.0001), and total fat 
mass (p<0.0001). Finally, there was a significant diet/exercise interaction on body fat 
percentage (p<0.05). HFS groups weighed significantly more (p<0.01), had significantly 
higher body fat percentage (p<0.01), and greater total fat mass (p<0.0001) than control 
diet groups. Exercise attenuated body fat gain in naïve- and NMS- control diet groups, 
however this effect was greater in naïve mice. Exercise also prevented naïve-HFS mice 
from gaining as much body fat as naïve-Sed-HFS mice (p<0.05), however this effect of 
exercise was not observed in NMS-HFS mice. 
Body weight, body fat percentage, fat free mass, and fat mass were measured 
every 2-3-weeks using EchoMRI (Figure 3.2). A significant effect of time was observed 
for all measurements (p<0.0001). Diet also significantly impacted body weight, body fat 
percentage, and total fat mass over time (p<0.0001), such that the HFS diet groups 
gained significantly more body weight and body fat percentage over time compared to 
control diet groups. Exercise influenced body weight (p<0.05), body fat percentage 
(p<0.0001), and total fat mass (p<0.0001), such that exercised groups gained less 
weight and body fat percentage over time compared to sedentary mice. NMS influenced  
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Data are displayed as mean ± S.E.M. Overall analyses were performed using multi-
variate ANOVA. Significant effect of exercise, γ, γγγγ  p<0.05, 0.0001; diet δ, δδδδ  
p<0.05, 0.0001; or exercise/diet interaction φ  p<0.05; 
&&, &&&, &&&& p<0.01, 0.001, 0.0001 vs. control diet; #, ##, ### p<0.05, 0.01, 0.0001 






Figure 3.2 EchoMRI was used to assess body composition of NMS- and naïve- Sed 
and -Ex mice immediately prior to and following the initiation of HFS and control diet 
interventions. A) A significant overall effect of time, exercise, a time/exercise interaction, 
a time/diet interaction, a time/stress/exercise/diet interaction, and a time/exercise/diet 
interaction, was observed on body weight. B) A significant overall effect of time, NMS, 
exercise, diet, a time/exercise interaction, a time/diet interaction, and a 
time/stress/exercise/diet interaction was observed on body fat percentage. C) A 
significant overall effect of time and a time/diet interaction was observed on fat free 
mass. D) A significant effect of time, NMS, exercise, diet, a time/exercise interaction, 
and a time/diet interaction was observed on fat mass. Bracket indicates a significant 
effect of time (ττττ, p<0.0001), exercise (γ, γγγ, γγγγ p<0.05, 0.001, 0.0001), diet 
(δδδδ p<0.0001), NMS (ψ p<0.05), a time/exercise interaction (ε, εεε  p<0.05, 0.001), a 
time/diet interaction (ΔΔ, ΔΔΔΔ p<0.01, 0.0001), a time/exercise/diet interaction 
(ωω p<0.01), or a time/NMS/exercise/diet interaction (χ, χχ p<0.05, 0.01), 4-way RM 
ANOVA. Post-hoc analyses are listed in Tables 3.6-3.8 for body weight, body fat 
percentage, and fat mass over time. 
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body fat percentage (p<0.05) and total fat mass (p< 0.05), such that NMS groups 
generally gained more body fat over time compared to naïve mice; this was particularly 
evident in control diet mice. Multiple interaction effects on body composition measures 
were also observed over time: time/exercise on body weight (p<0.05), body fat 
percentage (p<0.05), and total fat mass (p<0.001), time/diet on body weight (p<0.0001), 
body fat percentage (p<0.0001), fat free mass (p<0.01), and total fat mass (p<0.0001), 
time/exercise/diet on body weight (p<0.01), and time/NMS/exercise/diet on body weight 
(p<0.01) and body fat percentage (p<0.05).  
 Overall and post-hoc analyses were done on body composition data at each time 
point and results are listed in Table 3.6 (body weight), Table 3.7 (body fat percentage), 
and Table 3.8 (total fat mass). In summary, HFS diet had a significant overall impact on 
increasing body weight starting after only 1-week on the HFS diet (p<0.01) and lasting 
the duration of the experiment. Post-hoc analyses revealed that NMS-Ex-HFS mice 
weighed significantly more than NMS-Ex-Control (p<0.05) beginning after only 1-week 
on HFS diet, while naïve-Sed-HFS weighed significantly more than naïve-Sed-Control 
(p<0.05) and NMS-Sed-HFS weighed significantly more than NMS-Sed-Control 
(p<0.01) beginning after 3-weeks on the HFS diet. Naïve-Ex-HFS did not start weighing 
significantly more than naïve-Ex-Control until 6-weeks on the diet (p<0.01). Diet also 
had a significant overall effect on increasing body fat percentage beginning after only 1-
week on the HFS diet (p<0.0001) and lasting the duration of the experiment. Post-hoc 
analyses revealed that every HFS group had significantly more body fat percentage 
compared to their control diet counter parts (p<0.05) after 1-week on the diet with the 
exception of the naïve-Sed, which became significantly different after 3-weeks on the  
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Table 3.6: Body weight analyses of Naïve- and NMS- Sed- and Ex- Control and HFS 
diet groups before (pre) and every 2-3-weeks after introduction of the HFS diet. 














Effect of exercise p=0.011 NS NS p=0.036 NS p=0.012 







































diet N/A p=0.035 p=0.001 p<0.0001 p<0.0001 p<0.0001 
3-way ANOVA & LSD posttest. Significance set at p<0.05. NMS= neonatal maternal 
separation, Sed= sedentary, Ex= exercised, HFS= western diet, NS= no significance, 
N/A= not applicable. 
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Table 3.7: Body fat percentage analyses of Naïve- and NMS- Sed- and Ex- Control and 














Effect of NMS p=0.017 p=0.004 p=0.008 p=0.009 p=0.04 NS 




















Stress/Ex interaction  NS NS p=0.04 p=0.033 NS 







































































3-way ANOVA, LSD posttest. Significance set at p<0.05. NMS= neonatal maternal 
separation, Sed= sedentary, Ex= exercised, HFS= western diet, NS= no significance, 
N/A= not applicable.  
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Table 3.8: Fat mass analyses of Naïve- and NMS- Sed- and Ex- Control and HFS diet 















Effect of NMS p=0.038 p=0.009 p=0.012 p=0.012 NS NS 
Effect of exercise p<0.0001 p=0.003 p=0.003 p=0.001 p=0.002 p<0.0001 











































diet N/A p=0.004 p<0.0001 p<0.0001 p<0.0001 
p<0.000
1 
3-way ANOVA, LSD posttest. Significance set at p<0.05. NMS= neonatal maternal 
separation, Sed= sedentary, Ex= exercised, HFS= western diet, NS= no significance, 
N/A= not applicable 
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HFS diet (p<0.05). NMS also had an overall impact on body fat percentage starting prior 
to the introduction of the HFS diet (p<0.05) and lasting through the 11-weeks on the 
HFS diet. Post-hoc analyses revealed that naïve-Ex-Control had significantly higher 
body fat percentage than NMS-Ex-Control after 6-weeks on the diet (p<0.05) and 
Naïve-Ex-HFS had significantly higher body fat percentage than NMS-Ex-HFS after 3-
weeks on the diet (p<0.01), but this difference only lasted through 6-weeks on the diet. 
Exercise had the opposite effect that diet and NMS had on body fat percentage in that it 
reduced body fat percentage compared to sedentary groups. There was a significant 
overall effect of exercise starting prior to the introduction of the HFS diet (p<0.0001) and 
lasting through duration of the experiment. Post-hoc analyses revealed that naïve-Ex-
Control mice had significantly lower body fat percentage compared to naïve-Sed-
Control mice at the ‘Pre’ time point (p<0.0001) and this lasted through the duration of 
the experiment. Naïve-Ex-HFS had significantly lower body fat percentage compared to 
Naïve-Sed-HFS starting after only 1-week on the HFS diet (p<0.05), while NMS-Ex-
Control did not significantly differ from NMS-Sed-Control until 11-weeks on the HFS diet 
(p<0.05) and NMS-Ex-HFS never significantly differed from NMS-Sed-HFS (Table 3.7). 
Finally, total fat mass was influenced by diet, NMS, and exercise similarly to body fat 
percentage (Table 3.8).  
Feed efficiency is influenced by exercise, diet, and stress. 
Feed efficiency is a measure of an animal’s ability to turn energy consumed into 
weight. It is calculated as (weight gained per pair per week)/(calories consumed per pair 
per week). An overall effect of exercise (p<0.01), diet (p<0.0001), and a 





Figure 3.3 Weekly food intake was measured and is presented per pair because all 
mice were pair housed to avoid the stress of single housing. A) Feed efficiency 
represents the ability to convert calories consumed to weight gain. A significant overall 
effect of exercise, diet, and a NMS/exercise/diet interaction was observed on feed 
efficiency. NMS-Sed-Control had a greater feed efficiency compared to naïve-Sed-
Control, naïve-Ex-Control had a lower feed efficiency compared to naïve-Sed-Control, 
all HFS diet groups had significantly greater feed efficiency compared to their control 
counterparts, and naïve-Ex-HFS had a significantly lower feed efficiency compared to 
naïve-Sed-HFS and NMS-Ex-HFS. B) A significant overall effect of time, NMS, and 
exercise was observed on the amount of control diet consumed over time. Naïve-Ex-
Control ate significantly more than naïve-Sed-Control and NMS-Ex-Control every week. 
C) A significant overall effect of time was observed on the amount of HFS food 
consumed over time. There were no significant differences between groups. Bracket 
indicates a significant effect of exercise (γ, γγ  p<0.05, 0.01), diet (δδδδ  p<0.0001), 
NMS (ψ  p<0.05),  time (ττττ  p<0.0001), or a NMS/exercise/diet interaction (++ p<0.01), 
3-way ANOVA (A) or 3-way RM ANOVA (B&C). *, ** p<0.05. 0.01 vs. naïve, #, ##, 
### p<0.05, 0.01, 0.001 vs Sed, &, &&&, &&&& p<0.05, 0.001, 0.0001 vs. control diet, 
LSD posttest.  
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On the control diet, NMS-Sed mice had a significantly greater feed efficiency compared 
to naïve-Sed (p<0.05) and naïve-Ex had a significantly lower feed efficiency compared 
to naïve-Sed (p<0.001). All groups on the HFS diet had significantly greater feed 
efficiencies compared to their control diet counterparts (p<0.05). Similar to the control 
diet, naïve-Ex-HFS had a significantly lower feed efficiency compared to Naïve-Sed-
HFS. Finally, NMS-Ex-HFS had significantly higher feed efficiency compared to naïve-
Ex-HFS (p<0.05). 
Stress and exercise affect consumption of control, but not HFS, diet 
Food consumption was measured every week. On the control diet, there was an 
overall significant effect of time (p<0.0001), stress (p<0.05), and exercise (p<0.05; 
Figure 3.3B). Naïve -Ex-Control mice ate significantly more than naïve -Sed-Control 
(p<0.05) and NMS-Ex-Control (p<0.05) every week. On the HFS diet, there was an 
overall significant effect of time (p<0.0001), but there were no significant differences 
between the HFS diet groups (Figure 3.3C). 
Running distance is influenced by stress and diet 
Exercised mice were pair housed at 4-weeks of age to avoid the extra stress of 
single housing. Therefore, data is presented as average kilometers ran/day/pair. Over 
the course of the study, there was a significant overall effect of time (p<0.0001), NMS 
(p<0.01), and exercise (p<0.05) on running distance (Figure 3.4). Before the 
introduction of a HFS diet to half of the groups at 16-weeks of age (Pre), NMS mice ran 







Figure 3.4 At 4-weeks of age, NMS- and naïve mice were divided into sedentary (Sed) 
and exercised (Ex) groups. Ex groups were pair housed with access to a running wheel 
in their home cage and total distance ran/day/pair was recorded. At 16-weeks of age, all 
groups were further divided into control diet and high-fat/high-sucrose (HFS) groups. 
There was a significant overall effect of time, NMS, and diet on running distance over 
time. Before the start of the HFS diet (pre) there was a significant effect of NMS on 
running distance, NMS mice ran significantly less compared to naïve. After the 
introduction of the HFS diet, both HFS diet groups decreased their running distance. 
Naïve-Control mice ran significantly more than naïve-HFS and NMS-Control mice 
throughout the length of the study. Bracket indicates a significant effect of time (ττττ 
p<.0001), NMS (ψψ p<0.01), or diet (δ p<0.05), 3-way RM ANOVA; *, ** p<0.05, 0.01 
vs. naïve, & p<0.05 vs. control diet, Bonferroni posttest.  
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and NMS-HFS decreased their running distance. Naïve-Control ran significantly more 
than naïve-HFS (p<0.05) as well as NMS-Control (p<0.05 or 0.01) every week. 
Exercise and diet have opposite effects on fasting insulin level  
At 27-weeks of age, mice were fasted for 6-hours and serum insulin level was 
measured via blood collected by tail-clip. There was a significant overall effect of 
exercise (p<0.01) and diet (p<0.0001) on fasting insulin level (Figure 3.5A). Naïve- and 
NMS-Sed-HFS groups had significantly greater fasting insulin compared to naïve- and 
NMS-Sed-Control groups (p<0.01 and 0.00001, respectively). Fasting insulin levels of 
naïve- and NMS-Ex-HFS groups did not differ significantly from naïve- and NMS-Ex-
Control groups, but were significantly less than naïve-and NMS-Sed-HFS groups 
(p<0.01 and 0.001, respectively). 
NMS, exercise, and diet influence glucose tolerance 
 At 27-weeks of age, mice were fasted for 6-hours and a blood draw was taken via tail-
clip to determine baseline fasting serum glucose level. Next, an IP glucose injection (1 
g/kg) was administered and subsequent blood draws were taken at 15, 30, 60, and 120- 
minutes after injection to determine glucose tolerance over time. A time course of serum 
glucose level (Figure 3.5B) and area under the curve (AUC; Figure 3.5C) were 
analyzed. There was a significant overall effect of time (p<0.0001), NMS (p<0.001), 
exercise (p<0.0001), diet (p<0.0001), a time/diet interaction (p<0.01), and a 
time/exercise interaction (p<0.01) on glucose tolerance. 3-way ANOVA and post-hoc 
analyses for each time point were calculated and results are listed in Table 3.9. Briefly, 






Figure 3.5 At 27-weeks of age fasting insulin level and glucose tolerance were 
measured in naïve- and NMS- Ex- and Sed- Control- and high-fat/high-sucrose (HFS) 
mice. Mice were fasted for 6-hours and fasting insulin level and baseline glucose level 
were measured. An IP injection of 1g/kg glucose was administered to all mice and 
subsequent glucose measurements were taken at 15, 30, 60, and 120-minutes after 
injection. A) There was a significant effect of exercise and diet on fasting insulin level. 
Naïve-Sed-HFS and NMS-Sed-HFS groups had significantly higher insulin level 
compared to their control counterparts. Naïve-Ex-HFS and NMS-Ex-HFS had 
significantly lower fasting insulin level compared to their sedentary counterparts. B) 
There was a significant overall effect of time, NMS, exercise, diet, time/diet interaction, 
and time/exercise interaction on serum glucose levels during the glucose tolerance test 
(GTT). C) There was a significant overall effect of NMS, exercise, diet, diet/exercise 
interaction, and NMS/diet interaction on the GTT area under the curve (AUC).  NMS-
Sed-Control had a significantly greater GTT AUC compared to Naïve-Sed-Control and 
NMS-Ex-Control. Naïve-Sed-HFS, NMS-Sed-HFS, and NMS-Ex-HFS all had 
significantly greater GTT AUC compared to their control diet counterparts. Naïve-Ex-
HFS had a significantly lower GTT AUC compared to Naïve-Sed-HFS and NMS-Ex-
HFS. Bracket indicates a significant effect of exercise (γγ, γγγγ p<0.01, 0.0001), diet 
(δδδδ  p<0.0001), NMS (ψψψ, ψψψψ p<0.001, 0.0001), time (ττττ p<0.0001), a time/diet 
interaction (ΔΔ p<0.01), a time/exercise interaction (εε p<0.01), a diet/exercise 
interaction (φ p<0.05), and a NMS/diet interaction (λ p<0.05), 3-way ANOVA or 4-way 
RM ANOVA. &, &&, &&&& p<0.05, 0.01, 0.0001 vs. control diet; ##, ###, #### p<0.01, 
0.001, 0.0001 vs. Sed; **, *** p<0.01, 0.001 vs. naïve; Fishers LSD post-hoc test.  
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Table 3.9 Glucose tolerance test 
Multi-variate ANOVA, LSD posttest. Significance set at p<0.05. NMS= neonatal 




Time point (minutes) 0  15 30 60 120 
Overall analyses 
Effect of NMS NS p=0.004 NS p=0.007 p=0.002 
Effect of exercise NS p=0.018 p=0.004 p<0.0001 p<0.0001 
Effect of diet NS p=0.001 p=0.002 p<0.0001 p=0.001 
Exercise/diet interaction NS NS NS NS p=0.025 
NMS/exercise/diet interaction NS NS NS p=0.034 NS 
Post-hoc analyses 
Naïve-Sed-Control vs 
NMS-Sed-Control  Effect of NMS NS p=0.01 NS p=0.012 p=0.028 
Naïve-Ex-HFS vs. 
NMS-Ex-HFS Effect of NMS NS NS NS p=0.011 p=0.018 
Naïve-Sed-HFS vs. 
Naïve-Ex-HFS Effect of exercise NS p=0.024 p=0.008 p<0.0001 p<0.0001 
Naïve-Sed-Control vs. 
Naïve-Sed-HFS Effect of diet NS p=0.002 p=0.005 p<0.0001 p=0.001 
NMS-Control-Sed vs. 
NMS-Control-Ex Effect of exercise NS NS NS p=0.008 NS 
NMS-HFS-Sed vs. 
NMS-HFS-Ex Effect of exercise NS NS NS p=0.018 p=0.004 
NMS-Sed-Control vs. 
NMS-Sed-HFS Effect of diet NS NS NS p=0.041 p=0.035 
NMS-Ex-Control vs. 
NMS-Ex-HFS Effect of diet NS NS NS p=0.006 NS 
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level. There were also no significant differences between groups. However, following 
glucose injection there was a significant effect of NMS, exercise, and diet at each time 
point, with the exception of an effect of NMS at 30-minutes post injection (Table 3.9).  
Analysis of the glucose tolerance test (GTT) AUC further supported the results 
described above. A lower GTT AUC indicates better glucose tolerance, or a greater 
ability to clear glucose from the blood. There was a significant effect of NMS 
(p<0.0001), exercise (p<0.0001), diet (p<0.0001), a NMS/diet interaction (p<0.05), and 
an exercise/diet interaction (p<0.05) on GTT AUC (Figure 3.5C). On the control diet, 
NMS-Sed mice had a significantly greater GTT AUC compared to naïve-Sed mice 
(p<0.01) and NMS-Ex (p<0.01). On the HFS diet, all groups had a significantly greater 
GTT AUC compared to their control counterparts (p<0.05, 0.01, or 0.0001) with the 
exception of the Naïve-Ex group. Additionally, Naïve-Ex-HFS had a significantly lower 
GTT AUC than Naïve-Sed-HFS (p<0.001) and NMS-Ex-HFS (p<0.001). NMS-Ex-HFS 
had a significantly lower GTT AUC than NMS-Sed-HFS (p<0.01). 
NMS, exercise, and diet alter epididymal adipose macrophage and MC population as 
well as neuroendocrine signaling molecules 
At 27-weeks of age, mice were sacrificed, epididymal adipose tissue was 
removed and immediately frozen in liquid nitrogen, mRNA was extracted, and RT-PCR 
was used to quantify genes of interest (Figure 3.6). There was a significant effect of diet 
(p<0.0001), exercise (p<0.01), and an exercise/diet interaction (p<0.05) on mRNA for 
the general macrophage markers F4/80 and CD68 (Figure 3.6A). There was also a  
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Figure 3.6  
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Figure 3.6: RT-PCR was used to analyze mRNA levels in epididymal adipose tissue. A) 
F4/80 and CD68 mRNA was quantified to determine if there were differences in general 
macrophage markers. There was a significant overall effect of diet, exercise, and an 
exercise/diet interaction on both F4/80 and CD68 mRNA levels. There was also an 
effect of NMS and a NMS/diet interaction on CD68 mRNA levels.  All HFS groups, with 
the exception of naïve-Ex-HFS, had significantly higher mRNA levels of F4/80 and 
CD68 compared to control diet groups. Naïve- and NMS-Ex-HFS groups had 
significantly lower F4/80 and CD68 mRNA levels compared to naïve-and NMS-Sed-
HFS groups. NMS-Sed- and -Ex-HFS had significantly higher CD68 mRNA levels 
compared to naïve-Sed and -Ex-HFS. Next, CD11b and CD11c mRNA levels were to 
determine if changes in macrophages were pro-inflammatory or not. There was a 
significant overall effect of diet on both CD11b and CD11c mRNA levels, as well as an 
effect of exercise and an exercise/diet interaction on CD11c mRNA levels. Naïve- and 
NMS-Sed-HFS had significantly higher CD11b and CD11c mRNA levels compared to 
control diet counterparts. NMS-Ex-HFS had significantly greater CD11c mRNA levels 
compared to naïve-Ex-Control. Finally, naïve-and NMS-Ex-HFS had significantly lower 
CD11c mRNA levels compared to Sed-HFS groups. B) Various cytokine mRNA were 
also analyzed to determine the inflammatory status of the epididymal adipose and 
tryptase to assess putative mast cell infiltration. There was a significant overall effect of 
diet on TNFα mRNA levels, with NMS-Sed-HFS having significantly higher TNFα mRNA 
levels compared to NMS-Sed-Control. There were significant NMS/diet and 
exercise/diet interactions on tryptase mRNA levels, with NMS-Sed-HFS having 
significantly higher tryptase mRNA levels compared to NMS-Sed-Control, Naïve-Sed-
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HFS, and NMS-Ex-HFS. Naïve-Ex-HFS had significantly lower tryptase mRNA levels 
compared to naïve-Ex-Control. C) mRNA levels of leptin, glucocorticoid receptor (GR), 
and 11β− hydroxysteroid dehydrogenase type 1 (11-βHSD1) due to their roles in 
neuroendocrine signaling. A significant overall effect of diet was observed on leptin, GR, 
and 11-βHSD1 mRNA levels. Additionally, there was a NMS/diet interaction on leptin 
mRNA levels, such that naïve-Sed- and -Ex-HFS mice had significantly higher leptin 
mRNA levels compared to naïve-Sed- and Ex-control mice. Naïve-and NMS-Sed-HFS 
and NMS-Ex-HFS had significantly lower GR mRNA levels compared to naïve-and 
NMS-control and NMS-Ex-Control. Naïve-Sed- and Ex-HFS had significantly lower 11-
βHSD1 mRNA levels compared to naïve-Sed and Ex-control and NMS-Ex-Control had 
significantly lower 11-βHSD1 mRNA levels compared to naïve-Ex-Control. Bracket 
indicates a significant effect of diet (δδ, δδδ, δδδδ p<0.01, 0.001, 0.0001), exercise 
(γ, γγ p<0.05, 0.01), NMS (ψψ p<0.01), an exercise/diet interaction (Φ p<0.05), or a 
NMS/diet interaction (λ  p<0.05), 3-way ANOVA; &, &&, &&&& p<0.05, 0.01, 0.0001 vs. 
control diet; #, ##, ### p<0.05, 0.01, 0.001 vs sedentary; *, ** p<0.05, 0.01 vs. naïve; 
Fisher’s LSD posthoc test. 
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significant overall effect of NMS (p<0.01) and a NMS/diet interaction (p<0.05) on CD68 
mRNA. All HFS diet groups had significantly greater F4/80 and CD68 mRNA compared 
to control diet groups (p<0.05) with the exception of Naïve-Ex-HFS, which was not 
significantly different from Naïve-Ex-Control and significantly lower than Naïve-Sed-HFS 
(p<0.05). NMS-Ex-HFS also had significantly less F4/80 and CD68 mRNA than NMS-
Sed-HFS (p<0.05). NMS-Sed-and -Ex-HFS had significantly more CD68 mRNA than 
Naïve-Sed-and-Ex-HFS groups (p<0.05). CD11b and CD11c epididymal adipose mRNA 
were also measured to determine the inflammatory status of the macrophages. There 
was a significant effect of diet on both CD11b and CD11c mRNA (p<0.0001) as well as 
an effect of exercise (p<0.05) and an exercise/diet interaction (p<0.05) on CD11c 
mRNA. Naïve- and NMS-Sed-HFS had significantly greater CD11b and CD11c mRNA 
compared to Naïve-and- NMS-Sed-Control groups (p<0.05). CD11c mRNA levels in 
HFS groups increased 5-15-fold relative to the Naïve-Sed-Control group while CD11b 
mRNA levels in HFS groups only increased 2-3 fold. NMS-Ex-HFS also had significantly 
greater CD11c mRNA levels than NMS-Ex-Control (p<0.01). Finally, Naïve-and NMS-
Ex-HFS had significantly lower CD11c mRNA levels than Naïve-and-NMS-Ex-HFS 
(p<0.05).  
Multiple cytokines in the epididymal adipose were measured, including tumor 
necrosis factor alpha (TNFα), interleukin 1 beta (IL1-β), interleukin 6 (IL-6), and 
interferon gamma (IFNγ; Figure 3.6B). Only TNFα was significantly impacted with a 
significant overall effect of diet (p<0.001) and NMS-Sed-HFS had a significantly greater 
mRNA level compared to NMS-Sed-Control (p<0.05). As a means to evaluated MC 
infiltration, the level of tryptase mRNA in epididymal adipose was measured. There was 
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a significant overall effect of exercise (p<0.05) and an exercise/diet interaction (p<0.01) 
on tryptase mRNA levels, with NMS-Sed-HFS mice having significantly higher tryptase 
mRNA levels than Naïve-Sed-HFS (p<0.01), NMS-Ex-HFS (p<0.01), and NMS-Sed-
Control (p<0.01) mice. Naïve-Ex-HFS mice had significantly lower tryptase mRNA levels 
compared to Naïve-Ex-Control mice (p<0.05).  
To determine whether neuroendocrine signaling changes were occurring in 
epididymal adipose due to diet, exercise, and stress, mRNA levels of leptin, 
glucocorticoid receptor (GR), and 11 β-hydroxysteroid dehydrogenase type 1 (11-
βHSD1; Figure 3.6C) were measured. There was a significant effect of diet (p<0.01) and 
exercise (p<0.05) on leptin mRNA levels. Naïve-Sed- and -Ex-HFS had significantly 
higher leptin mRNA levels compared to naïve-Sed- and -Ex-Control groups (p<0.05). 
There was a significant effect of diet on both GR and 11-βHSD1 mRNA levels 
(p<0.001). Naïve-Sed-, NMS-Sed-, and naïve-Ex-HFS had significantly lower GR mRNA 
levels and naïve-Sed-and -Ex-HFS had significantly lower 11-βHSD1 mRNA levels 
compared to their control counterparts (p<0.05). NMS-Ex-Control had significantly lower 
11-βHSD1 mRNA levels compared to naïve-Ex-Control (p<0.05). 
3.5 Discussion 
Obesity-related metabolic syndrome is a serious illness that is highly prevalent in 
today’s society. In humans, environmental factors including early life stress (160-162), 
poor diet (178, 289), and low activity level (400-402) increase one’s risk to develop this 
disorder. Many pre-clinical studies have investigated the influence that HFS diet (411-
413, 416) and exercise (228, 404, 420) have on the development of obesity-related 
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metabolic syndrome, while only a few have investigated the role that early life stress 
plays (163, 164). To my knowledge, this is the first study to combine early life stress, 
exercise, and diet to evaluate outcomes related to this disorder.  
I first found that chow-fed adult female and male NMS-Sed mice have altered 
body composition compared to naïve-Sed and exercised mice (Tables 3.3 & 3.4). 
Studies have shown that female mice are not as susceptible to diet-induced weight gain 
as male mice (303). Our observations confirm this and are described in Chapter 4 of 
this dissertation. Therefore, male NMS- and Naïve- Ex- and -Sed mice were used in a 
HFS diet study to see if early life stress and exercise influenced the development of 
diet-induced obesity-related metabolic syndrome. All mice on the HFS diet gained a 
significant amount of weight throughout the study, compared to mice on the control diet 
(Table 3.5). NMS-Ex-HFS mice gained significantly more weight compared to NMS-Ex-
Control after only 1-week on the HFS diet while NMS-Sed-HFS and naïve-Sed-HFS 
weighed significantly more than their control diet counterparts after 3-weeks on the HFS 
diet. The last group to gain a significant amount of weight was the naïve-Ex-HFS group 
at 6-weeks on the diet (Figure 3.2A & Table 3.6). These results suggest that exercise 
was more beneficial in preventing weight gain in the naïve-HFS mice compared to 
NMS-HFS mice. This is further exemplified in body fat percentage where there was a 
significant overall effect of NMS, generally causing an increase in this measure over 
time compared to naïve mice (Figure 3.2b). There were significant differences between 
naïve-Ex-Control vs. NMS-Ex-Control groups as well as naïve-Ex-HFS vs. NMS-Ex-
HFS groups at multiple time points where the NMS groups had significantly more body 
fat percentage then naïve mice (Table 3.7) despite consuming the same amount of HFS 
 143 
diet (Figure 3.3C). Similar to weight gain, all groups on the HFS diet gained significant 
amounts of body fat, however the naïve-Ex-HFS gained the least amount (Table 3.5). 
This was also true for the naïve-Ex group on the control diet (Table 3.5), again, 
suggesting that naïve mice gained greater benefit from exercise compared to NMS 
mice. Interestingly, naïve-Ex mice also ate significantly more control diet compared to 
the other groups (Figure 3.3B), but they demonstrated appropriate energy balance by 
running more than NMS-Ex mice (Figure 3.4).  
The reduced running distance, and thereby energy expenditure, by NMS mice 
could partially underlie their increased weight and body fat gain compared to naïve 
mice. However, differences in feed efficiency, which is the ratio of weight gained/ energy 
consumed, suggest that basal differences in metabolism are also at play. NMS-Sed-
Control mice had significantly higher feed efficiency than naïve-Sed-Control mice, 
indicating that NMS increases potential weight gain, even in the absence of diet or 
exercise interventions. Exercise significantly lowered feed efficiency in both control- and 
HFS-fed naïve groups when compared to sedentary counterparts. In contrast, exercise 
did not significantly impact feed efficiency in NMS mice on either a control or HFS diet. 
Again, the low running distance of the NMS, particularly those on HFS diet, definitely 
contributes to the moderate impact on feed efficiency. Future studies can incorporate 
treadmill running or capping daily distances to determine the impact of NMS in mice 
with equivalent aerobic output.  
Glucose intolerance is one symptom of metabolic syndrome and a hallmark of 
prediabetes (167). Following a bolus glucose injection, NMS-Sed-Control mice were 
significantly less efficient at clearing glucose from circulation compared to Naïve-Sed-
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Control, indicating they were glucose intolerant. Exercise significantly improved glucose 
clearance of control-fed NMS mice, but serum glucose levels remained comparatively 
higher than that of naïve-Ex-Control. Exercise and HFS diet differentially affected NMS 
and naïve mice, with NMS-Ex-HFS having lower GTT than NMS-Sed-HFS, but higher 
than naïve-Ex-HFS and NMS-Ex-control. The only HFS-fed group that did not develop 
glucose intolerance was the naïve-Ex group. (Figure 3.5C). While it was not altogether 
surprising that the groups that gained significant amounts of weight and body fat 
became glucose intolerant, it was intriguing was that the control-fed NMS mice were 
more glucose intolerant than naïve-control. This finding supports the association 
between early life stress in humans and the development of obesity and related 
metabolic disorders in adulthood (6, 160-162).  
Increased fasting insulin level is another sign of insulin resistance, which is also a 
symptom of metabolic syndrome (167).  Again, significant effects of diet and exercise 
were observed in this study. HFS diet significantly increased fasting insulin level in both 
sedentary naïve and NMS mice, but this was reversed by exercise (Figure 3.5a). These 
data imply that a HFS diet can induce both glucose intolerance and insulin resistance, 
which can be partially prevented by voluntary exercise. Furthermore, the NMS-Sed-HFS 
group had the highest fasting insulin level (Figure 3.5A), suggesting that a combination 
of early life stress, sedentary caging, and HFS diet generated the most robust measures 
of metabolic syndrome.  
White adipose tissue distribution and composition is important in predicting the 
development of obesity-related diseases because it plays a key role in regulating 
systemic metabolic function and inflammation (168). Visceral fat accumulation is 
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associated with a greater risk of metabolic dysfunction (169) and leads to chronic low-
grade inflammation (170). This low-grade inflammation is associated with increased 
macrophage and MC infiltration as well as the increased prevalence of crown-like 
structures (CLS) and has been demonstrated in both obese mice and humans (171, 
172, 174, 421). CLSs are apoptotic adipocytes surrounded by pro-inflammatory 
macrophages. They are formed when there is a hypoxic environment, such as when 
adipose tissue growth outpaces angiogenesis and their accumulation eventually creates 
fibrotic tissue. RT-PCR was used to analyze the macrophage profile of epididymal 
adipose tissue. These analyses revealed an effect of diet and exercise on mRNA levels 
of the macrophage markers F4/80 and CD68 and an effect of NMS on CD68 mRNA 
levels. Diet and NMS caused an increase in these macrophage markers while exercise 
prevented this effect, particularly in naïve-HFS mice. The NMS-Sed-Control group also 
appeared to have more F4/80 and CD68 mRNA compared to naïve- or Ex-Control mice, 
however it did not reach significance (Figure 3.6a).  
Classically macrophages have been divided into two groups: M1, recruited pro-
inflammatory macrophages, which are F4/80+CD11c+, or M2 resident macrophages, 
which are F4/80+CD11b+ (422). While this dichotomy is largely an over simplification 
and there exists a spectrum of macrophage phenotypes (423), I was interested in 
determining the basic inflammatory state of the macrophages in our epididymal adipose 
tissue. There was a significant effect of diet on both CD11b and CD11c mRNA, but HFS 
diet increased the pro-inflammatory CD11c expression 5-15-fold and the non-
inflammatory CD11b expression only 2-3-fold, when compared to naïve-Sed-control 
levels (Figure 3.6A). This indicated that the increase in macrophages in epididymal 
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adipose tissue was mostly of the M1 pro-inflammatory type. Naïve- and NMS-HFS-Ex 
groups had significantly lower CD11c mRNA levels compared to naïve- and NMS-HFS-
Sed groups, indicating that exercise influenced the inflammatory status of the 
epididymal adipose tissue in a positive way. Similar to the F4/80 and CD68 results, 
NMS-Sed-Control had greater CD11c mRNA levels compared to naïve or exercised 
groups, but it did not reach significance (Figure 3.6A).  
To further investigate the inflammatory status of our mice, mRNA levels of 
multiple cytokines in the epididymal adipose tissue were measured. A significant overall 
effect of diet was observed on TNFα mRNA levels, where the NMS-Sed-HFS group had 
the greatest increase of TNFα mRNA and NMS-Sed-Control had a greater increase of 
TNFα mRNA compared to naïve or Ex groups (Figure 3.6B). This is a mechanistically 
significant finding because TNFα affects insulin sensitivity. Using a targeted null 
mutation for the gene encoding TNFα and two of its receptors, Uysal et al. (424) found 
that in diet-induced obese and ob/ob genetically modified obese mice, the mice with the 
null mutation for TNFα had significantly improved insulin sensitivity. The TNFα deficient 
mice had lower levels of circulating free fatty acids and did not have obesity-related 
reductions in insulin receptor signaling in muscle and fat tissues, suggesting that 
TNFα works through several mechanisms. Interestingly, the group with the highest 
TNFα in epididymal adipose, NMS-Sed-HFS, also had the highest fasting insulin level, 
suggesting that insulin resistance could be at least partially driven by increased visceral 
adipose TNFα.   
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Gurung et al., (173) recently showed that subcutaneous adipose tissue of 
individuals with metabolic syndrome had a 2.5-fold increase in MCs compared to control 
subjects.  This increase in MCs was positively correlated with markers of fibrosis and 
inflammation. Obese subjects have also been shown to have significantly higher serum 
tryptase levels (175). Furthermore, high-fat diet-induced obese mice display increased 
MCs in visceral adipose tissue (421). Here, RT-PCR was used to quantify the amount of 
tryptase mRNA in the epididymal adipose to determine putative MC infiltration. Overall, 
there were significant NMS/diet and exercise/diet interactions. By far, the highest level 
of tryptase mRNA was found in NMS-Sed-HFS adipose, which was reduced by exercise 
(Figure 3.6B). These results imply that, much like with glucose intolerance and insulin 
levels, the combination of early life stress, sedentary caging, and a HFS diet had a 
cumulative effect on increasing epididymal adipose MC infiltration. 
Despite the association of a greater number of MCs in obese humans and 
rodents, the role of MCs in the development of metabolic syndrome is conflicting. In 
support of MCs being involved in the development of metabolic syndrome, Liu et al., 
(175) used two MC-deficient genetic mouse models, KitW-sh/W-sh  (C57Bl/6) and 
KitW/Wv(WBB6F1/J), as well as wildtype mice treated with two different MC stabilizers, 
disodium cormoglycate (DSCG) and ketotifen, and found that, when fed a “Western 
diet” (20% fat, 45.2% carbohydrate, 22.6% protein; 12-13-weeks), these mice gained 
significantly less body weight than wildtype control mice on the same diet. MC-deficient 
mice also displayed higher glucose tolerance and insulin sensitivity compared to control 
mice on this Western diet. Interestingly, switching mice from a Western diet to a control 
diet and simultaneously treating them with a MC stabilizer resulted in greater 
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improvement in weight and glucose tolerance compared switching to a control diet 
alone. However, Gutierrez et al., (425) argue that it was the Kit deficiency, not the MC 
deficiency in the KitW-sh/W-sh  and KitW/Wv mice, that caused the resistance to high-fat diet 
induced weight gain, glucose intolerance, and insulin insensitivity. This group used a 
Kit-independent C57Bl/6 Cpa3Cre/+MC deficient mouse model. On a high-fat diet (60% 
kcal fat, 20% kcal protein, 20% kcal carbohydrate; 16-weeks), these mice displayed 
similar weight as C57Bl/6 Cpa3+/+ mice that were not MC deficient. Both groups of mice 
also had similar glucose tolerance and fasting insulin levels. Finally, they used DSCG to 
inhibit MC degranulation, similar to the dosage used by Liu et al (2009), but they found 
that this had no effect on weight gain in high-fat died fed mice with or without MCs. A 
major difference between these two studies was the percent of fat in the diets. Liu et al. 
(175) used a diet with 20% fat, while the Guiterrez et al., (425) diet contained 60% fat. 
The lengths of the diets also differed, 12-13-weeks vs. 16-weeks. While these 
differences may not explain all of the dissimilarities between the two studies, it raises 
the point that consistency between high-fat diet studies is necessary to appropriately 
compare results. 
Although there are arguments regarding the necessity of MCs for the 
development of obesity-related metabolic syndrome, they do play a clear role in altering 
the inflammatory state of adipose tissue. They are a source of TNFα (426) as well as 
other cytokines including macrophage colony stimulating factor (427), which causes 
hematopoietic stem cells to differentiate into macrophages. MCs also have been shown 
to express mRNA and protein for NGF and release NGF upon activation (428), which 
could then cause the maturation of more MC progenitors. Therefore, even if MCs are 
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not required for the development of obesity-related metabolic syndrome, they could 
contribute to its pathogenesis. In this study, data indicated that although HFS diet and 
stress alone did not increase MC tryptase in epididymal adipose tissue, the combination 
of these two factors did. Additionally, exercise prevented this significant increase 
(Figure 3.6B). Our laboratory has previously shown that MC degranulation is increased 
in urogenital organs (97, 98) and dura mater (Chapter 2) of NMS-Sed mice and that 
exercise prevents or attenuates this effect. Therefore, I hypothesize that NMS-induced 
dysfunction of the HPA axis leads to an increase in systemic CRF release and a 
subsequent widespread increase in MC infiltration and degranulation. The metabolic 
stress of a HFS diet could also cause MC activation and elicit further increases in 
adipose tissue MCs and infiltrating pro-inflammatory macrophage populations, 
eventually contributing to the development of obesity-related metabolic syndrome.  
To further study the role that the HPA axis might play in the development of HFS 
diet-induced obesity-related metabolic syndrome, GR mRNA levels in epididymal 
adipose tissue was measured because increased circulating GCs have been associated 
with the development of obesity, particularly in the visceral region (399). In adipose 
tissue, GCs promote differentiation of pre-adipocytes into mature adipocytes and 
increase lipoprotein lipase activity, which can increase the amount of adipose tissue and 
subsequently cause weight gain (429). Clinical studies in obese patients have shown 
simultaneous increases in GR and 11β-HSD1 (85, 86), which converts inactive GCs to 
their active form (430). 11β-HSD1 is also increased in adipose tissue of genetically 
obese rodent models, such as the obese Zucker rat (431), which is homozygous for a 
mutation in the leptin receptor gene. Furthermore, overexpression of 11β-HSD1 in 
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mouse adipose tissue leads to the development of visceral obesity and metabolic 
syndrome (87). However, Morton et al., (432) studied the effects of 2-and 18-weeks of a 
high-fat diet on 11β-HSD1 in adipose tissue of C57Bl/6J and A/J mice. They found that 
both short- and long-term high-fat diet caused a decrease in adipose 11β-HSD1, 
especially in the obesity-resistant A/J mice. Both strains also became obese on the 
long-term diet and the C57Bl/6J mice were hyperinsulinemic. High-fat diet-induced 
reduction in adipose 11β-HSD1 has also been demonstrated in Wistar rats, but it was 
transient and disappeared after 20-weeks on the diet (433). I measured 11β-HSD1 
mRNA in epididymal adipose tissue after 11-weeks on a HFS diet and found a 
significant overall effect of diet reducing 11β-HSD1 epididymal adipose mRNA. 11β-
HSD1 was reduced the most in naïve-Sed-HFS and Naïve-Ex-HFS (Figure 3.6C). 
These results paired with the studies described above imply that reduction in 11β-HSD1 
only occurs in diet-induced obesity in rodents, not genetically obese models. In line with 
HFS diet causing a reduction in 11β-HSD1 mRNA, there was also an effect of HFS diet 
reducing the amount of GR mRNA in epididymal adipose tissue. This diet-induced 
reduction reached significance in naïve-Sed-HFS, NMS-Sed-HFS, and NMS-Ex-HFS 
groups (Figure 3.6C). A down regulation of 11β-HSD1 and GR could be an adaptive 
mechanism to attempt to circumvent the detrimental metabolic consequences of 
increased GC signaling. This adaptive mechanism appears to function better in our 
naïve-HFS mice as their 11β-HSD1 mRNA levels were significantly reduced while NMS-
HFS mice 11β-HSD1 mRNA levels did not reach significance (Figure 3.6C). 
 151 
White adipose tissue is a complex endocrine organ that secretes adipokines, 
including leptin (434). Leptin communicates with its receptor in the hypothalamus to 
regulate food intake and energy expenditure by shutting down hunger signals (435). 
This circuitry is not fully programmed at birth making it susceptible to the influence of 
environmental factors (429). Circulating leptin usually peaks during development from 
P4-P16 in rodents (436) and this peak is important for proper formation of the 
hypothalamic feeding circuitry (435). Early life stress has been shown to reduce leptin 
levels early in life (437, 438), which could lead to altered programming of the leptin-
hypothalamic circuit and long-term changes in hunger signals and energy expenditure. 
When leptin mRNA in the epididymal adipose tissue was measured in this study, there 
was a significant overall effect of diet as well as a NMS/diet interaction. On the HFS 
diet, Naïve-Sed and -Ex groups had significantly higher leptin mRNA compared to their 
control diet counterparts. However, NMS-Sed and -Ex-HFS groups were not 
significantly different than groups on the control diet (Figure 3.6C). A HFS diet is 
expected to increase leptin levels, so that hunger signals are decreased and energy 
expenditure is increased to compensate for the extra energy that is being consumed. 
Our naïve-HFS groups showed an appropriate increase in leptin levels, however our 
NMS-HFS mice did not (Figure 3.6C). This suggests a NMS-induced alteration in leptin 
signaling. Increased leptin levels should not be present in mice on a control diet. 
However, NMS-Sed-Control mice had a much higher leptin mRNA level compared to 
naïve-Sed-control or NMS-Ex-Control (Figure 3.6c). This suggests that this group may 
be leptin-resistant, meaning that leptin is not as effective in suppressing food intake. It 
has been hypothesized that a hyperactive HPA axis, which leads to the elevation of GC 
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concentrations, is involved in leptin resistance in obesity (439). Our NMS protocol 
involves separating mice from P1- P21, which includes the important window of 
development of the leptin-hypothalamic feeding circuitry (435, 436). Therefore, proper 
programming of both the HPA axis and leptin signaling could be affected by NMS and 
have long-term consequences on metabolism. 
In summary, NMS, exercise, and diet all appear to influence factors related to 
metabolic syndrome. This was first demonstrated by the finding that chow-fed NMS-Sed 
female and male mice have altered body compositions compared to naïve and Ex mice 
and was further exemplified by our long-term HFS diet study. The NMS-Sed-HFS group 
had the highest fasting insulin level, the greatest amount of TNFα, pro-inflammatory 
macrophage marker CD11c, and MC tryptase mRNA in epididymal adipose tissue 
suggesting this group was more prone to visceral inflammation and development of 
insulin resistance compared to the other groups. NMS-Sed- and -Ex-HFS groups did not 
demonstrate a HFS diet induced increase in leptin levels, indicating they had alterations 
in the leptin-signaling pathway. Our results also implied that our NMS-Sed-Control mice 
were more susceptible to developing symptoms of metabolic syndrome compared to 
naïve- or Ex-control mice. NMS-Sed-Control mice had increased TNFα, pro-
inflammatory macrophage marker CD11c, and leptin mRNA levels compared to other 
groups on the control diet.  This suggests they are more prone to visceral inflammation 
and are leptin resistant. This group also had an increased GTT AUC, indicating they are 
less glucose tolerant. Finally, they had a greater feed efficiency, so they were better 
able to turn calories consumed into weight. Overall, exercise influenced measurements 
of obesity-related metabolic syndrome in both naïve and NMS mice but appeared to 
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have a stronger effect in naïve mice compared to NMS in some of our measurements. 
For example, exercise prevented the increase in body fat over time to a greater extent 
in naïve-Control and-HFS mice compared to NMS-Control and -HFS mice. It was also 
more beneficial in naïve-HFS mice in preventing a HFS diet-induced increase in the 
GTT AUC, where naïve-Ex-HFS had a significantly lower GTT AUC compared to NMS-
Ex-HFS mice. However, NMS-Ex-HFS GTT AUC was significantly lower than NMS-
Sed-HFS, implying that NMS mice still received some benefit from exercise. Evidence 
of exercise benefiting NMS and naïve mice equally was that both naïve- and NMS-Ex-
HFS groups had a significantly lower fasting insulin level compared to Sed-HFS groups. 
Exercise also prevented the NMS and HFS induced increase in epididymal tryptase 
mRNA. However, naïve-Ex-HFS groups were more protected from significant changes 
in pro-inflammatory macrophage infiltrates compared to all of the other HFS groups, 
which had significantly more CD11c epididymal adipose mRNA compared to their 
control diet counter parts. The increased benefit of exercise in naïve mice could be due 
to the fact that naïve mice ran significantly more than NMS mice. I hypothesize that 
these differences could be due to changes in reward pathways. Lovallo (2013) explains 
that early life stress in humans can lead to altered dopaminergic signaling (440), which 
influences motivated behaviors (441), including physical activity. Future studies in our 
laboratory will investigate if NMS mice have alterations in the mesolimbic dopamine 
system. This could cause them to be less motivated to run compared to naïve mice, due 









Chapter IV: The effect of an anti-inflammatory diet intervention on 




Individuals with functional pain disorders such as irritable bowel syndrome, 
interstitial cystitis/painful bladder syndrome, migraine, and fibromyalgia often present 
with symptoms of or are diagnosed with more than one disorder. Furthermore, these 
patients with co-morbid pain disorders are also more likely to present with mood 
disorders, including depression and anxiety, as well as with obesity-related metabolic 
syndrome. Although the exact cause of these co-morbid disorders is not fully 
established, a common underlying factor in many of these patients is a dysfunction of 
the hypothalamic-pituitary-adrenal (HPA) axis, which regulates the stress response, 
plays a role in the perception of pain, and impacts downstream metabolic functions. The 
HPA axis is not fully developed when children are born and therefore is susceptible to 
incorrect programming caused by early life perturbations. Early life stress is associated 
with improper programming of the HPA axis and the subsequent development of co-
morbid chronic pain, mood, and obesity-related metabolic syndrome in adulthood. 
These disorders are all associated with a chronic state of low-grade inflammation, which 
suggests that a reduction in inflammation could be a suitable therapeutic intervention for 
these patients. In support of this, humans that consume an anti-inflammatory diet exhibit 
a widespread reduction in inflammation and this type of diet is beneficial in the 
treatment of symptoms related to obesity-related metabolic syndrome and certain 
chronic pain conditions. However, how an anti-inflammatory diet influences the 
development of early life stress-induced co-morbid disorders is unknown. In this study, I 
investigate if an anti-inflammatory diet (AID) can be used as a non-pharmacological 
therapeutic intervention for the prevention of putative early life stress-induced co-morbid 
 156 
disorders in female and male mice. To do this, I used a mouse model of early life stress, 
neonatal maternal separation (NMS), to assess the development of widespread pain 
and obesity-related metabolic syndrome compared to non-stressed (naïve) mice and if 
AID could prevent the predicted development of these early life stress-induced co-
morbid disorders. I compared mice consuming AID to mice consuming a non-anti-
inflammatory diet (NAID), which had the same composition as AID but without the 
added anti-inflammatory components, and to mice on a control diet, which was similar 
to a standard rodent chow diet. I found complex sex, stress, and diet interactions in 
most of our measures. Specifically, female and male NMS-AID mice were more 
susceptible to weight and body fat percentage gain compared to mice on the other 
diets.  Female Naïve- and NMS-AID mice were also more glucose intolerant compared 
to NAID and control mice but male NMS-AID were not, despite them displaying 
increased susceptibility to weight and body fat gain. One finding that was consistent 
across groups was that AID was beneficial in the prevention of the development of 
stress and/or diet-induced perigenital sensitivity in female and male mice and hind paw 
sensitivity in female mice. Taken together, these data indicate that sex, stress, and diet 
are all important factors that play a role in the development of co-morbid chronic pain 
and obesity-related metabolic syndrome. Furthermore, although AID is able to treat pain 
disorders in humans and prevent the development of pain-like behaviors in our mice, 
studying a diet that has metabolic benefits in humans might not translate appropriately 




A recent report found that in the year 2016, 50- million adults in the United States 
suffered from chronic pain and 20- million from high-impact chronic pain, or pain that 
limited life or work activities most days during the past 6- months. This report also found 
that chronic pain is more prevalent in women and older adults (442). Individuals with 
chronic pain often suffer from co-morbid pain disorders, such as irritable bowel 
syndrome, chronic prostatitis, vulvodynia, interstitial cystitis/painful bladder syndrome, 
fibromyalgia, and migraine, as well as mood disorders and obesity-related metabolic 
syndrome (443-449). Obesity is another chronic disorder that is highly prevalent in the 
United States and unfortunately the incidence of obesity is rapidly increasing (385). 
Future predictions indicate that about 42% of the US population will be obese by 2030 
and this will cost an additional $549.5 billion each year for medical expenditures (450).  
Obesity is generally considered a fundamental pre-requisite for the development 
of metabolic syndrome (165), which is diagnosed when an individual suffers from 3 of 
the following 5 criteria: central obesity, insulin resistance, hypertension, high 
triglycerides, and low HDL-cholesterol (167). However, there is a subset of individuals 
that are metabolically obese but normal weight (166). Obesity is also a risk factor for the 
development of chronic pain in weight bearing joints (451) and is associated with a 
number of chronic pain disorders, including fibromyalgia, headache, abdominal and 
pelvic pain, and chronic neuropathic pain (447). Fibromyalgia is characterized by 
widespread pain and tenderness, fatigue, and disability. The most recent criteria for 
diagnosing fibromyalgia emphasizes the importance of using generalized widespread 
pain criteria, that “fibromyalgia remains a valid construct irrespective of other 
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diagnoses”, and that the fibromyalgia symptom scale should be used (452). Loevinger 
et al., (453) studied a sample of 109 adult premenopausal women with fibromyalgia and 
46 healthy women as controls and found that those with fibromyalgia were 5.6 times 
more likely to have metabolic syndrome then healthy controls. Additionally, the 
incidence of fibromyalgia was also associated with each of the metabolic syndrome 
criteria that were measured, including greater waist circumference, higher blood 
pressure, serum triglycerides, and total and LDL cholesterol. Other studies support an 
association between fibromyalgia and obesity-related metabolic syndrome as well (454, 
455) and patients with fibromyalgia are often diagnosed with other chronic pain 
disorders, such as irritable bowel syndrome, interstitial cystitis/painful bladder 
syndrome, and headache (446).  
These data highlight that there is a high incidence of co-morbidity in individuals 
with chronic pain and obesity-related metabolic syndrome. Although the exact cause of 
these co-morbid disorders is not fully understood, a common underlying factor in many 
of these patients is a dysfunctional hypothalamic-pituitary-adrenal (HPA) axis (3-7).  
HPA axis and early life stress  
 The HPA axis is a neuroendocrine system that regulates the stress response and 
plays a role in the perception of pain (9, 10). When the HPA axis is functioning 
appropriately, a stressful event causes the hypothalamus to release corticotropin-
releasing factor (CRF), which signals the anterior pituitary gland to release 
adrenocorticotrophic hormone (ACTH). ACTH signals the adrenal cortex to release 
glucocorticoids (GCs; cortisol in humans and corticosterone in rodents) that have 
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downstream metabolic effects including glucose and fat metabolism, control of the 
cardiovascular system, and regulation of the immune response (15-17). A negative 
feedback loop is established to turn off activation of the HPA axis by suppressing the 
production of CRF and ACTH upon cessation of the initial stressor (18, 19). Limbic 
structures including the hippocampus, amygdala, and prefrontal cortex, assist in 
resetting the HPA axis following a stressful event, as well as regulate its tone (Figure 
1.1). The hippocampus and prefrontal cortex usually dampen the HPA axis response 
while the amygdala usually increases it (16, 25).  
 The HPA axis is not fully developed when children are born and therefore is 
susceptible to incorrect programming caused by early life perturbations, such as stress 
(13). Early life stress is associated with improper development of the HPA axis and the 
subsequent development of co-morbid chronic pain, mood, and metabolic disorders in 
adulthood (3-7). The Adverse Childhood Experiences (ACE) study reveals evidence of 
the severe consequences of early life stress. This study evaluated the prevalence of 
early life stress in a cohort of over 9,500 individuals and found that half reported at least 
one ACE and one-fourth reported two or more ACEs (323). From this original cohort of 
individuals, over 50 studies have been published investigating the long-term effects of 
early life stress. These studies demonstrate that early life stress can lead to the 
development of a number of chronic diseases, including chronic pain in the form of 
migraine (324), and a lower health-related quality of life (456). They also found that 
individuals that had four or more ACEs had a 1.4- 1.6 fold increase in physical inactivity 
and severe obesity (323). Other groups have found that childhood neglect and 
maltreatment are two forms of early life stress that are associated with the development 
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of obesity in adulthood (160-162). Additionally, HPA axis hyperactivity is seen in 
patients with visceral obesity (395, 396). Finally, a large study of 3,000 individuals with 
chronic pain evaluated the association between a history of abuse, including abuse 
early in life, and how they ranked on the Fibromyalgia Scale using the 2011 
Fibromyalgia Survey Criteria and a Symptom Severity Scale. They found that the 
patients that had a history of abuse had greater pain severity, depression, anxiety, 
worse physical functioning, and higher scores on the Fibromyalgia Survey Criteria, also 
referred to as greater “fibromyalgianess”, compared to those without a history of abuse 
(457). Data from these studies indicate that experiences early in life can have long-term 
consequences resulting in the development of chronic pain and/or obesity in adulthood. 
Understanding why this association exists and how we can treat these disorders is 
extremely important. 
Neonatal maternal separation (NMS) 
To study the many consequences of early life stress, our laboratory uses a 
mouse model known as NMS. This stress paradigm involves separating pups as a 
whole litter from the dam for 3- hours/day starting from postnatal day 1 (P1) to P21. 
Previously our lab has shown that NMS in mice results in the development of symptoms 
similar to those experienced by chronic pelvic pain patients, including urogenital 
sensitivity, increased mast cell (MC) degranulation in urogenital organs, and altered 
limbic control of the HPA axis (96-98). NMS mice also show increased MC infiltrate or 
MC degranulation in the dura mater, a tissue important in the pathophysiology of 
migraine (Chapter 2) and weigh more and have increased body fat percentage 
compared to naïve mice on a standard chow diet (Chapter 3). Our laboratory has also 
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demonstrated that exercise in the form of voluntary wheel running is a therapeutic 
intervention that prevents or attenuates many NMS-induced effects (100, 229)(Chapters 
2 & 3). Patients with chronic pain and/or obesity-related metabolic syndrome often have 
trouble completing prescribed exercise regimes. Therefore, our goal is to determine if 
diet can be used as an alternative non-pharmacological therapeutic intervention. 
Specifically, in this study I am investigating if an anti-inflammatory diet (AID) can be 
used to prevent the predicted development of early life stress induced widespread pain 
and obesity-related metabolic syndrome. 
AID 
Many chronic pain, mood, and metabolic disorders are associated with a chronic 
state of low-grade inflammation (255, 256, 268). Therefore, an AID is thought to be a 
good dietary intervention for patients that suffer from these disorders (269). In humans, 
an AID is high in fruits, vegetables, lean or plant based protein, whole grains, high fiber, 
and healthy fats such as omega-3 fatty acids (FAs) (270). In this study, the AID used 
was developed from the AID used in Totsch et. al., (282). It is made of 20% protein, 
45% carbohydrate with 0% sucrose, and 35% fat. The fat source is soybean and 
flaxseed oil, which are high in omega-3 FAs. It is made on a hi-maize 260-starch 
background, which is a high fiber resistant starch that aids in maintaining healthy blood 
sugar levels. AID also includes epigallocatechin gallate (EGCG), sulforaphane, 
resveratrol, curcumin, and ginseng (Table 4.1), all of which have anti-inflammatory 
properties. Furthermore, all of these anti-inflammatory ingredients are beneficial in 
treating symptoms of obesity-related metabolic syndrome, pain, and  
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interact with the HPA axis to prevent the development of stress-induced depression-like 
behaviors in rodents as described below (Summarized in Table 4.2). 
EGCG is the most abundant polyphenol found in green tea and is known for its 
antioxidant properties (458). In humans, a diet that is supplemented with polyphenols 
aids in preventing the development of obesity, metabolic syndrome, and type 2 diabetes 
(459). The beneficial effect of EGCG on the development of obesity-related metabolic 
syndrome is also seen in pre-clinical research. For example, male C57Bl/6 mice fed a 
high-fat diet supplemented with EGCG (3200 mg/kg diet) for 16-weeks had lower 
adipose tissue, lower fasting blood glucose and cholesterol compared to mice fed a 
high-fat diet with no EGCG (460). Pre-clinical studies have also shown EGCG’s 
therapeutic properties for the treatment of pain. Chronic constriction injury (CCI) in rats 
leads to decreased mechanical and heat pain thresholds and increased pro-
inflammatory cytokines in the spinal dorsal horn. However, after intrathecal injection of 
EGCG (1 mg/kg) starting 1- day before and continuing 3- days after CCI, pro-
inflammatory cytokines were reduced, the anti-inflammatory cytokine IL-10 was 
significantly increased, and pain thresholds were increased (461). Finally, EGCG 
influences the HPA axis. Lee et al., (462) used a single prolonged stress paradigm that 
caused cognitive deficits and decreased hippocampal brain-derived neurotrophic factor 
(BDNF) in rats. However, rats that received IP injections of EGCG (25 mg/kg) following 
the stressful event had improved cognition and did not show alteration in hippocampal 
BDNF.  
Sulforaphane is found in cruciferous vegetables such as broccoli, cauliflower, 
and Brussel sprouts and has antioxidant, anti-inflammatory, and neuroprotective effects  
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(475, 476). Furthermore, it prevents the differentiation of pre-adipocytes into adipocytes 
in vitro (477), which is important in the development of obesity. C57Bl/6N mice fed a 
high-fat diet supplemented with sulforaphane (1000 mg/kg diet) for 6-weeks had lower 
feed efficiency, body weight, visceral adipose tissue, and fat accumulation in the liver 
compared to mice on a high-fat diet without sulforaphane (463). Furthermore, IP 
administered sulforaphane (0.1-100 mg/kg) for 7- days prevented the development of 
CCI-induced mechanical and thermal hypersensitivity and increased pro-inflammatory 
cytokine levels seen in CCI mice not treated with sulforaphane (464). Finally, 
sulforaphane prevents stress-induced changes in mood disorders through alteration of 
the HPA axis. Wu et. al., (465) used a chronic mild stress paradigm in mice to induce 
depressive and anxiety like behaviors. However, mice that received repeated IP 
injections of sulforaphane (10 mg/kg) did not display stress-induced behaviors. 
Sulforaphane-treated mice had increased sucrose preference, increased immobility time 
in a forced swim test, and increased time in the center of an open field test compared to 
mice that did not receive treatment. They also demonstrated that sulforaphane 
administration inhibited the stress-induced increase in serum ACTH and corticosterone.   
 Resveratrol is a natural polyphenol and phytoalexin that is produced by several 
plants and fruits in response to injury, including grapes, apples, raspberries, blueberries, 
pistachios, plums, and peanuts and has anti-inflammatory and antioxidant effects (478). 
150 mg/day of resveratrol benefited obese men by reducing resting metabolic rate and 
decreasing circulating inflammatory markers, fatty acids, and glycerol compared to 
obese men that received a placebo. Resveratrol-treated men also had enhanced 
muscle mitochondrial respiration (479). Benefits of resveratrol on symptoms of 
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metabolic syndrome were also seen in C57Bl/6J mice fed a high-fat diet supplemented 
with resveratrol for 20-weeks (200 g/kg diet). These mice had reduced hepatic steatosis 
and adipose tissue macrophages, and were more insulin sensitive compared to mice 
fed a high-fat diet without resveratrol supplementation. Resveratrol supplementation 
also improved high-fat diet-induced memory impairments; the authors suggest this is 
likely due to reduced inflammation in the hippocampus (466). Additionally, resveratrol 
reduces pain-like symptoms in mice. For example, in a mouse model of streptozotocin-
induced diabetic neuropathy, mice develop higher glucose levels, tail and paw heat 
hyperalgesia, and increased circulating TNFα. However, resveratrol treatment (5, 10, 
and 20mg/kg) daily for 4-weeks attenuated thermal hyperalgesia, decreased circulating 
TNFα levels, and whole brain nitric oxide in a dose dependent manner (467). Finally, 
resveratrol can prevent the development of mood disorders through alterations of the 
HPA axis. This was demonstrated in rats that were administered exogenous 
corticosterone and subsequently developed depression-like symptoms, such as 
anhedonia in sucrose preference test, and a decrease in hippocampal BDNF. However, 
when Swiss albino mice were treated with resveratrol (80g/kg) before corticosterone 
injection for 3-weeks, these effects were prevented (468).  
 Curcumin is the most bioactive polyphenol in the spice turmeric and has anti-
inflammatory, anti-oxidant, and anti-angiogenesis properties (480). In both high-fat diet-
induced C57Bl/6J mice and ob/ob genetically obese mice, dietary curcumin 
supplementation (300 mg/kg) improved glucose tolerance and insulin sensitivity, as well 
as reduced adipose tissue macrophage infiltration (469). Clinical trials demonstrated 
that humans treated with curcumin and piperine, which enhances the bioavailability of 
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curcumin, have decreased circulating triglyceride and inflammatory cytokine levels but 
no changes in body weight or body fat (481, 482). Clinical data also reveal that 
curcumin (1,500 mg/day for 4-weeks) used for treatment of knee osteoarthritis patients 
is just as effective as ibuprofen treatment, but curcumin has less reported 
gastrointestinal problems (181). Pre-clinical work investigating the influence of curcumin 
on pain demonstrates that in a rat model of CCI, curcumin (100mg/kg) starting the day 
after the operation and lasting 14-days prevents the development of thermal and 
mechanical paw hypersensitivity (470). Additionally, in humans with major depressive 
disorder, 500 mg twice daily for 8-weeks of curcumin was more effective than placebo in 
improving depressive symptoms (483). Finally, curcumin can treat depression-like 
symptoms through alterations in the HPA axis. This was observed in a 20-day chronic 
unpredictable stress paradigm in Sprague-Dawley rats that resulted in a deficit in 
escape behaviors in a shuttle box test, which is used to evaluate depression-like 
behavior in rodents, as well as elevated serum corticosterone and decreased 
hippocampal glucocorticoid receptor and BDNF mRNA. However, 21-day administration 
of curcumin at 5 or 10 mg/kg reversed these stress-induced behavioral and molecular 
effects (471).  
 Ginseng is a medicinal herb and its root has been used for thousands of years in 
Asia because of its anti-inflammatory and anti-oxidant properties. The major 
pharmacological compounds in ginseng are ginsenosides but it also contains 
flavonoids, alkaloids, lignans, and vitamins (484). Ginseng extract (4g x 2 times a day) 
taken for 8-weeks by obese adult women significantly reduced body weight and body 
mass index (485). Interestingly, this study showed that the gut microbiota differed in 
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those that significantly lost weight and those that did not. Positive effects from ginseng 
supplementation on weight and pain are also demonstrated in pre-clinical studies. For 
example, mice that were fed a high-fat diet supplemented with wild ginseng ethanol 
extract (250 and 500 mg/kg) had lower body weight and smaller adipocytes compared 
to mice on a non-supplemented high-fat diet (472). The mice that received ginseng also 
had lower fasting glucose levels and improved insulin sensitivity. Furthermore, 
ginsenoside (50mg/kg) inhibited the development of pain-like behaviors following 
capsaicin injection into the hind paw, including biting or licking of the paw (473). Finally, 
ginseng interacts with the HPA axis and treats depression-like behaviors in male 
C57BL/6J mice treated with chronic unpredictable stress for 8-weeks. Stressed mice 
developed depression-like responses during forced swim and tail suspension tests and 
had elevated serum corticosterone. However, when mice were treated IP 10 mL/kg 
ginsenoside during the last 14- days of the stressor, the depression-like behaviors and 
increased serum corticosterone did not develop. Additionally, ginsenoside up-regulated 
hippocampal BDNF mRNA in mice that underwent chronic mild stress (474).  
 Dietary fat source can also influence inflammation. Omega-6 FAs are considered 
pro-inflammatory, while omega-3 FAs are considered anti-inflammatory (270) and it is 
the ratio of the two that determine inflammatory status. Increased omega-3 FAs have 
been linked to long-term health benefits such as improved weight management and 
cardiovascular, immune, and neuronal function (486) and increased omega-6 FAs is 
linked to an increased risk of developing obesity (487). A study investigating the effect 
of omega-3 FA supplementation in high-fat diet-induced obese mice showed that 
including omega-3 FAs in the diet prevented increased macrophage infiltration in 
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adipose tissue normally seen in a high-fat diet not supplemented with omega-3 FAs 
(284). Interestingly, body weight was higher in the mice whose diet was supplemented 
by omega-3 FAs but their plasma triglyceride concentrations were significantly lower. 
The ratio of FAs also influences pain in patients. For example, an increase in omega 3-
FA consumption paired with a reduction in omega-6 FAs reduced headache pain and 
improved quality of life in a study of chronic headache patients (179). Additionally, 
Goldberg and Katz (180) found that adding omega-3 FAs to the diet of patients with 
rheumatoid arthritis, as well as joint pain associated with inflammatory bowel diseases 
and dysmenorrhea, reduced joint pain intensity, number of painful joints, and NSAID 
consumption for the treatment of joint pain. The AID used in this study is made of 35% 
fat that comes from flaxseed and soybean oils (Table 4.1), which are considered a 
healthy fat source because they contain a greater omega-3 to omega-6 FA ratio (488).  
 Finally, the amount of dietary added sugar is also an important factor to consider 
in diet studies. A diet high in added sugar, usually fructose-containing sugars such as 
high fructose corn syrup or sucrose, is associated with the development of metabolic 
syndrome, cardiovascular disease, and type 2 diabetes (489). Added sugar contributes 
to the positive energy balance associated with obesity and the subsequent development 
of metabolic syndrome. The detrimental consequences of added sugar were 
demonstrated in a clinical study that compared the effects of consuming glucose- or 
fructose- sweetened beverages for 10-weeks. They found that although subjects gained 
the same amount of weight, those that consumed fructose-sweetened beverages had 
increased liver lipogenesis, dyslipidemia, and visceral adipose tissue as well as 
decreased insulin sensitivity compared to those that consumed glucose-sweetened 
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beverages (490). The AID used in this study has 0% added sucrose in an attempt to 
avoid the negative effects of added sugar (Table 4.1). 
Sex differences 
 Women are overrepresented in many chronic pain disorders and healthy women 
are more sensitive to experimentally induced pain compared to healthy men (491, 492). 
Additionally, females display higher levels of basal circulating corticosterone compared 
to males (298) and sex differences have been found in animal responses to stress (297, 
493, 494). Finally, obesity is more prevalent among women (386), while type 2 diabetes 
mellitus is diagnosed at a lower age and body mass index in men (387). However, pre-
clinical studies suggest that female mice are resistant to diet-induced weight gain and 
other metabolic alterations compared to males (303, 414). Due to the high incidence of 
sex differences in these disorders, both female and male mice were used in this study. 
Significance 
Co-morbid pain, mood, and obesity-related metabolic syndrome are all highly 
prevalent in the United States and many individuals that suffer from these co-morbid 
disorders have experienced early life stress. Unfortunately, most pharmacological 
therapeutic treatments for these disorders are not universally successful or have 
dangerous side effects. Therefore, studying appropriate treatments to prevent the 
development of stress-induced chronic disorders is important. Anti-inflammatory 
components are successful in the treatment of obesity-related metabolic syndrome, 
certain chronic pain disorders, and also influence the HPA axis in rodents (Table 4.2). In 
this study AID (Table 4.1) is used as a therapeutic intervention for putative early life 
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stress-induced co-morbid disorders. To my knowledge, this is the first study to 
investigate the influence of AID in NMS female and male mice and evaluate sex, stress, 
and diet interactions. 
4.3 Methods 
Neonatal maternal separation: Pregnant C57Bl/6 dams at 14-16- day gestation were 
ordered from Charles River and housed in the Department of Laboratory Animal 
Resources at the University of Kansas Medical Center. Litters were divided equally into 
NMS and naïve groups. NMS pups were removed as whole litters from their home cage 
for 180- minutes (11am-2pm) daily beginning at postnatal day 1 (P1) until P21. During 
separation, pups were placed in a clean glass beaker with bedding from their home 
cage. The beaker was placed in an incubator maintained at 33°C and 50% humidity. 
Naïve mice remained undisturbed in their home cage except for normal animal 
husbandry. All mice were weaned on P22 and pair-housed with same-sex litter mates 
and ad libitum access to water and a control diet composed of 20% kcal protein, 70% 
kcal carbohydrate (3.5% sucrose) and 10% kcal cat (Research Diets, Inc. New 
Brunswick, NJ; Table 4.1). 
Anti-inflammatory diet (AID): At 4-weeks of age, female and male naïve and NMS mice 
were further divided. Half remained on the control diet and half were switched to AID, 
which was composed of 20% kcal protein, 45% kcal carbohydrate (0% sucrose), and 
35% kcal fat with a Hi-Maize 260 starch source and added anti-inflammatory 
components: EGCG, sulforaphane, resveratrol, curcumin, and ginseng (Research Diets, 
Inc. New Brunswick, NJ); Table 4.1). Food intake was measured weekly. 
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Non-anti-inflammatory diet (NAID): At 4-weeks of age in a different cohort, female and 
male naïve and NMS mice were further divided. Half remained on the control diet and 
half were switched to NAID, which was composed of 20% kcal protein, 45% kcal 
carbohydrate (0% sucrose), and 35% kcal fat with a Hi-Maize 260 starch source 
(Research Diets, Inc. New Brunswick, NJ; Table 4.1). Food intake was measured 
weekly. 
Feed efficiency:  Food consumption per pair and weight gain were measured every 
week. Feed efficiency was then calculated as weight gained/calories consumed per pair 
of mice per week. An average feed efficiency was quantified from weekly feed efficiency 
throughout the course of the experiment. 
Body composition analysis: Mice were weighed and placed in an EchoMRI 2015 to 
measure lean mass and fat mass. Total weight, percent body fat, and free fat mass 
were quantified. 
Perigenital mechanical sensitivity: Perigenital mechanical withdrawal threshold was 
assessed every 4-weeks starting after 4-weeks on the AID or NAID diets. For 2-days 
prior to the test day, mice were acclimated to a sound proof room for 30-minutes and 
then placed into individual clear plastic chambers (11 x 5 x 3.5 cm) on a wire mesh 
screen elevated 55cm above a table for 30-minutes. On the test day, mice were also 
acclimated to the sound proof for 30-minutes and then placed on the table for 30-
minutes. The up-down method was performed to test mechanical sensitivity using a 
standard set of Semmes-Weinstein monofilaments (1.65, 2.36, 2.83, 3.22, 3.61, 4.31, 
4.74 g; Stoelting, Wood Dale, IL) (372, 495). Beginning with the 3.22 g monofilament, 
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mice received a single application to either the scrotum or perivaginal area. A negative 
response was followed by the next larger filament and a positive response (considered 
a brisk jerk or licking the affected area) was followed by the next smaller filament. The 
experimenter continued to move up or down the series, depending on the previously 
elicited response, for an additional four applications after the first positive response was 
observed for a minimum of five or a maximum of nine total monofilament applications. 
The value in log units of the final monofilament applied in the trial series was used to 
calculate 50% g threshold for each mouse (372).  
Hind paw mechanical sensitivity: Hind paw sensitivity was assessed every 4-weeks 
starting after 5-weeks on the AID or NAID diets. On the test day, mice were acclimated 
to a sound proof room for 30- minutes and then placed into individual clear plastic 
chambers (11 x 5 x 3.5 cm) on a wire mesh screen elevated 55cm above a table for 30-
minutes. An electronic von Frey device (IITC Life Science Inc. Woodland Hills, CA) was 
used to measure hind paw withdrawal threshold. A filament was applied to the hind paw 
and the force that elicited a withdrawal was recorded from the electronic device. Each 
mouse was tested 6-times. The highest and the lowest value of each mouse were 
excluded. Therefore, an average of 4-measurements/mouse was quantified.   
Nestlet behavior: After 16-17-weeks on the AID or NAID diets, a nestlet building assay 
was carried out. One hour before the start of the dark phase, mice were individually 
placed in a clean cage with 3g-nestlet material. Pictures were taken of the nestlets the 
next morning and un-torn nestlet material was weighed. Nestlet score was assigned 
using a nestlet rating scale ranging from 1-5 (496). 
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Fasting insulin: After 18-19-weeks on the AID or NAID diets, fasting insulin level was 
measured. Following a 6- hour fast, blood was collected via tail-clip, placed on ice for 1- 
hour, and centrifuged at 10,000 rpm for 10- minutes. Serum was collected and frozen 
until analyses using an insulin ELISA kit (American Laboratory Products Company, 
Salem, NH). 
Glucose Tolerance Test: After 18-19-weeks on the AID or NAID diets, a glucose 
tolerance test was carried out. Following a 6-hour fast, mice were given an IP injection 
of glucose at 1 g/kg body weight. Blood glucose levels (glucose diagnostic reagents, 
Sigma) were measured via tail clip immediately before glucose injection and 15, 30, 60, 
and 120- minutes thereafter. 
Corticosterone level: At After 18-19-weeks on the AID or NAID diets, mice were 
sacrificed during the early half of the light cycle (0800-1100- hours) and trunk blood was 
collected, placed on ice for 1-hour, and centrifuged at 10,000 rpm for 10-minutes. 
Serum was removed and frozen until analysis using a corticosterone ELISA kit 
(American Laboratory Products Company, Salem, NH). 
Statistical analyses:  Comparisons were made between control groups from the AID and 
NAID cohorts based on sex and NMS status and no significant differences were 
observed for body weight, body fat, food intake, feed efficiency, fasting insulin, serum 
glucose levels, nestlet building behavior, and serum corticosterone; therefore, the 
control groups were combined for statistical comparisons. Calculations of the 
measurements described above, with the exceptions of perigenital and hind paw 
sensitivity, were made in Excel (Microsoft, Redmond, WA) and statistical analyses were 
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performed using GraphPad Prism (GraphPad, La Jolla, CA) or IBM SPSS Statistics 
(IBM Corporation, Armonk, NY). Differences between groups were determined by 2- or 
3-way ANOVA or 3-or 4- way RM ANOVA and Bonferroni posttest. Statistical 
significance was set at p<0.05. For hind paw sensitivity, using Generalized Estimating 
Equation (GEE) framework, the following model was created for each diet/sex: 
 𝐻𝑖𝑛𝑑𝑝𝑎𝑤!" = 𝛼! + 𝛼!𝑤𝑒𝑒𝑘!" + 𝛼!𝑤𝑒𝑒𝑘!"! + 𝛼!𝑠𝑡𝑟𝑒𝑠𝑠!" + 𝜀!" and for perigenital sensitivity 
the following model was created for each diet/sex: 
  log 𝑃𝑒𝑟𝑖𝑔𝑒𝑛𝑖𝑡𝑎𝑙!" = 𝛼! + 𝛼!𝑤𝑒𝑒𝑘!" + 𝛼!𝑤𝑒𝑒𝑘!"! + 𝛼!𝑠𝑡𝑟𝑒𝑠𝑠!" + 𝜀!". To fit these models, 
a Markov structure was employed for the working correlation matrix. For posttest 
analyses, each subgroup was compared in terms of area under the curve.  
4.4 Results 
Female and male NMS mice on the AID diet are more susceptible to weight gain over 
time compared to other groups. 
Body weight was measured weekly throughout the course of the experiment in 
female and male mice after the introduction of the AID or NAID diets (Figure 4.1). There 
was a significant overall effect of time (p<0.0001), diet (p<0.01), NMS (p<0.01), and a 
time/diet interaction (p<0.01) for female body weight (Figure 4.1A). Female NMS-AID 
mice weighed significantly more than female NMS-control mice at 7, 9, and 14-18-
weeks on their respective diets (p<0.05). Female NMS-AID mice also weighed 








Figure 4.1 Body weight was measured weekly in female and male mice on a control, 
AID, or NAID diet. A) In female mice there was a significant overall effect of time, NMS, 
diet, and a time/diet interaction. At weeks 7, 9, and 14-18 NMS-AID weighed 
significantly more than NMS-Control and at weeks 14-18 NMS-AID weighed significantly 
more than NMS-NAID. B) In male mice there was a significant overall effect of time, 
diet, and a NMS/time interaction. Starting at 5-weeks on the diet and lasting through the 
duration of the experiment, NMS-AID mice weighed significantly more than NMS-
Control mice, starting after 10-weeks on the diet and lasting through the duration of the 
experiment NMS-NAID mice weighed significantly more than NMS-control mice and 
naïve-NAID mice weighed significantly more than naïve-control mice, and starting at 14-
weeks on the diet naïve-AID mice weighed significantly more than naïve-control mice. In 
an overall analysis of female and male body weight over time, there was a significant 
effect of time (p<0.0001), NMS (p<0.05), a sex/time interaction (p<0.0001), a diet/time 
interaction (p<0.0001), a sex/diet interaction (p<0.01), and a sex/diet/time interaction 
(p<0.001), 4-way RM ANOVA. Bracket indicates a significant effect of time (ττττ 
p<0.00001), NMS (ψψ p<0.01), diet (δδδδ p<0.0001), a time/stress interaction (β 
p<0.05), or a time/diet interaction (Δ p<0.01); 3-way RM ANOVA. & p<0.05 vs. control 
diet, * p<0.05 vs. naïve; Bonferroni posttest.  
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mice, there was a significant overall effect of time (p<0.0001), diet (p<0.0001), and a 
NMS/time interaction (p<0.05) on body weight (Figure 4.1B). Starting at 5-weeks on the  
diets and lasting through the duration of the experiment, male NMS-AID mice weighed 
significantly more than male NMS-control mice (p<0.05). Starting at 10-weeks on the 
diets and lasting through the duration of the experiment, male NMS-NAID weighed 
significantly more than male Naïve-NAID (p<0.05) and male naïve-NAID weighed 
significantly more than male naïve-Control (p<0.05). Starting at 14-weeks on the diets, 
male naïve-AID started weighing significantly more than male naïve-Control (p<0.05). In 
an overall analysis of female and male body weight over time, there was a significant 
effect of time (p<0.0001), NMS (p<0.05), a sex/time interaction (p<0.0001), a diet/time 
interaction (p<0.0001), a sex/diet interaction (p<0.01), and a sex/diet/time interaction 
(p<0.001). Analyses of body weight at sacrifice are listed in Tables 4.3 (female) and 4.4 
(male).  
Female and male NMS mice on the AID diet are more susceptible to body fat 
percentage gain over time compared to other groups. 
Body composition was assessed using EchoMRI every 2-4-weeks starting 4-
weeks after the introduction of the AID or NAID diets and body fat percentage was 
quantified (Figure 4.2). In female mice, there was a significant overall effect of time 
(p<0.0001), diet (p<0.0001), and a time/diet interaction (p<0.0001) on body fat 
percentage (Figure 4.2A). At every time point that was measured, female NMS-AID 
mice had a significantly higher body fat percentage compared to female NMS-control 
mice (p<0.05) and at 4, 8, 16, and 18-weeks on the diets, female NMS-AID had a  
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Data are expressed as mean  ± S.E.M. Significant effect of diet, δδδδ p<0.0001, or NMS 
ψ  p<0.05, 2-way ANOVA. &, && p<0.05, 0.01 vs. control diet, Bonferroni posttest. 
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Figure 4.2 Beginning 4-weeks after the start of the AID or NAID diets, body composition 
was assessed using EchoMRI and body fat percentage was quantified in female and 
male mice. A) In female mice there was a significant overall effect of time, diet, and a 
time/diet interaction. Female NMS-AID mice had a significantly greater body fat 
percentage compared to female NMS-control mice at every time point that body 
composition was measured. Female NMS-AID mice had a significantly higher body fat 
percentage compared to female NMS-NAID mice at the 16- and 18- week 
measurements and female naïve-AID mice had a significantly greater body fat 
percentage compared to female naïve-control mice at the 18- week measurement. B) In 
male mice there was a significant overall effect of time, diet, and a time/diet interaction 
on body fat percentage. Male NMS-AID mice had a significantly higher body fat 
percentage compared to male NMS-control mice starting at the 8- week measurement 
and lasting the duration of the experiment. Male naïve-NAID mice had a significantly 
higher body fat percentage compared to male naïve-control mice starting at the 12-
week measurement and male naïve-AID mice had a significantly higher body fat 
percentage compared to male naïve-control mice at the 16-week measurement, which 
lasted the duration of the experiment. In an overall analysis of female and male body fat 
percentage over time there was a significant effect of time (p<0.0001), diet (p<0.0001), 
sex (p<0.05), a NMS/diet interaction (p<0.05), a diet/sex interaction (p<0.05), a diet/time 
interaction (p<0.0001), a sex/time interaction (p<0.0001), and a sex/diet/time interaction 
(p<0.0001), 4-way RM ANOVA. Bracket indicates a significant effect of time (ττττ 
p<0.0001), diet (δδδδ p<0.0001), or a time/diet interaction (ΔΔΔΔ p<0.0001); 3-way RM 
ANOVA. & p<0.05 vs. control, # p<0.05 vs. NAID; Bonferroni posttest. 
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significantly higher body fat percentage compared to female NMS-NAID mice (p<0.05). 
At 18-weeks on the diets, female naïve-AID mice had a significantly higher body fat 
percentage compared to female naïve-control mice (p<0.05). In male mice, there was a 
significant overall effect of time (p<0.0001), diet (p<0.0001), and a time/diet interaction 
(p<0.0001) on body fat percentage (Figure 4.2B). At 8, 12, 16, and 18-weeks on the 
diets, male NMS-AID had a significantly higher body fat percentage compared to male 
naïve-AID mice (p<0.05). At 12, 16, and 18-weeks on the diets male NMS-NAID mice 
had a significantly higher body fat percentage compared to male NMS-control mice 
(p<0.05). At 16-weeks on the diets, male naïve-AID mice had a significantly higher body 
fat percentage compared to male naïve-control mice (p<0.05). In an overall analysis of 
female and male body fat percentage over time there was a significant effect of time 
(p<0.0001), diet (p<0.0001), sex (p<0.05), a NMS/diet interaction (p<0.05), a diet/sex 
interaction (p<0.05), a diet/time interaction (p<0.0001), a sex/time interaction 
(p<0.0001), and a sex/diet/time interaction (p<0.05). Analyses of body fat percentage at 
sacrifice are listed in Tables 4.3 (female) and 4.4 (male). 
Sex influences food intake while diet influences food feed efficiency 
Food intake was measured weekly and is reported as food consumed per pair 
due to the fact that mice were pair housed to avoid the added stress of single housing 
(Figure 4.3). In female mice, there was a significant effect of time on food intake 
(p<0.05; Figure 4.3A) with no significant differences between groups in post-hoc 
analysis. In male mice, there was a significant effect of time (p<0.0001) and diet 
(p<0.01) on food intake (Figure 4.3C). After 1-week on the diets, male naïve-AID mice 






Figure 4.3 Food intake is reported as food consumed per pair because mice were pair 
housed to avoid the extra stress of single housing. Feed efficiency is calculated as 
weight gained/calories consumed per week. An average feed efficiency was quantified 
from weekly feed efficiency throughout the course of the experiment. In female mice, 
there was a significant effect of time on food intake (A) and of diet on feed efficiency 
(B). Female NMS-NAID mice had a significantly lower feed efficiency compared to 
NMS-AID mice. C) In male mice, there was a significant overall effect of time and diet 
on food intake. After 1- week on the diets, naïve-AID mice ate significantly more than 
naïve-control mice and, at 5- weeks on the diets, NMS-AID mice ate significantly more 
than NMS-control mice. D) There was also a significant effect of diet on feed efficiency 
in male mice. In an overall analysis of female and male feed efficiency, there was a 
significant overall effect of diet (p<0.01), sex (p<0.0001), and a diet/sex interaction 
(p<0.05), 3-way ANOVA. Bracket indicates a significant effect of time (τ, ττττ p<0.05, 
0.0001) or diet (δ, δδ, δδδ p<0.05, 0.01, 0.001), A, C: 3-way RM ANOVA, B, C: 2-way 
ANOVA;  # p<0.05 vs. AID, & p<0.05 vs. control, Bonferroni posttest. 
  
 186 
diets, NMS-AID ate significantly more than NMS-control mice (p<0.05). Feed efficiency 
is calculated as weight gained/calories consumed per week. An average feed efficiency 
was quantified from weekly feed efficiency throughout the course of the experiment in 
female and male mice (Figure 4.3). In female mice, there was a significant overall effect 
of diet on average feed efficiency (p<0.0001; Figure 4.3B). Female NMS-NAID mice had 
a significantly lower feed efficiency compared to female NMS-AID mice (p<0.05). In 
male mice, there was a significant overall effect of diet on average feed efficiency 
(p<0.05; Figure 4.3D). In an overall analysis of female and male feed efficiency, there 
was a significant overall effect of diet (p<0.01), sex (p<0.0001), and a diet/sex 
interaction (p<0.05). 
Male naïve-AID and –NAID mice are insulin resistant compared to male naïve-control 
mice, while male NMS mice nor female mice do not differ in their fasting insulin levels.  
After 18- 19- weeks on the diets, mice were fasted for 6-hours and blood was 
drawn via tail-clip. Serum was collected and an insulin ELISA was performed (Figure 
4.4). In female mice, there were no significant effects of NMS or diet or differences 
between groups for fasting insulin level (Figure 4.4A). In male mice, naïve-AID and -
NAID groups had a significantly higher fasting insulin level compared to naïve-control 
mice (p<0.05; Figure 4.4B). In an overall analysis of female and male fasting insulin 
level there was a significant effect of sex, with males having much higher fasting insulin 
levels than female (p<0.0001). 
Female naïve- and NMS-AID and male naïve- AID and NAID mice are more glucose 
intolerant compared to their control diet counterparts.  
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Figure 4.4: After 18-19- weeks on the AID or NAID diets, mice were fasted for 6- hours, 
blood was collected, and serum insulin level was measured in female and male mice. A) 
In female mice, there was no significant effect of diet or stress on fasting serum insulin 
level. B) In males, naïve-AID and -NAID mice had significantly higher serum fasting 
insulin level compared to male naïve-control mice. There was a significant overall effect 
of sex on fasting insulin level (p<0.0001; 3-way ANOVA). 2-way ANOVA; & p<0.05 vs. 
control diet, Bonferroni posttest.  
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After 18-19 weeks on the diets a glucose tolerance test (GTT) was performed. 
After a 6- hour fast, blood was drawn via tail-clip to determine a baseline fasting glucose 
level. Then an IP injection of 1g/kg body weight glucose was administered and 
subsequent blood draws were taken at 15, 30, and 60, and 120- minutes after injection. 
In female mice, there was a significant effect of time (p<0.0001), diet (p<0.01), a 
time/diet interaction (p<0.05), and a NMS/diet/time interaction (p<0.05) on serum 
glucose levels (Figure 4.5A). Female NMS-AID mice had a significantly higher blood 
glucose level compared to female NMS-control mice 15, 30, and 60- minutes after 
glucose injection (p<0.05). Female NMS-AID mice had a significantly higher blood 
glucose level compared to female NMS-NAID mice (p<0.05) and female naïve-AID mice 
had a significantly higher blood glucose level compared to female naïve-control mice 
(p<0.05) 30- minutes after glucose injection. GTT area under the curve (AUC) was also 
quantified and analyzed. There was a significant effect of diet on female GTT AUC 
(p<0.0001; Figure 4.5B). Female naïve- and NMS-AID mice had a significantly greater 
GTT AUC compared to their control diet counterparts (p<0.05) and female NMS-NAID 
mice had a significantly greater GTT AUC compared to female NMS-control mice 
(p<0.05). In male mice, there was a significant overall effect of time (p<0.0001) and diet 
(p<0.0001) on glucose tolerance over time (Figure 4.5 C). Male naïve-NAID mice had a 
significantly greater blood glucose level compared to male naïve-control mice 30- and 
60- minutes after glucose injection (p<0.05). There was a significant effect of diet on 
male GTT AUC (p<0.0001; Figure 4.5D). Male naïve-AID (p<0.05) and -NAID mice 
(p<0.01) had a significantly greater GTT AUC compared to male naïve-control mice. In 
an overall analysis of female and male GTT there was a significant effect of time  
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Figure 4.5: At 18-19 weeks on the AID or NAID diets, a glucose tolerance test (GTT) 
was performed in female and male mice. After a 6- hour fast, a baseline blood draw was 
taken, followed by an IP injection of 1g/kg body weight glucose and blood draws were 
taken 15, 30, 60, and 120- minutes after injection. Serum was collected and glucose 
level was determined. A) In female mice there was a significant effect of time, diet, a 
time/diet interaction, and a time/NMS/diet interaction. Female NMS-AID mice had a 
significantly greater glucose level compared to female NMS-control mice at 15, 30, and 
60- minutes after glucose injection. Female NMS-AID mice had a significantly greater 
serum glucose level compared to female NMS-NAID mice and female naïve-AID mice 
had a significantly greater serum glucose level compared to female naïve-control mice 
30- minutes after glucose injection. B) There was a significant effect of diet on female 
GTT AUC. Female naïve- and NMS-AID mice had a significantly greater GTT AUC 
compared to female naïve-and NMS-control mice, respectively. Female NMS-NAID 
mice had a significantly greater GTT AUC compared to female NMS-control mice. C) In 
male mice there was a significant effect of time and diet on GTT. At 30- and 60- minutes 
after glucose injection, male naïve-NAID mice had a significantly higher serum glucose 
level compared to male naïve-control mice. D) There was a significant effect of diet on 
male GTT AUC. Male naïve-AID and -NAID mice had a significantly greater GTT AUC 
compared to male naïve-control mice. In an overall analysis of female and male GTT 
there was a significant effect of time (p<0.0001), diet (p<0.0001), sex (p<0.0001), a 
sex/time interaction (p<0.0001), and a diet/time interaction (p<0.0001), 4-way RM 
ANOVA. In an overall analysis of female and male GTT AUC there was a significant 
effect of sex (p<0.0001), and diet (p<0.0001), 3-way ANOVA. Bracket indicates a 
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significant effect of time (ττττ p<0.0001), diet (δδ, δδδδ p<0.01, 0.0001), a time/diet 
interaction (Δ p<0.01), or a time/NMS/diet interaction (Ω p<0.05); A, C: 3-way RM 
ANOVA, B, D: 2-way ANOVA; &, &&, &&&& p<0.05, 0.01, 0.0001 vs. control diet, # 
p<0.05 vs. NAID, Bonferroni posttest. 
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(p<0.0001), diet (p<0.0001), sex (p<0.0001), a sex/time interaction (p<0.0001), and a 
diet/time interaction (p<0.0001). In an overall analysis of female and male GTT AUC 
there was a significant effect of sex (p<0.0001), and diet (p<0.0001). 
AID prevents the development of NMS- or diet-induced perigenital sensitivity in female 
and male mice 
Perigenital mechanical sensitivity was measured every 4- weeks beginning 4- 
weeks after the start of the AID or NAID diets using von Frey monofilaments and the up-
down method.  AUC was analyzed to determine differences in withdrawal thresholds 
over the course of the experiment (Figure 4.6). In females, naïve-AID mice had a 
significantly greater perigenital withdrawal threshold AUC compared to naïve-NAID mice 
(p<0.001) and NMS-AID mice had significantly greater withdrawal threshold AUC 
compared to NMS-control (p<0.05) and NMS-NAID (p<0.0001) mice (Figure 4.6B). In 
male mice on the NAID diet there was an overall effect of stress (p<0.01; Figure 4.6C), 
where naïve-NAID mice had significantly greater withdrawal AUC over time compared 
to NMS-NAID mice (p<0.01; Figure 4.6D). Additionally, male naïve-AID mice had a 
significantly greater perigenital withdrawal threshold AUC compared to male naïve-
control (p<0.01) and naïve-NAID mice (p<0.0001) and male NMS-AID mice had 
significantly greater perigenital withdrawal threshold AUC compared to NMS-control 
(p<0.05) and NMS-NAID (p<0.0001) mice. Finally, male NMS-control mice had a 
significantly greater perigenital withdrawal threshold over time compared to male NMS-







Figure 4.6 Perigenital mechanical withdrawal threshold was measured using von Frey 
monofilaments and the up-down method every 4- weeks beginning 4- weeks after the 
start of the AID or NAID. AUC was analyzed to determine differences in withdrawal 
thresholds over the course of the experiment.  In females, naïve-AID mice had a 
significantly greater perigenital withdrawal threshold AUC compared to female naïve-
NAID mice (B). Additionally, female NMS-AID mice had a significantly greater 
withdrawal threshold AUC compared to female NMS-control and NMS-NAID mice. In 
male mice on the NAID diet there was an overall significant effect of stress on 
perigenital mechanical withdrawal threshold over time (C). Male naïve-NAID mice had a 
significantly greater perigenital withdrawal threshold AUC compared to male NMS-NAID 
mice (D). Additionally, male naïve-AID mice had a significantly greater perigenital 
withdrawal threshold AUC compared to male naïve-control and naïve-NAID mice and 
male NMS-AID mice had significantly greater perigenital withdrawal threshold AUC 
compared to male NMS-control and NMS-NAID mice. Finally, male NMS-control mice 
had a significantly greater perigenital withdrawal threshold AUC compared to male 
NMS-NAID mice. Bracket indicates a significant effect of NMS for male NAID mice (ψψ  
p<0.01), ###, #### p<0.001, 0.0001 vs. NAID &, && p<0.05, 0.01 vs. control diet, ** 
p<0.01 vs. naive. Generalized estimating equation framework and Markov structure.  
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AID prevents the development of NMS- induced hind paw sensitivity in female mice, 
while male mice do not differ in their hind paw sensitivity. 
Hind paw mechanical sensitivity was measured every 4- weeks starting after 5-
weeks on the AID and NAID diets using an electronic von Frey instrument.  AUC was 
analyzed to determine differences in withdrawal thresholds over the course of the 
experiment. In female mice, there was an overall effect of stress on hind paw 
mechanical withdrawal threshold in mice on the control (p<0.001) and NAID diets 
(p<0.0001; Figure 4.7A). Female naïve-control mice had a significantly greater hind paw 
withdrawal threshold AUC compared to female NMS-control mice (p<0.05) and female 
naïve-NAID mice had a significantly greater hind paw withdrawal threshold AUC 
compared to female NMS-NAID mice (p<0.01; Figure 4.7B). There were no significant 
differences in female-AID mice or in male mice (Figure 4.7 C&D).  
Nestlet building behavior is not influenced by sex, NMS, or diet.  
After 16-17- weeks on the AID or NAID diets, nestlet building behavior was assessed. 
There were no significant effects of NMS or diet in female or male mice in nestlet 
building behavior. There were also no significant differences between groups and no 
significant effect of sex (Figure 4.8).  
Significant sex/diet interactions alter serum corticosterone level. 
After 18-19- weeks on the AID or NAID diets mice were sacrificed between 0800-
1100 hours and trunk blood was collected. In female mice, there was a significant effect 






Figure 4.7: Hind paw mechanical withdrawal threshold was measured every 4-weeks 
using an electronic von Frey instrument beginning after 5-weeks on the AID or NAID. 
The AUC was analyzed to determine differences in withdrawal thresholds over the 
course of the experiment. In female mice, there was an overall effect of stress in mice 
on the control and NAID diets (A). Female naïve-control mice had a significantly greater 
hind paw withdrawal threshold AUC compared to female NMS-control mice and female 
naïve-NAID mice had significantly greater hind paw withdrawal threshold AUC 
compared to female NMS-NAID mice (B). There were no significant differences in hind 
paw mechanical withdrawal threshold in male mice (C & D). Bracket indicates a 
significant effect of NMS for female mice on the control diet and NAID (ψψψ p<0.001); 








Figure 4.8 After 16-17- weeks on the AID or NAID diets, nestlet building behavior was 
assessed in female and male mice. There were no significant effects of stress or diet on 
nestlet building behavior in female (A) or male (B) mice; 2-way ANOVA and Bonferroni 








Figure 4.9 After 18-19- weeks on the AID or NAID diets, female and male mice were 
sacrificed and trunk blood was collected. Serum corticosterone level was then 
determined. A) In female mice, there was a significant overall effect of diet on serum 
corticosterone level. Female NMS-AID and -NAID mice had significantly lower serum 
corticosterone compared to female NMS-control mice. B) In males, NMS-NAID mice 
had significantly lower serum corticosterone compared to NMS-control and -AID mice. 
Bracket indicates a significant effect of diet (δ p<0.05); 2-way ANOVA. & p<0.05 vs. 
control diet, # p<0.05 vs. AID; Bonferroni posttest. 
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NAID mice had significantly lower serum corticosterone compared to female naïve-
control (p<0.05) mice. In males, NMS-NAID mice had significantly lower serum 
corticosterone level compared to NMS-control and -AID mice (p<0.05; Figure 4.9B). In 
an overall analysis of female and male serum corticosterone level there was a 
significant overall sex/diet interaction (p<0.01). 
4.5 Discussion 
 Chronic pain (442) and obesity-related metabolic syndrome (385) are two 
conditions that are highly prevalent in the United States. These disorders are often 
experienced co-morbidly and with mood disorders such as depression and anxiety (443-
449). A common underlying factor in many patients with these disorders is a 
dysfunctional HPA axis (3-7), which regulates the stress response, influences the 
perception in pain, and has downstream metabolic effects (15-17). Incorrect 
programming of the HPA axis can occur when an individual experiences stressful 
events early in life because this axis is not fully developed at birth (13). Early life stress 
has been associated with the development of chronic pain, mood, and obesity-related 
metabolic syndrome in adulthood (3-7). Our laboratory has previously demonstrated 
that NMS, a mouse model of early life stress, elicits the development of symptoms 
similar to those experienced by chronic urogenital pain and migraine patients (96-98, 
125) (Chapter 2). We have also demonstrated that older NMS mice weigh more and 
have increased body fat percentage compared to naïve mice on a standard chow diet 
and that NMS mice are more susceptible to some factors related to high-fat/high-
sucrose diet-induced obesity-related metabolic syndrome (Chapter 3). Furthermore, we 
have shown that exercise is able to prevent or attenuate the development of these 
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chronic pain and metabolic symptoms (100, 229) (Chapters 2 & 3). However, because 
many individuals with chronic pain and/or obesity-related metabolic syndrome are not 
able or are unwilling to complete exercise recommendations, this study investigates if a 
dietary intervention might prevent the development of NMS-induced symptoms. 
Many chronic pain, mood, and metabolic disorders are associated with a chronic 
state of low-grade inflammation (255, 256, 268) and an AID or diet supplemented with 
anti-inflammatory substances are beneficial in attenuating or preventing the 
development of obesity-related metabolic syndrome and pain in humans (181, 459, 477, 
479, 481, 482) and rodents (Table 4.2). These diets have also been shown to interact 
with the HPA axis and prevent the development of depression-like behavior in rodents 
(Table 4.2). Therefore, I investigated if AID would influence early life stress-induced co-
morbid widespread pain, obesity related-metabolic syndrome, and depression-like 
behavior. Additionally, because of the sex differences that exist in the incidence of 
chronic pain, metabolic syndrome, and responses to stress (297, 298, 386, 387, 491-
494), both female and male mice were used in this study. I hypothesized that mice 
consuming AID would be protected from developing NMS-induced widespread pain, 
obesity-related metabolic syndrome, and depression-like behavior compared to mice on 
a non-anti-inflammatory diet (NAID) or control diet, which was similar to a standard 
rodent chow diet. My results demonstrate sex differences in stress, metabolic, and pain 
measurements. Additionally, I found complex diet, sex, and stress interactions.  
Weight was measured every week and body fat percentage was measured every 
4- weeks. Male mice weighed more and had greater body fat percentage compared to 
female mice. When each sex was analyzed separately, the groups that were the most 
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susceptible to weight and body fat gain were female and male NMS-AID groups 
(Figures 4.1 and 4.2). This was surprising because the AID and NAID both had 35% 
kcal fat content compared to the control diet’s 10% kcal fat control (Table 4.1). 
Therefore, although weight gain was expected in mice consuming either AID or NAID, it 
was expected to happen at the same rate. The finding that NMS-AID females were 
susceptible to diet-induced weight and body fat gain was particularly intriguing because 
female mice are thought to be resistant to diet-induced development of obesity-related 
metabolic syndrome (303, 414), which was seen in female NMS-NAID mice. Male NMS-
NAID mice were also delayed in their weight gain compared to NMS-AID. Thus, 
something about the added anti-inflammatory components enhanced weight gain in 
NMS mice specifically. Finally, male naïve-AID mice were less susceptible to weight 
gain compared to male naïve-NAID mice as hypothesized. 
Food intake and feed efficiency were also analyzed in this study to see if an 
increase in either of these measures could explain the NMS-AID group’s increased 
susceptibility to gains in weight and body fat percentage. Feed efficiency is a measure 
of an animal’s ability to turn energy consumed into weight and a greater feed efficiency 
is indicative of a greater ability to put on weight from calories consumed. Similar to 
weight and body fat percentage, males generally had greater feed efficiency and ate 
more at the beginning of the study compared to females (Figure 4.3). Female food 
intake did not significantly differ between groups (Figure 4.3A) but there was a 
significant effect of diet on feed efficiency. Female mice consuming AID had greater 
feed efficiency compared to the other groups and NMS-AID feed efficiency was 
significantly greater than NMS-NAID (Figure 4.3B). Increased feed efficiency in the 
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female AID mice partially explains why female NMS-AID gained significantly more 
weight and body fat percentage compared to female NMS-NAID. However, this does 
not explain why female NMS-AID was more susceptible to died-induced weight and 
body fat gain compared to female naïve-AID mice. In males, there was a significant 
overall effect of diet on food intake (Figure 4.3C) and feed efficiency, where both the 
AID and NAID diets had greater feed efficiency compared to mice on the control diet 
(Figure 4.3D). Male NMS- and naïve-AID both ate more at the beginning of the study 
compared to other groups until 7-weeks on the diets. However, the amount that they ate 
was similar throughout the study and NMS-AID mice weighed significantly more than 
NMS-Control after only 5-weeks on the diet but naïve-AID did not start weighing 
significantly more than naïve-Control until 14-weeks on the diets. Similarly, NMS-AID 
had a significantly higher body fat percentage compared to NMS-Control at the 8-week 
measurement but naïve-AID did not reach significance until the 16-week measurement. 
Therefore, an increase in food intake cannot completely account for NMS-AID mice 
being more susceptible to weight and body fat percentage gain compared to naïve-AID 
mice, but it does explain why they were more susceptible compared to NMS-NAID mice. 
Additionally, although it did not reach statistical significance, male NMS-AID had the 
greatest feed efficiency out of all the groups (Figure 4.3D), which could partially explain 
the findings that they were the most susceptible to weight and body fat gain. 
After 18-19- weeks on the diets fasting insulin level was measured and glucose 
tolerance test area under the curve (GTT AUC) was analyzed to assess other 
diagnostic criteria of obesity-related metabolic syndrome. A higher fasting insulin level 
suggests that an animal is more insulin resistant and a greater GTT AUC is indicative of 
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lower glucose tolerance. Male mice had higher fasting insulin level and greater GTT 
AUC compared to female mice (Figures 4.4 & 4.5). There were no significant 
differences between the fasting insulin levels of female groups (Figure 4.4A). However, 
in males, naïve-AID and-NAID had significantly greater fasting insulin level compared to 
male naïve-Control mice. Interestingly, NMS-AID and -NAID mice did not have 
significantly different fasting insulin levels compared to male NMS-Control mice (Figure 
4.4B). There was a significant overall effect of diet on GTT AUC in both female and 
male mice (Figure 4.5B & D). In females, naïve- and NMS-AID and NMS-NAID had a 
significantly greater GTT AUC compared to their control diet counter parts (Figure 
4.5B). In males, similar to their fasting insulin levels, naïve-AID and -NAID had 
significantly greater GTT AUC compared to naïve-Control and but NMS-AID and -NAID 
did not significantly differ from NMS-Control (Figure 4.5D). Insulin resistance and 
glucose intolerance are often seen in patients with obesity-related metabolic syndrome 
(167). Therefore, the finding that female naïve- and NMS-AID mice had greater GTT 
AUC is in line with them having higher body fat percentages compared to control mice 
at the time of these measures. Likewise, male naïve-AID and -NAID mice displayed 
these same trends. However, although male NMS-AID mice weighed more and had 
increased body fat percentage compared to NMS-Control mice, they did not display 
significantly higher fasting insulin level or greater GTT AUC compared to NMS-control 
mice. This suggests that although AID had a detrimental effect on male NMS body 
composition, it was protective towards other factors associated with obesity-related 
metabolic syndrome. These data are interesting because obesity usually leads to the 
development of other symptoms associated with metabolic syndrome (165), including 
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insulin resistance and glucose intolerance. Additional symptoms of metabolic syndrome 
include hypertension, high triglycerides, and low HDL-cholesterol (167). Future studies 
in our laboratory will investigate if AID influenced circulating triglyceride and cholesterol 
levels differently in our groups of mice. It could be that although NMS-AID mice were 
susceptible to changes in body composition, their other metabolic functions were not 
altered. This would be in line with clinical trials demonstrating that individuals with 
obesity-related metabolic syndrome treated with curcumin have decreased circulating 
triglyceride and inflammatory cytokine levels but no changes in body weight or body fat 
(481, 482). 
To investigate potential NMS-induced co-morbid obesity-related metabolic 
syndrome and chronic pain as well as the effect of AID on the development of these 
disorders, perigenital and hind paw mechanical sensitivity was measured every 4- 
weeks throughout the course of the experiment. These two measures were taken 
because our laboratory has previously demonstrated that NMS causes perigenital 
sensitivity (96-98) and hind paw sensitivity represents widespread hypersensitivity, 
similar to what is seen in fibromyalgia patients (452). When the AUC of these pain-like 
responses over time was analyzed, in female mice, AID significantly improved 
perigenital withdrawal thresholds (Figure 4.6A) and prevented NMS-induced 
development of hind paw hypersensitivity (Figure 4.7A). In male mice, AID prevented 
the development of diet and stress induced-perigenital sensitivity (Figure 4.6B) but there 
were no significant differences in hind paw sensitivity between any of the groups (Figure 
4.7B).  
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These data suggest that female mice are more susceptible to widespread 
sensitivity compared to male mice. Male AID and control mice had higher perigenital 
withdrawal thresholds compared to female AID and control mice and female NAID and 
control mice displayed stress-induced hind paw hypersensitivity while male mice did 
not. It is generally accepted that sex differences exist in the incidence of chronic pain 
disorders as well as in laboratory-evoked pain responses. Females are over 
represented in most pain conditions that present in both sexes including fibromyalgia, 
migraine, temporomandibular disorder, irritable bowel syndrome, and interstitial 
cystitis/painful bladder syndrome, while males suffer more frequently from cluster 
headache and post-traumatic stress headache (497). Additionally, females exhibit 
increased sensitivity to evoked painful stimuli compared to males (491, 492). The 
mechanisms behind sex differences in pain are attributed to a complex interaction 
between biological and psychosocial mechanisms. Although psychosocial mechanisms 
cannot be directly measured in rodents, biological mechanisms can. Pre-clinical work 
has revealed that pain processing is a complex circuitry that involves the peripheral and 
central nervous systems and both inhibitory and facilitatory mechanisms. Sex hormones 
are known to influence this pathway at multiple levels through complicated interactions 
(498). Further support for sex hormones playing a role in chronic pain is that certain 
disorders, including migraine and temporomandibular disorder, peak in prevalence 
during the reproductive years (499). While I have not investigated differences in sex 
hormone levels in these mice or what mechanism might be behind the sex differences 
seen in the pain-like behaviors, it is clear that these results are in line with other studies 
that demonstrate sex differences in results from pre-clinical and clinical pain research. 
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Patients with chronic pain and obesity-related metabolic syndrome are often 
diagnosed with depression (448, 449) and the anti-inflammatory components in the AID 
used in this study all interact with the HPA axis and prevent the development of stress-
induced depressive like symptoms in rodents (Table 4.2). Therefore, a nestlet building 
assay (496) was used as a natural, non-evoked method to assess depression-like 
behavior in this study. Wild and laboratory female and male mice build nests when they 
have access to appropriate nest building material (500) and poor nest building is 
thought to be a sign of poor wellbeing (501) or depression-like behavior. Our lab has 
found that mice subjected to chronic foot-shock stress have significantly lower nestlet 
scores compared to those that do not experience food-shock (502). Therefore, I 
hypothesized that NMS mice would also show lower nestlet building scores, suggesting 
greater depression-like behavior compared to naïve mice. Additionally, I hypothesized 
that AID mice would not exhibit stress-induced depression-like behavior. However, there 
were not significant differences in nestlet building behavior in female or male mice 
overall or between the different groups (Figure 4.8). The lack of differences in this 
measure of depression-like behavior could be due to the method that we used. Other 
studies that have evaluated stress induced depression-like behavior and the role of anti-
inflammatory components have used various methods such as the forced swim test 
(465, 487) or the sucrose preference test as a measure of anhedonia (465, 468). 
Therefore, different results might have been observed if a different method to measure 
depression-like behavior had been used. 
 The last measure in this study was serum corticosterone level to investigate if 
there were differences in HPA axis output in these mice. Corticosterone in rodents and 
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cortisol in humans are GCs released by the adrenal glands in a circadian rhythm as well 
as upon activation of the HPA axis (15-17). In naïve laboratory rodents, corticosterone 
peaks in the early evening just before the start of the dark cycle and is lowest at the 
beginning of the light cycle (383). However, the normal circadian rhythm of 
corticosterone can be altered by stress (383) and early life stress in particular disrupts 
the appropriate programming of the HPA axis (13), which could result in changes in GC 
output. Furthermore, sex differences are seen in adult stress responses in rodents that 
have experienced early life stress (493, 494, 503). In line with this, female NMS-Control 
mice had increased serum corticosterone compared to male NMS-Control mice. 
Additionally, an overall analysis revealed a significant sex/diet interaction on serum 
corticosterone level. In female mice, there was an overall significant effect of diet, where 
AID and NAID mice had a lower corticosterone level compared to control mice, which 
reached significance in NMS mice (Figure 4.9A). In male mice, naïve-AID and -NAID 
had greater corticosterone level compared to naïve-control and NMS-AID had higher 
corticosterone level compared to NMS-control, but NMS-NAID had a significantly lower 
corticosterone level compared to NMS-control and NMS-AID (Figure 4.9B).  
Little is published about long-term dietary effects on the HPA axis. However, it is 
known that high-fat diet fed rodents have decreased adipose tissue 11β-hydroxysteroid 
dehydrogenase type 1 (11β-HSD1) (432, 433)(Chapter 3), which converts inactive 
cortisol and corticosterone into their active forms (430). This could subsequently 
decrease the amount of circulating corticosterone. While AID and NAID had only a 
moderately high percent of dietary fat (35%), this could explain why circulating 
corticosterone was decreased in female AID and NAID mice. Conversely, it does not 
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explain why male AID and NAID mice, with the exception of NMS-NAID, had higher 
circulating corticosterone levels. Additionally, the anti-inflammatory ingredients in AID 
have all been shown to interact with the HPA axis and either prevent a stress-induced 
increase in serum corticosterone (465, 471, 474) or decrease in hippocampal BDNF 
(462, 468, 471, 474), which is a limbic structure that usually dampens activation of the 
HPA axis (16, 25). However, in female NMS mice there were not significant differences 
in AID and NAID corticosterone level. It could be that because my stress paradigm was 
early in life and the HPA axis was already altered by the time AID was administered, 
such that it was too late to prevent the stress-induced effects on corticosterone. This 
stress paradigm is different than other studies described that use adult stress 
paradigms (Table 4.2), in which animals should have an appropriately-functioning HPA 
axis. In male NMS mice, AID did prevent the development of the hypocortisolism 
displayed by NMS-NAID males. Studies in humans have shown both hypercortisolism 
(104, 105) and hypocortisolism (9, 106) in adults that report a history of childhood abuse 
or stress. Hypocortisolism is postulated to come about as a compensatory response to 
a preceding period of hypercortisolism and excessive glucocorticoid release (102). 
Excess or deficient glucocorticoids are both detrimental to appropriate functioning of 
pain, metabolic, and immune systems as discussed in Chapter 1. This could explain 
why male NMS-NAID had lower perigenital withdrawal threshold compared to naïve-
NAID and NMS-control and -AID.  
Taken together, these data suggest that an AID has differential therapeutic 
benefits for male vs. female and naïve vs. NMS mice. Interestingly, no group benefited 
in every measure. Male naïve-AID mice were protected from significant weight and 
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body-fat percentage gain as well as the development of perigenital sensitivity over time 
compared to naïve-NAID mice but they were susceptible to developing insulin 
resistance and glucose intolerance compared to naïve-control mice. Male NMS-AID 
mice were susceptible to increased weight and body fat percentage compared to NMS-
NAID mice, but they were protected from developing perigenital sensitivity over time 
compared to NMS-NAID mice as well as insulin resistance and glucose intolerance 
compared to NMS-control mice. Female naïve-AID mice were protected from weight 
and body-fat percentage gain as well as the development of perigenital sensitivity 
compared to naïve-NAID mice, but they were susceptible to glucose intolerance 
compared to naïve-control and –NAID mice. Finally, female NMS-AID mice were 
susceptible to weight and body fat percentage gain compared to NMS-NAID mice and 
were glucose intolerant compared to NMS-control and -NAID, but were protected from 
stress-induced hind paw sensitivity and diet-induced perigenital sensitivity.  
The differences in these measurements demonstrate complex sex, diet, and 
stress interactions that influence pain, metabolic, and stress pathways. It was surprising 
that the AID and NAID had different metabolic effects depending on sex and stress 
condition. Both diets had the same proportions and sources of protein, carbohydrates, 
and fat. The only difference between the two diets was that the NAID did not have the 
anti-inflammatory additives (Table 4.1). Other groups have demonstrated the metabolic 
benefits of adding anti-inflammatory components to a high-fat diet. However, these 
studies only used naïve male mice and had quantities of anti-inflammatory additives that 
were 2-1000 times the amount used in this study (Table 4.2). The present study was 
unique in that it used different stress conditions, both female and male mice, and the 
 214 
amount of anti-inflammatory components were based on quantities that are more 
realistically attainable in the human diet (504). Additionally, other studies use diets with 
beef tallow and lard as their fat source, which are high in omega-6 FAs, while the fat 
source for our laboratory’s AID and NAID is soybean and flaxseed oils, which are high 
in omega-3 FAs. Although omega-3 FAs are beneficial in humans in regards to weight 
loss and metabolic function (179, 180, 486), in mice the addition of omega-3 FAs to a 
high-fat diet actually caused an increase in body weight but decreased macrophage 
infiltration and plasma triglyceride concentration compared to mice fed a high-fat diet 
without added omega-3 FAs (284). I did not measure macrophage infiltration in the 
adipose tissue of my mice to determine their inflammatory status. However, it would be 
interesting to see if this varied in the different sex/stress/diet groups and if so, if these 
variations could help explain my results.  
Studying a diet that has metabolic benefits in humans might not translate 
completely to rodents because humans and rodents have different digestive systems 
and nutrient needs. Although the general anatomy of mouse and human digestive 
systems are similar, there are some differences that allow these two species to extract 
different nutrients from the diet. For example, humans have a greater small to large 
intestine length and surface area ratio compared to mice and mice have a large cecum 
that allows them to ferment plant materials (505). Mice and humans also differ in the 
bacterial species found in their gut microbiome, which is made up of microbial 
organisms with properties that contribute to an animal’s metabolic capacity and help to 
breakdown dietary components that animals otherwise would not be able to (506). One 
study found that 85% of the gut bacteria found in mice are not found in humans (507). 
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These differences in digestive capability could be why humans get a metabolic benefit 
from an anti-inflammatory diet with smaller quantities of anti-inflammatory components 
compared to studies in rodents that generally use much higher quantities of anti-
inflammatory components to see positive metabolic results.  
The stress-induced differences in this study could also have been influenced by 
differences in the microbiomes of stressed and non-stressed mice. The gut microbiota 
communicates with the brain in a bidirectional manner, referred to as the brain-gut axis, 
and plays a role in neural, endocrine, immune, and metabolic pathways (508, 509). 
Sudo et al., (510) demonstrated that the gut microbiome is important in the appropriate 
development of the HPA axis and stress response in adulthood. They showed that 
germ-free mice had higher ACTH and corticosterone levels after restraint-stress in 
adulthood compared to specific-pathogen free mice. Additionally, they found that a 
hyper-responsive HPA axis in germ free mice could be attenuated by gut transplantation 
with specific pathogen free mice early in development but not at a later stage. In a 
different study, Mahoney et al., (511) showed that NMS rats had visceral 
hypersensitivity, increased corticosterone level, increased immune response after 
challenge with lipopolysaccharide, and significantly different gut microbiota compared to 
their non-separated counterparts. The gut microbiome is important to digest food 
appropriately and if this system is altered, such as by early life stress, animals are not 
able to appropriately process the foods that they eat. Sex differences also exist in the 
composition of the gut microbiota. In humans, puberty has been shown to initiate the 
start of sexually dimorphic changes in the gut microbiome that continue to change until 
adulthood (512). In rodents, testosterone appears to be particularly important in the 
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development of gut microbial sex differences. This was demonstrated in a study that 
used castration to reduce testosterone levels, which prevented the development of sex 
differences in gut microbiota of adult mice (512). Finally, obesity in humans and rodents 
has been shown to be associated with an abundance of Firmicutes and deficiency in 
Bacteroidetes species (507, 513). Authors from these studies suggest that guts that are 
colonized with this ratio of bacterial species are better equipped to take energy from the 
diet and turn it into fat. Turnbaugh et al., (514) showed that when germ free mice were 
colonized with microbiota from obese mice they had significantly greater body fat 
compared to germ free mice colonized with microbiota from lean mice. It is plausible 
that NMS and/or sex hormones in the mice in the present study altered the gut 
microbiota in a way that made it possible for different groups to use different nutrients in 
the AID and NAID. It would be interesting to analyze the gut microbiota in these mice to 
see if differences emerge that could explain these results. 
Despite differences in the metabolic benefits of AID, one consistent finding in this 
study was that AID prevented the development of widespread diet or stress-induced 
hypersensitivity in male and female mice. This is an exciting finding because many 
pharmacological agents have been studied for treating widespread pain, which is seen 
in fibromyalgia patients, but none have proved to be universally successful. Shapiro et 
al., (515) demonstrated that a behavioral weight loss program, which consisted of 
education about diet and physical activity, led to weight loss and an improvement in 
fibromyalgia symptoms. The results from the present study suggest that an anti-
inflammatory diet can prevent the development of pain independent of weight or body 
fat percentage, at least in rodents. Totsch et al., (2018) created the AID that was used 
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in this study and found similar results. In their study, they compared the influence of AID 
to a high-fat/high-sucrose “standard American diet (SAD)” and a control diet. Their 
major findings were that male AID mice weighed less and had less fat mass compared 
to male SAD mice but weighed more and had greater fat mass compared to male 
control mice. But, this effect of AID increasing weight and body fat was not seen in 
females. Additionally, both male and female AID mice were more glucose intolerant 
compared to control mice. Finally, AID shortened recovery time after an injection in the 
hind paw of the inflammatory substance Complete Freund’s Adjuvant in both male and 
female mice compared to mice on the SAD but not compared to mice on the control 
diet, as measured by mechanical withdrawal threshold (282). Although there are 
differences in the experimental design of the present study compared to Totsch et al., 
(2018), both studies found that although AID caused metabolic differences, it was 
beneficial for the treatment of pain.  
In conclusion, I found complex sex, diet, and stress interactions that influence 
pain, metabolic, and stress pathways in mice. Although I attempted to study a diet that 
would confer metabolic benefits to humans (AID), it appears that these metabolic 
benefits may not translate appropriately in mice. This could be due to species 
differences in metabolic and dietary needs, or because of different digestion 
capabilities. However, a promising finding in this study was that AID did prevent the 
development of stress and/or diet-induced widespread pain in mice. This suggests that 
an AID could be a good treatment option for humans with early life stress-induced 
chronic pain disorders. Future work in our laboratory will evaluate other symptoms of 
metabolic syndrome in these mice including circulating triglyceride and cholesterol 
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levels. We will also determine the inflammatory status of these mice by assessing 
circulating cytokines and adipose tissue macrophage infiltration. I hypothesize that 










Chapter V: Discussion  
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Although acute stress is crucial for survival, stress can become detrimental when 
experienced in the long-term, especially early in life such as when children are 
subjected to maltreatment, neglect, physical or emotional abuse, or witness parental 
discord. Early life stress is associated with the development of co-morbid chronic pain, 
such as migraine, fibromyalgia, and chronic pelvic pain, mood, and obesity-related 
metabolic syndrome in adulthood (3-7). This has partially been attributed to improper 
function of the hypothalamic-pituitary-adrenal (HPA) axis, which regulates the stress 
response, plays a role in pain perception, and has downstream metabolic effects (9, 10, 
17). Our laboratory has previously used a mouse model of early life stress known as 
neonatal maternal separation (NMS), to study chronic urogenital pain disorders in 
female and male mice (96-98). Additionally, we have used exercise in the form of 
voluntary wheel running as a therapeutic intervention (100, 229). Expanding our 
knowledge of the many consequences of early life stress, as well as investigating non-
pharmacological interventions for early life stress-induced disorders, has been the 
purpose of the studies described in this dissertation. Specifically, I investigated if NMS 
in mice could also be used as a model for susceptibility to evoked migraine (chapter 2) 
and obesity-related metabolic syndrome (chapter 3) and if exercise (chapters 2 and 3) 
or an anti-inflammatory diet (chapter 4) could be used as therapeutic interventions for 
the treatment of these putative stress-induced disorders.  
This research is significant because pre-clinical models investigating early life 
stress induced migraine and obesity-related metabolic syndrome are lacking. Millions of 
Americans currently suffer from migraine (304) and obesity-related metabolic syndrome 
(385) and although not all migraineurs or individuals with obesity-related metabolic 
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syndrome have a history of early life stress, many do and the lack of pre-clinical models 
replicating early life stress-induced disorders leaves gaps in our knowledge. 
Additionally, the rate of childhood maltreatment is rising (12), which suggests that the 
incidence of early life stress-induced disorders will rise as well. Establishing a pre-
clinical model that naturally replicates human disorders is the first step in understanding 
the mechanisms underlying the association between early life stress and the 
subsequent development of co-morbid disorders. My overall goal is to use translational 
models so that I can have a positive impact on human health. 
5.1 NMS in female mice alters susceptibility to evoked migraine 
Migraine is a complex neurological disorder that is difficult to study in rodents. In 
clinical research, one can ask an individual if they are experiencing migraine symptoms, 
whereas in pre-clinical studies, the researcher has to evaluate animal behavior and infer 
if they are suffering from migraine-like symptoms. This task is made more difficult by the 
fact that rodents are prey animals and therefore do not readily show pain-like 
symptoms. However, because of the high clinical incidence of migraine in chronic 
urogenital pain patients (8) and because migraine is associated with early life stress 
(323-325), I was interested in studying if NMS mice were more susceptible to evoked 
migraine compared to naïve mice and if exercise could be use a therapeutic intervention 
for the treatment of migraine-like symptoms (Chapter 2). 
It is generally accepted that the dura mater is an important tissue involved in 
migraine pathophysiology (309). It is populated with mast cells (MC) (300) and 
innervated by the ophthalmic division of the trigeminal nerve (313). When MCs become 
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activated, they release vasoactive, nociceptive, and inflammatory molecules (e.g. 
histamine, bradykinin, serotonin, CGRP, SP) (44) and they can expand their population 
during immune and inflammatory responses by increasing recruitment, survival, and 
maturation of MC precursors in the area (319). Additionally, MCs are increased in 
migraineurs (39) and histamine levels, a major component of MC granules released 
upon activation, are higher in the serum of migraineurs during migraine attacks (153). 
Evaluation of MC characteristics in the dura mater in female and male NMS- and naïve-
Sedentary (Sed) and -Exercised (Ex) mice revealed that female NMS-Sed mice had 
significantly greater dural MC degranulation compared to female naïve-Sed and this 
effect was attenuated by exercise. Additionally, male NMS-Sed mice had significantly 
more dural MC compared to male naïve-Sed and this effect was also attenuated by 
exercise. These data suggested that because NMS mice had altered dural MC 
characteristics, they might be more susceptible to evoked migraine-like behaviors. The 
subsequent evoked-migraine studies were continued in female mice because migraine 
affects three times more females then males (305, 306). 
A commonly used method to evoke migraine involves a surgically implanted 
cannula to administer noxious solutions onto the dura mater (329-331). While this 
method is successful in evoking migraine-like symptoms, it is time consuming and might 
alter some of the natural behaviors exhibited by rodents. In Chapter 2 of this 
dissertation, I used a novel non-surgical method (339) to administer an inflammatory 
soup (IS) to the dura mater and subsequently evaluated mouse grimace score (MGS) 
and widespread allodynia, or increased sensitivity to normally non-painful stimuli. MGS 
is a tool used to indicate if an animal is experiencing ‘pain’ (353) and widespread 
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allodynia is a symptom commonly experienced during a migraine attack in humans 
(307). Results indicated that compared to groups that had saline applied to their dura 
mater, groups that had IS applied had significantly lower forepaw mechanical 
withdrawal thresholds, suggesting they had wide spread hypersensitivity. This implied 
that the dural application method was working, however there were not differences 
between naïve- and NMS-Sed and -Ex groups. I also tried a ‘two-hit’ experiment where 
we applied saline or IS to the dura and then 3- days later applied IS to all mice. I chose 
to explore this method because it has been shown that one migraine-like event can lead 
to meningeal sensitization, or priming, to subsequent events (378). However, this study 
did not demonstrate consistent results.  
Next, an intraperitoneal (IP) nitroglycerin (NTG) injection was used to attempt to 
evoke migraine-like behaviors, including MGS and hind paw mechanical withdrawal 
threshold. NTG injection is another method commonly used to evoke migraine-like 
symptoms in rodents (340, 345, 346) and also evokes migraines in human migraineurs 
(344). Compared to groups that received an IP saline injection, all of the groups that 
received an IP NTG injection had significantly increased MGS and hind paw sensitivity 
was decreased in NMS-Sed-NTG mice compared to the other NTG groups. Finally, 
photophobia, or sensitivity to light, was tested, which is one symptom that meets the 
diagnostic criteria of migraine according to the International Classification of Headache 
Disorders (381). Following IP NTG injection, NMS-Sed mice significantly decreased 
their time spent in the light compared to baseline while the other groups did not. This 
suggests that NMS-Sed mice were more photophobic following NTG injection compared 
to the other groups.  
 224 
While these results demonstrate that female NMS-Sed mice might be more 
susceptible to NTG evoked migraine, there are still questions regarding the mechanism 
behind this. Female NMS-Sed have increased dural MC degranulation, therefore I 
believe that this plays a role in their susceptibility to NTG evoked migraine. However, I 
have not evaluated activation in other tissues that are important in migraine 
pathophysiology, including the trigeminal ganglia (TG) and trigeminal nucleus caudalis 
(TGN) (310, 311). Markovics et al., (345) measured c-Fos expressing cells in the TG 
and TGN following IP NTG injection and demonstrated significant neuronal activation in 
both tissues. Furthermore, Ramachandran et al., (516) demonstrated a significant 
increase in the expression of phosphorylated extracellular signal-related kinases 
(pERK) in the dura mater, TGN, and TG after NTG infusion. Based on my behavioral 
results, I hypothesize that NMS-Sed mice will display greater NTG induced activation in 
the TG and TGN compared to naïve and Ex mice. Future studies will test this 
hypothesis. 
A surprising finding from this migraine work was that exercise consistently 
increased MGS in naïve and NMS mice following dural application of saline or IS as well 
as in mice that did not receive an application of any solutions. It is unclear why I saw 
this effect of exercise. MGS is a spontaneous pain-like behavior and simply evaluating 
MGS suggests that Ex mice are experiencing more pain than Sed mice. However, Ex 
mice did not display greater evoked pain behavior in the measurements of paw 
withdrawal threshold or increased photophobic behavior. It could be that Ex mice are 
more prone to sleeping, due to excess energy expenditure, throughout their dark cycle 
and their eyes appear more closed during the testing period. Only 2 of the facial 
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behaviors of the original 5 that make up the MGS were used, orbital tightening and ear 
position. The other 3 facial behaviors are check bulge, nose bulge, and whisker position 
(353). However, the MGS was created in white CD-1 mice and these behaviors proved 
to be very difficult to evaluate in a black mouse. It is possible that if all 5 of the facial 
behaviors were included in the assessment of MGS, there could have been different 
conclusions. However, an automated ‘eye squint’ assay has also been developed that 
highly correlates with MGS (380), suggesting that eye squint alone is predictive of what 
all 5 MGS behaviors will reveal. Another factor that could have influenced the MGS data 
is the isoflurane anesthesia that administered prior to MGS testing, even in those mice 
that did not have any solution applied to their dura. Miller et al., (517) measured MGS in 
DBA/2 mice before and 30- minutes after isoflurane anesthesia and found a significant 
increase in MGS following anesthesia. Although MGS was measured 1- hour after 
isoflurane administration in my studies, it is possible that Ex mice were not able to 
recover as quickly from the isoflurane and therefore exhibited a higher MGS. To my 
knowledge, this study is the first to use MGS in Ex mice and my findings bring into 
question the accuracy of the MGS if it is used in conditions other than in the naïve 
sedentary CD-1 mice that it was constructed from. In support of this, Miller and Leach  
(518) found sex and strain differences in baseline MGS measurements of C57BL/6, 
C3H/He, CD-1, and BALB/c mice. This differs from the original report of MGS, which did 
not find statistically significant sex differences in their mice (353). 
Taken together, the data in this study indicate that both the method used to 
evoke migraine and the subsequent behaviors that are evaluated are critical when 
designing a migraine study in mice. These results demonstrate that female NMS-Sed 
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mice have greater dural MC degranulation and are more susceptible to NTG-evoked 
hind paw sensitivity and photophobia compared to NMS-Ex or naïve mice. Despite the 
strong association between early life stress and the development of migraine in 
adulthood (323-325), I could not find any other studies in the literature that evaluate 
early life stress as a factor in the development of evoked migraine-like behaviors in 
rodents. Further, although exercise improves migraine frequency and intensity, as well 
as stress level in human migraineurs (364, 365), it appears that these studies are the 
first to investigate exercise in rodents as a therapeutic intervention for evoked migraine-
like behaviors.  This work is important because many pharmacological treatments are 
not universally successful and have unwanted off-target side effects. Voluntary exercise 
provides a much safer intervention, if carried out appropriately. By establishing NMS as 
a model to study early life stress-induced susceptibility to evoked-migraine like 
behaviors, as well as exercise as a therapeutic intervention for these behaviors, future 
work can now focus on the mechanisms behind these findings and work to translate 
them to human migraineurs that experienced early life stress.  
5.2 Lifestyle factors alter metabolic function in male mice 
 Early life stress in humans not only increases an individual’s susceptibility to 
developing chronic pain disorders, it also increases the susceptibility to developing 
obesity (160-162), which is generally considered a pre-requisite for the development of 
obesity-related metabolic syndrome. This syndrome is diagnosed when an individual 
suffers from 3 of the following 5 criteria: central obesity, insulin resistance, hypertension, 
high triglycerides, and low HDL-cholesterol (167).  Additionally, obesity-related 
metabolic syndrome and chronic pain are often experienced co-morbidly (447, 453). 
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Therefore, Chapter 3 of this dissertation expands our studies from early life stress-
induced chronic pain to early life stress-induced obesity-related metabolic syndrome. I 
first used our laboratory’s mouse model of early life stress, NMS, to study the body 
composition of naïve- and NMS-Sed and -Ex mice. I found that on a standard chow diet, 
adult female and male NMS-Sed mice had altered body composition compared to adult 
female and male naïve-Sed or -Ex mice (Tables 3.3 & 3.4). 
 A sedentary lifestyle (400-402) and a diet with a high proportion of saturated fat 
and refined sugars (HFS), referred to as a “Western diet” (286, 287), are both significant 
environmental risk factors associated with the development of obesity and related 
chronic diseases. Unfortunately, HFS diet consumption has grown due to its 
convenience and lower cost compared to healthier foods such as fruits and vegetables 
(288). Sedentary behavior is also highly prevalent in the United States, where most 
individuals do not meet the recommended requirements for daily physical activity (403). 
With this information in mind, I was interested in studying if lifestyle factors, including 
diet and exercise, influence NMS and naïve mice differently in the development of 
obesity-related metabolic syndrome. Therefore, naïve-and NMS- Sed and -Ex male 
mice were exposed to a HFS or control diet. This resulted in 8 groups of male mice: 
naïve-Sed-Control, naïve-Sed-HFS, naïve-Ex-Control, naïve-Ex-HFS, NMS-Sed-
Control, NMS-Sed-HFS, NMS-Ex-Control, and NMS-Ex-HFS. Male mice were used for 
this study because other groups have demonstrated that female mice are resistant to 
diet-induced obesity-related metabolic syndrome (303, 414).  
I found that although all HFS groups developed characteristics similar to 
symptoms of metabolic syndrome including increased weight, body fat percentage, and 
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fat mass (Figure 3.2), as well as insulin resistance and glucose intolerance (Figure 3.5) 
compared to control diet groups, exercise was fairly protective in some of these 
measures, especially in naïve-Ex-HFS mice. These results suggest that naïve mice gain 
greater benefit from exercise than NMS mice. However, this could be due to the fact 
that naïve mice run significantly more than NMS mice before and after the introduction 
of a HFS diet (Figure 3.4). Early life stress in humans leads to altered dopaminergic 
signaling (440), which influences motivated behaviors (441). Voluntary wheel running in 
rodents is considered rewarding, as most rodents will choose to run when provided a 
running wheel (231). Therefore, future studies in our laboratory investigate if NMS alters 
reward pathways, such as the mesocorticolimbic dopamine system, that could 
potentially explain why NMS mice run significantly less than naïve mice.  
White adipose tissue distribution and composition is important in predicting the 
development of obesity-related diseases because it plays a key role in regulating 
systemic metabolic function and inflammation (168). Visceral fat accumulation is 
associated with a greater risk of metabolic dysfunction (169) and leads to chronic low-
grade inflammation (170). Therefore, macrophage, MC tryptase, and pro-inflammatory 
cytokine mRNA were measured in epididymal adipose tissue to assess the 
inflammatory status of visceral adipose in the mice. I found that the adipose tissue of 
HFS mice, especially that of NMS-Sed-HFS mice, had significantly greater pro-
inflammatory macrophage mRNA levels and significantly increased mRNA levels of the 
pro-inflammatory cytokine TNFα. Naïve-Ex-HFS mice were more protected from these 
pro-inflammatory changes than NMS-Ex-HFS mice, similar to this group being more 
protected from the other metabolic changes. NMS-Sed-HFS mice also had significantly 
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more MC tryptase compared to the other groups. MCs are filled with granules that 
contain tryptase, histamine, heparin, as well as other proteases and cytokines (44). 
Upon activation they release these factors and cause an inflammatory response (45, 
46). Their role in the development of obesity-related metabolic syndrome is 
controversial. Obese individuals with metabolic syndrome have increased MCs in 
subcutaneous adipose tissue compared to control subjects (173) and a certain MC 
deficient mouse model is protected from the development of diet-induced obesity (175), 
while another model is not (425).  However, it is clear that regardless of whether they 
contribute directly to the development of obesity-related metabolic syndrome, they do 
contribute to the pro-inflammatory environment associated with visceral obesity. In 
previous studies, our laboratory has found that female and male NMS-Sed mice have 
increased MCs and MC degranulation in urogenital organs (96-98) and dura mater 
(Chapter 2) and that exercise attenuates this effect (100, 229) (Chapter 2). Therefore, it 
appears that NMS-Sed mice have widespread increases in MCs and MC degranulation, 
which could be one factor linking the development of co-morbid chronic pain and 
obesity-related metabolic syndrome. 
Glucocorticoid receptor (GR) and 11 β-hydroxysteroid dehydrogenase type 1 (11-
βHSD1) mRNA levels were also measured in epididymal adipose. Glucocorticoids 
(GCs) are the final output of the HPA axis (15-17) and they bind to GRs (68), which are 
found throughout the body (67). In adipose tissue, GCs promote the differentiation of 
pre-adipocytes to mature adipocytes (429) and 11-βHSD1 converts inactive GCs to their 
active form (430). Obese humans (85, 86) and genetic (87, 431) rodent models of 
obesity have increased levels of adipose tissue GR and 11-βHSD1. However, other 
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groups have found that a HFS diet actually causes a decrease in adipose tissue GR 
and 11-βHSD1 (432, 433). In line with these results, in this study a HFS diet resulted in 
an overall decrease in GR and 11-βHSD1 mRNA levels in epididymal adipose tissue 
(Figure 3.6). I posit this may represent a compensatory mechanism to attenuate the 
detrimental metabolic consequences of increased GC signaling.  
Finally, leptin mRNA in epididymal adipose tissue was measured because it is an 
important adipokine that communicates with its receptor in the hypothalamus to regulate 
food intake and energy expenditure by shutting down hunger signals (435). I 
hypothesized that HFS mice would have increased leptin levels, which should down 
regulate hunger signals to compensate for the extra energy that is being consumed. I 
indeed found that naïve-Sed- and -Ex-HFS mice had significantly higher leptin levels 
compared to naïve-Sed- and Ex-Control mice. However, NMS-Ex- and Sed-HFS mice 
did not, suggesting an alteration in the leptin-hypothalamic feeding circuit. This circuitry 
is not fully programmed at birth (429), which makes it susceptible to the influence of 
environmental factors that cause long-term changes in hunger signals and energy 
expenditure.  Therefore, it is likely that early life stress not only alters the HPA axis, but 
other hypothalamic-driven axes involved in metabolism, as well, and together these 
alterations could potentially underlie the association between early life stress and the 
subsequent development of obesity-related metabolic syndrome in adulthood. 
An interesting finding in this study is that male NMS-Sed-Control mice were more 
glucose intolerant than naïve-Sed-Control mice (Figure 3.5) and had a greater amount 
of pro-inflammatory macrophage, TNFα, and leptin mRNA in their epididymal adipose 
tissue (Figure 3.6). Mice on a control diet are not expected to have altered leptin 
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signaling. Therefore, an increased leptin level in this dietary condition suggests that 
NMS-Sed-Control mice are leptin resistant. Together, these data imply that at a basal 
level, without any sort of lifestyle change (e.g. exercise or diet), male NMS mice have 
altered metabolic functioning compared to male naïve mice. This supports human data 
indicating that early life stress in humans is associated with the development of obesity-
related metabolic syndrome (160-162). 
In conclusion, these data demonstrate that NMS in mice models early life stress-
induced alterations in metabolic function and that exercise is a beneficial therapeutic 
option for treating some symptoms of stress- and diet-induced obesity-related metabolic 
syndrome. To my knowledge, this is the first study to combine early life stress, exercise, 
and HFS diet to investigate the complex environmental interactions that contribute to 
the development of obesity-related metabolic syndrome. My goal was to replicate 
common environmental factors that are associated with an increased incidence of this 
syndrome in humans. In this way, my results are more translatable than other studies 
that do not take all lifestyle factors into consideration. Now that we have a mouse model 
to study early life stress-induced obesity-related metabolic syndrome, future work can 
focus on investigating the specific mechanism(s) underlying this association. It is clear 
that many pathways are altered by NMS, including the HPA axis, reward pathways, and 
the leptin-hypothalamic feeding circuit. Our laboratory plans to study how these 
pathways interact and lead to the development of such a debilitating syndrome. Finally, 
future work in our laboratory will evaluate the effect, if any, of a HFS diet in female 
NMS- and naïve- Sed- and Ex- mice to determine if there are sex differences in the 
development of early life stress- and HFS- induced obesity-related metabolic syndrome. 
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5.3 Stress and sex differences in response to an anti-inflammatory diet  
Many chronic pain, mood, and metabolic disorders are associated with a chronic 
state of low-grade inflammation (255, 256, 268). Therefore, a diet high in anti-
inflammatory components is recommended as a good dietary intervention for these 
patients (269). An anti-inflammatory diet (AID), which is similar to the Mediterranean 
diet, is high in fruits, vegetables, lean protein or plant based protein, whole grains, high 
fiber, and healthy fats such as omega-3 fatty acids (FAs) (270). AID improves many of 
the symptoms of metabolic syndrome and reduces certain forms of chronic pain in 
humans. For example, patients with metabolic syndrome that consumed a 
Mediterranean diet for 2-years showed decreased weight, gained cardiovascular 
benefits, and increased insulin sensitivity compared to the non-intervention group (279). 
This form of diet has also been shown to reduce the development of diabetes by around 
20% (210). Although somewhat different than AID, a vegetarian diet with increased 
antioxidant and anti-inflammatory properties has positive results on pain and quality of 
life in rheumatic and fibromyalgia patients (519, 520). Furthermore, Kuptniratsaikul et 
al., (181) compared the treatment of knee osteoarthritis patients with curcumin, the main 
active ingredient in turmeric that has anti-inflammatory properties, versus treatment with 
ibuprofen and found that both treatments were effective in reducing knee pain but 
individuals taking curcumin reported fewer gastrointestinal problems. 
Studies in rodents have also investigated the influence of anti-inflammatory 
components for the treatment of high-fat diet-induced obesity-related metabolic 
syndrome (460, 463, 466, 469, 472), chronic pain (461, 464, 467, 473), and stress-
induced depression-like behavior (462, 465, 468, 471, 474) (Summarized in Table 4.2). 
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However, these studies focus on the therapeutic effect of one anti-inflammatory 
component in quantities that are not likely attainable in the human diet. In my study, I 
used an AID that was composed of 20% protein, 45% carbohydrates, with 0% coming 
from sucrose, and 35% fat from flaxseed and soybean oils, which are high in omega-3 
FAs and considered healthy fats. This diet also had added anti-inflammatory ingredients 
in quantities attainable in the human diet (504) including epigallocatechin gallate 
(EGCG), sulforaphane, resveratrol, curcumin, and ginseng (Table 4.1). In female and 
male NMS and naïve mice, perigenital and hind paw sensitivity were measured to 
evaluate chronic widespread pain, body weight, body fat percentage, fasting insulin 
level, and glucose tolerance to evaluate obesity-related metabolic syndrome, nestlet 
building to evaluate depression-like behavior, and serum corticosterone level to 
evaluate differences in HPA axis output. I compared these measures in mice on the AID 
to mice on a non-inflammatory diet (NAID) and a control diet. NAID had the same 
composition as AID but without the added anti-inflammatory components and the 
control diet was similar to a standard laboratory rodent chow diet and was composed of 
20% protein, 70% carbohydrates, and 10% fat (Table 4.1). 
Complex sex, diet, and stress interactions that influenced metabolic, pain, and 
stress outcomes were revealed. These data indicate that AID had differential 
therapeutic benefits for male vs. female and naïve vs. NMS mice and that no group 
benefited in every measure. AID and NAID both have a higher fat content compared to 
the control diet (35% vs. 10%). Therefore, increased weight gain on these two diets was 
expected but I hypothesized that weight gain from the two diets would happen at the 
same rate or NAID mice would be more susceptible to weight gain compared to AID. 
 234 
While this was true in naïve male mice, the opposite effect in NMS female and male 
mice was seen. These groups were actually more susceptible to weight and body fat 
gain on the AID (Figures 4.1 & 4.2). In males, this could be partially attributed to them 
eating more at the beginning of the study (Figure 4.3) compared to the other groups, but 
I do not believe this was the sole cause of their weight gain due do the fact that male 
naïve-AID mice also ate more at the beginning of the study but they did not weigh 
significantly more or have a higher body fat percentage than naïve-control mice until at 
the very end of the study. Additionally, female NMS-AID mice did not eat significantly 
more compared to the other groups (Figure 4.3), but they still gained significantly more 
weight and body fat.  
Another unexpected finding was that female naïve- and NMS-AID mice were 
more glucose intolerant compared to female naïve- and NMS-control mice (Figure 
4.5B). This result was surprising as neither AID nor NAID had added sucrose, so mice 
on either of these diets were not accustomed to processing this form of carbohydrate. 
However, female mice on the AID diet were more glucose intolerant than female mice 
on the NAID diet, whose glucose tolerance did not significantly differ from mice on the 
control diet. This suggests that there is another factor causing the female AID mice to 
become more glucose intolerant. Interestingly, despite the fact that male NMS-AID mice 
were more susceptible to weight and body fat gain, they had similar fasting insulin level 
and glucose tolerance compared to NMS-Control mice but male naïve-AID and –NAID 
had higher fasting insulin level and were more glucose intolerant compared to naïve-
control (Figures 4.4B and 4.5D). In humans, obesity is usually a pre-requisite for the 
development of the other symptoms of metabolic syndrome (165), including insulin 
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resistance and glucose intolerance. However, this might not be the case in male NMS-
AID mice. Data suggests that while AID has negative consequences in regard to body 
composition in NMS mice, it was protective in the development of other metabolic 
syndrome symptoms in male NMS mice. This is similar to a subset of humans that are 
classified as ‘metabolically normal, healthy obese’ (OBMN), who seem to be protected 
from obesity-related metabolic syndrome despite being overweight or obese. Unlike 
other obese individuals with metabolic syndrome, OBMN individuals usually become 
obese during childhood but do not develop insulin resistance, high triglycerides, and low 
HDL- cholesterol (521). Karelis et al., (522) studied this phenomenon in a group of 
obese postmenopausal women and reported that OBMN women had a better 
inflammatory profile compared to women with obesity-related metabolic syndrome. 
Specifically, they had 92.7% less C-reactive protein levels. The authors suggest that 
this could be one reason OBMN are protected from developing the other symptoms of 
metabolic syndrome. 
I have so far analyzed only a few of the known factors that constitute obesity-
related metabolic syndrome in my mice, including body fat percentage, fasting insulin 
level, and glucose tolerance. Future work in our laboratory will evaluate if sex, NMS, 
and/or diet influenced other symptoms of this syndrome including circulating triglyceride 
and cholesterol levels. These data will help us determine if these mice actually suffer 
from obesity-related metabolic syndrome, or only a subset of the characteristics. Future 
work in our laboratory will also evaluate the inflammatory status of the visceral adipose 
tissue in these mice. White adipose tissue distribution and composition is important in 
predicting the development of obesity-related diseases because it plays a key role in 
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regulating systemic metabolic function and inflammation (168). Visceral fat 
accumulation is associated with a greater risk of metabolic dysfunction (169) and leads 
to chronic low-grade inflammation (170). In Chapter 3 of this dissertation, I found that 
male NMS-Sedentary mice on a control or high-fat/high-sucrose (HFS) diet were 
particularly susceptible to pro-inflammatory changes in their visceral adipose tissue 
compare to NMS-Ex and naïve mice (Figure 3.6). It will be interesting to see if AID 
prevented stress- and diet-induced adipose tissue changes in these mice and if this can 
help explain my complex results.  
To study the development of co-morbid obesity-related metabolic syndrome and 
chronic pain, hind paw and perigenital sensitivity were measured over time. I 
hypothesized that mice consuming NAID would gain weight and subsequently develop 
widespread sensitivity, similar to observations in patients with fibromyalgia that are often 
also diagnosed with obesity-related metabolic syndrome (453-455). I also postulated 
that NMS mice would be particularly susceptible to the development of widespread pain 
on both the control and NAID diets, because our laboratory has previously 
demonstrated NMS-induced perigenital sensitivity (96-98), and that AID would prevent 
diet- and stress-induced development of wide spread hypersensitivity. Remarkably, 
despite the sex/stress/diet differences in my metabolic measures, I found that AID was 
consistently beneficial in preventing the development of diet- and/or stress-induced 
perigenital sensitivity in female and male mice and hind paw sensitivity in female mice. 
This is an exciting finding because many pharmacological agents have been studied for 
the treatment of widespread pain but none have proved to be universally successful. 
Although clinical studies reveal that fibromyalgia symptoms can be improved with 
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weight loss (515), this study suggests that AID can prevent the development of stress- 
and diet-induced pain independent of weight or body fat percentage, at least in rodents.  
The inflammatory response influences both peripheral and central nervous 
systems and a long-term increase in inflammation can lead to the development of acute 
and chronic pain (256). As explained in section 5.1, MCs are involved in the 
inflammatory response and when they become activated such as by endogenous 
neuropeptides, they release vasoactive, nociceptive, and inflammatory molecules (44). 
MCs are increased in a number of chronic pain disorders including irritable bowel 
syndrome (37), interstitial cystitis/painful bladder syndrome (38), migraine (39), and 
fibromyalgia (40). They reside close to sensory nerve endings (47-49), including small 
unmyelinated (C-fiber) or thinly myelinated (Aδ-fiber) peptidergic neurons that 
predominately make up peripheral sensory innervation. These fibers express receptors 
involved in nociception, including transient receptor potential vanilloid 1 (TRPV1), 
transient receptor potential ankyrin 1 (TRPA1), and protease-activated receptor 2 
(PAR2) that respond to noxious thermal, chemical, and mechanical stimuli (51-53) and 
are co-expressed (58-60). Tryptase is one peptide released upon MC activation. This 
peptide is known to activate the PAR2 receptor, which subsequently sensitizes TRPV1 
and TRPA1 receptors (55-57). When these nociceptors become activated, they can 
generate an action potential that signals pain in the central nervous system. They also 
perform an efferent function by releasing inflammatory molecules including substance P 
(SP) and calcitonin gene related peptide (CGRP) in the peripheral tissue (63-66). SP 
and CGRP activate MCs, so this process can cause a loop of activation that can 
eventually lead to chronic pain. Although I did not evaluate MCs in this study, previous 
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work in our lab demonstrates that NMS mice have increased MC and/or increased MC 
activation in urogenital organs compared to naïve mice (96-98). I also found that NMS-
Sedentary-HFS diet mice have increased tryptase in their adipose tissue (Figure 3.6). 
Future work in our laboratory will evaluate MC characteristics in the urogenital organs 
and adipose tissue to establish if AID prevented NMS- and/or high-fat diet-induced 
increases in MCs and MC activation. If AID is able to prevent the inflammatory loop that 
can lead to the development of chronic pain this could explain why there was reduced 
hypersensitivity in mice consuming AID. 
In conclusion, in this study I found complex sex, diet, and stress interactions that 
influence pain, metabolic, and stress pathways in mice. Although I attempted to study a 
diet that would confer metabolic benefits to humans (AID), it appears that these 
metabolic benefits may not translate appropriately in mice. This could be due to species 
differences in metabolic and dietary needs, or because of different digestion 
capabilities. Despite this finding, these results are intriguing and lead to new questions 
in our laboratory regarding why stressed mice respond differently to diet interventions 
compared to non-stressed mice. A promising finding in this study was that AID 
prevented the development of stress- and/or diet-induced widespread pain, regardless 
of the metabolic state of the mice. This suggests that AID could be a good treatment 
option for humans with early life stress-induced chronic pain disorders. Future work in 
our laboratory will evaluate other symptoms of metabolic syndrome, including circulating 
triglyceride and cholesterol levels. We will also determine the inflammatory status of 
these mice by assessing circulating cytokines, adipose tissue macrophage infiltration, 
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and MC characteristics in urogenital and adipose tissues. I hypothesize that these data 
will help explain some of the differences in these groups of mice.  
5.4 Overall conclusions 
 The rate of childhood maltreatment is very high (12, 323) and many studies have 
demonstrated an association between adverse childhood events and the development 
of co-morbid chronic pain, mood, and obesity-related metabolic syndrome in adulthood 
(3-7). Therefore, establishing pre-clinical models to study the many consequences of 
early life stress is extremely important. This work will help us determine the 
mechanisms that underlie this association and aid in the development of appropriate 
therapeutic interventions for these early life stress-induced disorders. This dissertation 
used a mouse model of early life stress, NMS, to expand our studies and provide 
evidence that this model is also more susceptible to evoked migraine-like behaviors, 
obesity-related metabolic syndrome, and diet-induced metabolic changes. I also show 
that exercise is a therapeutic intervention that can prevent the development of early life 
stress-induced susceptibility to evoked-migraine or certain symptoms associated with 
obesity-related metabolic syndrome. Additionally, although the presumed metabolic 
benefits of an AID do not translate completely to rodents, I obtained preliminary 
evidence that AID may be a good therapeutic intervention for the prevention of early life 
stress- or high-fat diet-induced widespread hypersensitivity.  While it is well accepted 
that early life stress alters the HPA axis and this has consequences in stress, pain, and 
metabolic systems, there are other mechanisms underlying the development of these 
disorders that are not as well established. My data suggest that NMS also alters reward, 
metabolic, and/or digestive pathways and that sex differences exist in many of these 
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pathways. Studying the interactions of the pathways that are altered by NMS is key if 
we want to understand how we can prevent the development of or treat early life stress 
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